BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Naugler WE, Sakurai T, Kim S, Maeda S, Kim K, Elsharkawy AM, Karin M. Gender disparity in liver cancer due to sex differences in MyD88-dependent IL-6 production. Science. 2007;317:121-124. [PMID: 17615358 DOI: 10.1126/science.1140485] [Cited by in Crossref: 1224] [Cited by in F6Publishing: 1124] [Article Influence: 87.4] [Reference Citation Analysis]
Number Citing Articles
1 Ma L, Chua MS, Andrisani O, So S. Epigenetics in hepatocellular carcinoma: an update and future therapy perspectives. World J Gastroenterol 2014;20:333-45. [PMID: 24574704 DOI: 10.3748/wjg.v20.i2.333] [Cited by in CrossRef: 61] [Cited by in F6Publishing: 57] [Article Influence: 8.7] [Reference Citation Analysis]
2 Chen X, Wang Y, Tao J, Shi Y, Gai X, Huang F, Ma Q, Zhou Z, Chen H, Zhang H, Liu Z, Sun Q, Peng H, Chen R, Jing Y, Yang H, Mao Y, Zhang H. mTORC1 Up-Regulates GP73 to Promote Proliferation and Migration of Hepatocellular Carcinoma Cells and Growth of Xenograft Tumors in Mice. Gastroenterology. 2015;149:741-52. e14. [PMID: 25980751 DOI: 10.1053/j.gastro.2015.05.005] [Cited by in Crossref: 33] [Cited by in F6Publishing: 35] [Article Influence: 5.5] [Reference Citation Analysis]
3 Braun R, Buetow K. Pathways of distinction analysis: a new technique for multi-SNP analysis of GWAS data. PLoS Genet 2011;7:e1002101. [PMID: 21695280 DOI: 10.1371/journal.pgen.1002101] [Cited by in Crossref: 49] [Cited by in F6Publishing: 38] [Article Influence: 4.9] [Reference Citation Analysis]
4 Zhou M, Yang H, Learned RM, Tian H, Ling L. Non-cell-autonomous activation of IL-6/STAT3 signaling mediates FGF19-driven hepatocarcinogenesis. Nat Commun 2017;8:15433. [PMID: 28508871 DOI: 10.1038/ncomms15433] [Cited by in Crossref: 69] [Cited by in F6Publishing: 65] [Article Influence: 17.3] [Reference Citation Analysis]
5 Ohno T, Shimizu M, Shirakami Y, Miyazaki T, Ideta T, Kochi T, Kubota M, Sakai H, Tanaka T, Moriwaki H. Preventive effects of astaxanthin on diethylnitrosamine-induced liver tumorigenesis in C57/BL/KsJ-db/db obese mice. Hepatol Res 2016;46:E201-9. [PMID: 26147624 DOI: 10.1111/hepr.12550] [Cited by in Crossref: 12] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
6 Klein SL. Sex influences immune responses to viruses, and efficacy of prophylaxis and treatments for viral diseases. Bioessays. 2012;34:1050-1059. [PMID: 23012250 DOI: 10.1002/bies.201200099] [Cited by in Crossref: 141] [Cited by in F6Publishing: 119] [Article Influence: 15.7] [Reference Citation Analysis]
7 Li S, Saviano A, Erstad DJ, Hoshida Y, Fuchs BC, Baumert T, Tanabe KK. Risk Factors, Pathogenesis, and Strategies for Hepatocellular Carcinoma Prevention: Emphasis on Secondary Prevention and Its Translational Challenges. J Clin Med 2020;9:E3817. [PMID: 33255794 DOI: 10.3390/jcm9123817] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
8 Trucco LD, Roselli E, Araya P, Nuñez NG, Mena HA, Bocco JL, Negrotto S, Maccioni M. Downregulation of adaptor protein MyD88 compromises the angiogenic potential of B16 murine melanoma. PLoS One 2017;12:e0179897. [PMID: 28662055 DOI: 10.1371/journal.pone.0179897] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
9 Sümbül AT, Akkız H, Bayram S, Bekar A, Akgöllü E, Sandıkçı M. p53 codon 72 polymorphism is associated with susceptibility to hepatocellular carcinoma in the Turkish population: a case-control study. Mol Biol Rep. 2012;39:1639-1647. [PMID: 21607615 DOI: 10.1007/s11033-011-0903-2] [Cited by in Crossref: 23] [Cited by in F6Publishing: 17] [Article Influence: 2.3] [Reference Citation Analysis]
10 Jiang L, Yan Q, Fang S, Liu M, Li Y, Yuan YF, Li Y, Zhu Y, Qi J, Yang X, Kwong DLW, Guan XY. Calcium-binding protein 39 promotes hepatocellular carcinoma growth and metastasis by activating extracellular signal-regulated kinase signaling pathway. Hepatology 2017;66:1529-45. [PMID: 28605041 DOI: 10.1002/hep.29312] [Cited by in Crossref: 24] [Cited by in F6Publishing: 28] [Article Influence: 6.0] [Reference Citation Analysis]
11 Taniguchi K, Karin M. NF-κB, inflammation, immunity and cancer: coming of age. Nat Rev Immunol 2018;18:309-24. [DOI: 10.1038/nri.2017.142] [Cited by in Crossref: 718] [Cited by in F6Publishing: 610] [Article Influence: 239.3] [Reference Citation Analysis]
12 Ramirez MC, Bourguignon NS, Bonaventura MM, Lux-Lantos V, Libertun C, Becu-Villalobos D. Neonatal xenoestrogen exposure alters growth hormone-dependent liver proteins and genes in adult female rats. Toxicol Lett 2012;213:325-31. [PMID: 22842222 DOI: 10.1016/j.toxlet.2012.07.015] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 2.3] [Reference Citation Analysis]
13 Jennemann R, Federico G, Mathow D, Rabionet M, Rampoldi F, Popovic ZV, Volz M, Hielscher T, Sandhoff R, Gröne HJ. Inhibition of hepatocellular carcinoma growth by blockade of glycosphingolipid synthesis. Oncotarget 2017;8:109201-16. [PMID: 29312601 DOI: 10.18632/oncotarget.22648] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
14 Nagai N, Kudo Y, Aki D, Nakagawa H, Taniguchi K. Immunomodulation by Inflammation during Liver and Gastrointestinal Tumorigenesis and Aging. Int J Mol Sci 2021;22:2238. [PMID: 33668122 DOI: 10.3390/ijms22052238] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
15 El Mahdy Korah T, Abd Elfatah Badr E, Mohamed Emara M, Ahmed Samy Kohla M, Gamal Saad Michael G. Relation between sex hormones and hepatocellular carcinoma. Andrologia 2016;48:948-55. [PMID: 26791111 DOI: 10.1111/and.12536] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.2] [Reference Citation Analysis]
16 Phillips JM, Goodman JI. Multiple genes exhibit phenobarbital-induced constitutive active/androstane receptor-mediated DNA methylation changes during liver tumorigenesis and in liver tumors. Toxicol Sci 2009;108:273-89. [PMID: 19233941 DOI: 10.1093/toxsci/kfp031] [Cited by in Crossref: 27] [Cited by in F6Publishing: 22] [Article Influence: 2.3] [Reference Citation Analysis]
17 Kwekel JC, Vijay V, Han T, Moland CL, Desai VG, Fuscoe JC. Sex and age differences in the expression of liver microRNAs during the life span of F344 rats. Biol Sex Differ 2017;8:6. [PMID: 28174625 DOI: 10.1186/s13293-017-0127-9] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 4.8] [Reference Citation Analysis]
18 Heijmans J, Wielenga MC, Rosekrans SL, van Lidth de Jeude JF, Roelofs J, Groothuis P, Ederveen A, de Jonge-Muller ES, Biemond I, Hardwick JC, D'Haens G, Hommes DW, Muncan V, van den Brink GR. Oestrogens promote tumorigenesis in a mouse model for colitis-associated cancer. Gut 2014;63:310-6. [PMID: 23408349 DOI: 10.1136/gutjnl-2012-304216] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 3.3] [Reference Citation Analysis]
19 Watanabe T, Tokumoto Y, Joko K, Michitaka K, Horiike N, Tanaka Y, Tada F, Kisaka Y, Nakanishi S, Yamauchi K, Yukimoto A, Nakamura Y, Hirooka M, Abe M, Hiasa Y. Sex difference in the development of hepatocellular carcinoma after direct-acting antiviral therapy in patients with HCV infection. J Med Virol. 2020;. [PMID: 32374470 DOI: 10.1002/jmv.25984] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
20 Welling TH, Fu S, Wan S, Zou W, Marrero JA. Elevated serum IL-8 is associated with the presence of hepatocellular carcinoma and independently predicts survival. Cancer Invest 2012;30:689-97. [PMID: 23072563 DOI: 10.3109/07357907.2012.732161] [Cited by in Crossref: 21] [Cited by in F6Publishing: 16] [Article Influence: 2.3] [Reference Citation Analysis]
21 Khandekar MJ, Cohen P, Spiegelman BM. Molecular mechanisms of cancer development in obesity. Nat Rev Cancer. 2011;11:886-895. [PMID: 22113164 DOI: 10.1038/nrc3174] [Cited by in Crossref: 532] [Cited by in F6Publishing: 463] [Article Influence: 53.2] [Reference Citation Analysis]
22 Allavena P, Garlanda C, Borrello MG, Sica A, Mantovani A. Pathways connecting inflammation and cancer. Curr Opin Genet Dev. 2008;18:3-10. [PMID: 18325755 DOI: 10.1016/j.gde.2008.01.003] [Cited by in Crossref: 255] [Cited by in F6Publishing: 224] [Article Influence: 19.6] [Reference Citation Analysis]
23 Zhang XX, Wang LF, Jin L, Li YY, Hao SL, Shi YC, Zeng QL, Li ZW, Zhang Z, Lau GK. Primary biliary cirrhosis-associated hepatocellular carcinoma in Chinese patients: incidence and risk factors. World J Gastroenterol. 2015;21:3554-3563. [PMID: 25834320 DOI: 10.3748/wjg.v21.i12.3554] [Cited by in CrossRef: 22] [Cited by in F6Publishing: 19] [Article Influence: 4.4] [Reference Citation Analysis]
24 Lafaro KJ, Demirjian AN, Pawlik TM. Epidemiology of hepatocellular carcinoma. Surg Oncol Clin N Am. 2015;24:1-17. [PMID: 25444466 DOI: 10.1016/j.soc.2014.09.001] [Cited by in Crossref: 168] [Cited by in F6Publishing: 158] [Article Influence: 24.0] [Reference Citation Analysis]
25 Cheng HY, Kang PJ, Chuang YH, Wang YH, Jan MC, Wu CF, Lin CL, Liu CJ, Liaw YF, Lin SM, Chen PJ, Lee SD, Yu MW. Circulating programmed death-1 as a marker for sustained high hepatitis B viral load and risk of hepatocellular carcinoma. PLoS One. 2014;9:e95870. [PMID: 25427199 DOI: 10.1371/journal.pone.0095870] [Cited by in Crossref: 33] [Cited by in F6Publishing: 33] [Article Influence: 4.7] [Reference Citation Analysis]
26 Peshkova IO, Schaefer G, Koltsova EK. Atherosclerosis and aortic aneurysm – is inflammation a common denominator? FEBS J 2016;283:1636-52. [DOI: 10.1111/febs.13634] [Cited by in Crossref: 55] [Cited by in F6Publishing: 35] [Article Influence: 11.0] [Reference Citation Analysis]
27 Baptissart M, Vega A, Maqdasy S, Caira F, Baron S, Lobaccaro JM, Volle DH. Bile acids: from digestion to cancers. Biochimie. 2013;95:504-517. [PMID: 22766017 DOI: 10.1016/j.biochi.2012.06.022] [Cited by in Crossref: 73] [Cited by in F6Publishing: 67] [Article Influence: 8.1] [Reference Citation Analysis]
28 Rolvering C, Zimmer AD, Ginolhac A, Margue C, Kirchmeyer M, Servais F, Hermanns HM, Hergovits S, Nazarov PV, Nicot N, Kreis S, Haan S, Behrmann I, Haan C. The PD-L1- and IL6-mediated dampening of the IL27/STAT1 anticancer responses are prevented by α-PD-L1 or α-IL6 antibodies. J Leukoc Biol 2018;104:969-85. [PMID: 30040142 DOI: 10.1002/JLB.MA1217-495R] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.7] [Reference Citation Analysis]
29 Wang W, Ye Y, Wang T, Zhang F, Geng L, Yu J, Zhou L, Yan S, Zheng S. Prognostic prediction of male recipients selected for liver transplantation: With special attention to neutrophil to lymphocyte ratio. Hepatol Res. 2016;46:899-907. [PMID: 26666880 DOI: 10.1111/hepr.12633] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 1.2] [Reference Citation Analysis]
30 Wang R, Liu Y, Sun H, Wang T, Li C, Fan J, Wang Z. Estradiol is significantly associated with prognosis in non-surgical liver cancer patients: from bench to bedside. Aging (Albany NY) 2021;13:3483-500. [PMID: 33428602 DOI: 10.18632/aging.202280] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
31 Williams M, Liu X, Zhang Y, Reske J, Bahal D, Gohl TG, Hollern D, Ensink E, Kiupel M, Luo R, Das R, Xiao H. NCOA5 deficiency promotes a unique liver protumorigenic microenvironment through p21WAF1/CIP1 overexpression, which is reversed by metformin. Oncogene 2020;39:3821-36. [PMID: 32203160 DOI: 10.1038/s41388-020-1256-x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
32 Katz SF, Lechel A, Obenauf AC, Begus-Nahrmann Y, Kraus JM, Hoffmann EM, Duda J, Eshraghi P, Hartmann D, Liss B, Schirmacher P, Kestler HA, Speicher MR, Rudolph KL. Disruption of Trp53 in livers of mice induces formation of carcinomas with bilineal differentiation. Gastroenterology. 2012;142:1229-1239.e3. [PMID: 22342966 DOI: 10.1053/j.gastro.2012.02.009] [Cited by in Crossref: 55] [Cited by in F6Publishing: 50] [Article Influence: 6.1] [Reference Citation Analysis]
33 Ward A, Morettin A, Shum D, Hudson JW. Aberrant methylation of Polo-like kinase CpG islands in Plk4 heterozygous mice. BMC Cancer 2011;11:71. [PMID: 21324136 DOI: 10.1186/1471-2407-11-71] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 1.5] [Reference Citation Analysis]
34 Abe K, Thung SN, Wu HC, Tran TT, Le Hoang P, Truong KD, Inui A, Jang JJ, Su IJ. Pre-S2 deletion mutants of hepatitis B virus could have an important role in hepatocarcinogenesis in Asian children. Cancer Sci. 2009;100:2249-2254. [PMID: 19719772 DOI: 10.1111/j.1349-7006.2009.01309.x] [Cited by in Crossref: 37] [Cited by in F6Publishing: 39] [Article Influence: 3.1] [Reference Citation Analysis]
35 Dahan J, Nouët Y, Jouvion G, Levillayer F, Adib-Conquy M, Cassard-Doulcier AM, Tebbi A, Blanc F, Remy L, Chen J, Cairo S, Werts C, Si-Tahar M, Tordjmann T, Buendia MA, Wei Y. LIM-only protein FHL2 activates NF-κB signaling in the control of liver regeneration and hepatocarcinogenesis. Mol Cell Biol 2013;33:3299-308. [PMID: 23775124 DOI: 10.1128/MCB.00105-13] [Cited by in Crossref: 28] [Cited by in F6Publishing: 17] [Article Influence: 3.5] [Reference Citation Analysis]
36 Guerrieri F, Belloni L, Pediconi N, Levrero M. Pathobiology of Hepatitis B Virus-Induced Carcinogenesis. In: Liaw Y, Zoulim F, editors. Hepatitis B Virus in Human Diseases. Cham: Springer International Publishing; 2016. pp. 95-121. [DOI: 10.1007/978-3-319-22330-8_5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
37 Mai CW, Kang YB, Pichika MR. Should a Toll-like receptor 4 (TLR-4) agonist or antagonist be designed to treat cancer? TLR-4: its expression and effects in the ten most common cancers. Onco Targets Ther. 2013;6:1573-1587. [PMID: 24235843 DOI: 10.2147/ott.s50838] [Cited by in Crossref: 13] [Cited by in F6Publishing: 32] [Article Influence: 1.6] [Reference Citation Analysis]
38 Bitton-Worms K, Pikarsky E, Aronheim A. The AP-1 repressor protein, JDP2, potentiates hepatocellular carcinoma in mice. Mol Cancer 2010;9:54. [PMID: 20214788 DOI: 10.1186/1476-4598-9-54] [Cited by in Crossref: 29] [Cited by in F6Publishing: 25] [Article Influence: 2.6] [Reference Citation Analysis]
39 O’Neill LA. The interleukin-1 receptor/Toll-like receptor superfamily: 10 years of progress. Immunol Rev. 2008;226:10-18. [PMID: 19161412 DOI: 10.1111/j.1600-065x.2008.00701.x] [Cited by in Crossref: 423] [Cited by in F6Publishing: 216] [Article Influence: 35.3] [Reference Citation Analysis]
40 Wan MLY, El-Nezami H. Targeting gut microbiota in hepatocellular carcinoma: Probiotics as a novel therapy. Hepatobiliary Surg Nutr. 2018;7:11-20. [PMID: 29531939 DOI: 10.21037/hbsn.2017.12.07] [Cited by in Crossref: 41] [Cited by in F6Publishing: 38] [Article Influence: 13.7] [Reference Citation Analysis]
41 Li J, Yang D, He Y, Wang M, Wen Z, Liu L, Yao J, Matsuda K, Nakamura Y, Yu J. Associations of HLA-DP variants with hepatitis B virus infection in southern and northern Han Chinese populations: a multicenter case-control study. PLoS One. 2011;6:e24221. [PMID: 21904616 DOI: 10.1371/journal.pone.0024221] [Cited by in Crossref: 41] [Cited by in F6Publishing: 45] [Article Influence: 4.1] [Reference Citation Analysis]
42 Rong Z, Fan T, Li H, Li J, Wang K, Wang X, Dong J, Chen J, Wang F, Wang J, Wang A. Differential Proteomic Analysis of Gender-dependent Hepatic Tumorigenesis in Hras12V Transgenic Mice. Mol Cell Proteomics 2017;16:1475-90. [PMID: 28512230 DOI: 10.1074/mcp.M116.065474] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
43 Cheung OK, Cheng AS. Gender Differences in Adipocyte Metabolism and Liver Cancer Progression. Front Genet. 2016;7:168. [PMID: 27703473 DOI: 10.3389/fgene.2016.00168] [Cited by in Crossref: 25] [Cited by in F6Publishing: 20] [Article Influence: 5.0] [Reference Citation Analysis]
44 Lu JW, Wang H, Yan-Li J, Zhang C, Ning H, Li XY, Zhang H, Duan ZH, Zhao L, Wei W. Differential effects of pyrrolidine dithiocarbamate on TNF-alpha-mediated liver injury in two different models of fulminant hepatitis. J Hepatol. 2008;48:442-452. [PMID: 18215436 DOI: 10.1016/j.jhep.2007.10.014] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 2.1] [Reference Citation Analysis]
45 Feng H, Cheng AS, Tsang DP, Li MS, Go MY, Cheung YS, Zhao GJ, Ng SS, Lin MC, Yu J. Cell cycle-related kinase is a direct androgen receptor-regulated gene that drives β-catenin/T cell factor-dependent hepatocarcinogenesis. J Clin Invest. 2011;121:3159-3175. [PMID: 21747169 DOI: 10.1172/jci45967] [Cited by in Crossref: 82] [Cited by in F6Publishing: 43] [Article Influence: 8.2] [Reference Citation Analysis]
46 Ohno T, Shimizu M, Shirakami Y, Baba A, Kochi T, Kubota M, Tsurumi H, Tanaka T, Moriwaki H. Metformin suppresses diethylnitrosamine-induced liver tumorigenesis in obese and diabetic C57BL/KsJ-+Leprdb/+Leprdb mice. PLoS One 2015;10:e0124081. [PMID: 25879666 DOI: 10.1371/journal.pone.0124081] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 2.7] [Reference Citation Analysis]
47 Li Q, Wang L, Tan W, Peng Z, Luo Y, Zhang Y, Zhang G, Na D, Jin P, Shi T, Ma D, Wang L. Identification of C1qTNF-related protein 4 as a potential cytokine that stimulates the STAT3 and NF-κB pathways and promotes cell survival in human cancer cells. Cancer Lett 2011;308:203-14. [PMID: 21658842 DOI: 10.1016/j.canlet.2011.05.005] [Cited by in Crossref: 32] [Cited by in F6Publishing: 23] [Article Influence: 3.2] [Reference Citation Analysis]
48 Sun H, Yang W, Tian Y, Zeng X, Zhou J, Mok MTS, Tang W, Feng Y, Xu L, Chan AWH, Tong JH, Cheung YS, Lai PBS, Wang HKS, Tsang SW, Chow KL, Hu M, Liu R, Huang L, Yang B, Yang P, To KF, Sung JJY, Wong GLH, Wong VWS, Cheng ASL. An inflammatory-CCRK circuitry drives mTORC1-dependent metabolic and immunosuppressive reprogramming in obesity-associated hepatocellular carcinoma. Nat Commun 2018;9:5214. [PMID: 30523261 DOI: 10.1038/s41467-018-07402-8] [Cited by in Crossref: 27] [Cited by in F6Publishing: 24] [Article Influence: 9.0] [Reference Citation Analysis]
49 Macek Jilkova Z, Kurma K, Decaens T. Animal Models of Hepatocellular Carcinoma: The Role of Immune System and Tumor Microenvironment. Cancers (Basel) 2019;11:E1487. [PMID: 31581753 DOI: 10.3390/cancers11101487] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 5.5] [Reference Citation Analysis]
50 Zunke F, Rose-john S. The shedding protease ADAM17: Physiology and pathophysiology. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research 2017;1864:2059-70. [DOI: 10.1016/j.bbamcr.2017.07.001] [Cited by in Crossref: 127] [Cited by in F6Publishing: 109] [Article Influence: 31.8] [Reference Citation Analysis]
51 Koo BW, Lim DJ, Oh AY, Na HS. Retrospective Comparison between the Effects of Propofol and Inhalation Anesthetics on Postoperative Recurrence of Early- and Intermediate-Stage Hepatocellular Carcinoma. Med Princ Pract 2020;29:422-8. [PMID: 32074612 DOI: 10.1159/000506637] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
52 Yip TC, Wong GL, Chan HL, Tse YK, Liang LY, Hui VW, Lee HW, Lui GC, Kong AP, Wong VW. Elevated testosterone increases risk of hepatocellular carcinoma in men with chronic hepatitis B and diabetes mellitus. J Gastroenterol Hepatol 2020;35:2210-9. [PMID: 32343449 DOI: 10.1111/jgh.15079] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
53 He G, Dhar D, Nakagawa H, Font-Burgada J, Ogata H, Jiang Y, Shalapour S, Seki E, Yost SE, Jepsen K, Frazer KA, Harismendy O, Hatziapostolou M, Iliopoulos D, Suetsugu A, Hoffman RM, Tateishi R, Koike K, Karin M. Identification of liver cancer progenitors whose malignant progression depends on autocrine IL-6 signaling. Cell. 2013;155:384-396. [PMID: 24120137 DOI: 10.1016/j.cell.2013.09.031] [Cited by in Crossref: 289] [Cited by in F6Publishing: 258] [Article Influence: 36.1] [Reference Citation Analysis]
54 Krämer OH, Heinzel T. Phosphorylation-acetylation switch in the regulation of STAT1 signaling. Mol Cell Endocrinol 2010;315:40-8. [PMID: 19879327 DOI: 10.1016/j.mce.2009.10.007] [Cited by in Crossref: 62] [Cited by in F6Publishing: 61] [Article Influence: 5.2] [Reference Citation Analysis]
55 Rakoff-Nahoum S, Medzhitov R. Toll-like receptors and cancer. Nat Rev Cancer. 2009;9:57-63. [PMID: 19052556 DOI: 10.1038/nrc2541] [Cited by in Crossref: 586] [Cited by in F6Publishing: 532] [Article Influence: 45.1] [Reference Citation Analysis]
56 Wang HJ, Jiang YF, Wang XR, Zhang ML, Gao PJ. Elevated serum interleukin-38 level at baseline predicts virological response in telbivudine-treated patients with chronic hepatitis B. World J Gastroenterol 2016;22:4529-37. [PMID: 27182162 DOI: 10.3748/wjg.v22.i18.4529] [Cited by in CrossRef: 12] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
57 Yang L, Inokuchi S, Roh YS, Song J, Loomba R, Park EJ, Seki E. Transforming growth factor-β signaling in hepatocytes promotes hepatic fibrosis and carcinogenesis in mice with hepatocyte-specific deletion of TAK1. Gastroenterology. 2013;144:1042-1054.e4. [PMID: 23391818 DOI: 10.1053/j.gastro.2013.01.056] [Cited by in Crossref: 90] [Cited by in F6Publishing: 85] [Article Influence: 11.3] [Reference Citation Analysis]
58 Ringelhan M, Pfister D, O'Connor T, Pikarsky E, Heikenwalder M. The immunology of hepatocellular carcinoma. Nat Immunol. 2018;19:222-232. [PMID: 29379119 DOI: 10.1038/s41590-018-0044-z] [Cited by in Crossref: 281] [Cited by in F6Publishing: 259] [Article Influence: 93.7] [Reference Citation Analysis]
59 Montella M, D'Arena G, Crispo A, Capunzo M, Nocerino F, Grimaldi M, Barbieri A, D'Ursi AM, Tecce MF, Amore A, Galdiero M, Ciliberto G, Giudice A. Role of Sex Hormones in the Development and Progression of Hepatitis B Virus-Associated Hepatocellular Carcinoma. Int J Endocrinol 2015;2015:854530. [PMID: 26491442 DOI: 10.1155/2015/854530] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 4.0] [Reference Citation Analysis]
60 Wang Y, Ye F, Ke Q, Wu Q, Yang R, Bu H. Gender-dependent Histone Deacetylases Injury May Contribute to Differences in Liver Recovery Rates of Male and Female Mice. Transplantation Proceedings 2013;45:463-73. [DOI: 10.1016/j.transproceed.2012.06.063] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.5] [Reference Citation Analysis]
61 Schmidt T, Ben-Batalla I, Schultze A, Loges S. Macrophage-tumor crosstalk: role of TAMR tyrosine kinase receptors and of their ligands. Cell Mol Life Sci 2012;69:1391-414. [PMID: 22076650 DOI: 10.1007/s00018-011-0863-7] [Cited by in Crossref: 30] [Cited by in F6Publishing: 24] [Article Influence: 3.0] [Reference Citation Analysis]
62 Grohmann M, Wiede F, Dodd GT, Gurzov EN, Ooi GJ, Butt T, Rasmiena AA, Kaur S, Gulati T, Goh PK, Treloar AE, Archer S, Brown WA, Muller M, Watt MJ, Ohara O, McLean CA, Tiganis T. Obesity Drives STAT-1-Dependent NASH and STAT-3-Dependent HCC. Cell. 2018;175:1289-1306.e20. [PMID: 30454647 DOI: 10.1016/j.cell.2018.09.053] [Cited by in Crossref: 98] [Cited by in F6Publishing: 91] [Article Influence: 32.7] [Reference Citation Analysis]
63 Sun J, Sun WJ, Li ZY, Li L, Wang Y, Zhao Y, Wang C, Yu LR, Li LZ, Zhang YL. Daidzein increases OPG/RANKL ratio and suppresses IL-6 in MG-63 osteoblast cells. Int Immunopharmacol 2016;40:32-40. [PMID: 27576059 DOI: 10.1016/j.intimp.2016.08.014] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 2.4] [Reference Citation Analysis]
64 Hendifar A, Yang D, Lenz F, Lurje G, Pohl A, Lenz C, Ning Y, Zhang W, Lenz HJ. Gender disparities in metastatic colorectal cancer survival. Clin Cancer Res. 2009;15:6391-6397. [PMID: 19789331 DOI: 10.1158/1078-0432.ccr-09-0877] [Cited by in Crossref: 118] [Cited by in F6Publishing: 66] [Article Influence: 9.8] [Reference Citation Analysis]
65 Baiges A, Turon F, Simón-Talero M, Tasayco S, Bueno J, Zekrini K, Plessier A, Franchi-Abella S, Guerin F, Mukund A, Eapen CE, Goel A, Shyamkumar NK, Coenen S, De Gottardi A, Majumdar A, Onali S, Shukla A, Carrilho FJ, Nacif L, Primignani M, Tosetti G, La Mura V, Nevens F, Witters P, Tripathi D, Tellez L, Martínez J, Álvarez-Navascués C, Fraile López ML, Procopet B, Piscaglia F, de Koning B, Llop E, Romero-Cristobal M, Tjwa E, Monescillo-Francia A, Senzolo M, Perez-LaFuente M, Segarra A, Sarin SK, Hernández-Gea V, Patch D, Laleman W, Hartog H, Valla D, Genescà J, García-Pagán JC; REHEVASC, VALDIG an EASL consortium, Abernethy group. Congenital Extrahepatic Portosystemic Shunts (Abernethy Malformation): An International Observational Study. Hepatology 2020;71:658-69. [PMID: 31211875 DOI: 10.1002/hep.30817] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 9.5] [Reference Citation Analysis]
66 Zahran AM, Zahran ZAM, El-Badawy O, Abdel-Rahim MH, Ali WAM, Rayan A, Abbas El-Masry M, Abozaid MAA, Hetta HF. Prognostic impact of toll-like receptors 2 and 4 expression on monocytes in Egyptian patients with hepatocellular carcinoma. Immunol Res 2019;67:157-65. [PMID: 31028612 DOI: 10.1007/s12026-019-09075-x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 9.0] [Reference Citation Analysis]
67 Liang S, Ma HY, Zhong Z, Dhar D, Liu X, Xu J, Koyama Y, Nishio T, Karin D, Karin G, Mccubbin R, Zhang C, Hu R, Yang G, Chen L, Ganguly S, Lan T, Karin M, Kisseleva T, Brenner DA. NADPH Oxidase 1 in Liver Macrophages Promotes Inflammation and Tumor Development in Mice. Gastroenterology 2019;156:1156-1172.e6. [PMID: 30445007 DOI: 10.1053/j.gastro.2018.11.019] [Cited by in Crossref: 33] [Cited by in F6Publishing: 31] [Article Influence: 11.0] [Reference Citation Analysis]
68 Kido T, Tabatabai ZL, Chen X, Lau YC. Potential dual functional roles of the Y-linked RBMY in hepatocarcinogenesis. Cancer Sci 2020;111:2987-99. [PMID: 32473614 DOI: 10.1111/cas.14506] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
69 Rahbari R, Zhang L, Kebebew E. Thyroid cancer gender disparity. Future Oncol 2010;6:1771-9. [PMID: 21142662 DOI: 10.2217/fon.10.127] [Cited by in Crossref: 205] [Cited by in F6Publishing: 176] [Article Influence: 20.5] [Reference Citation Analysis]
70 Hetzler KL, Hardee JP, Puppa MJ, Narsale AA, Sato S, Davis JM, Carson JA. Sex differences in the relationship of IL-6 signaling to cancer cachexia progression. Biochim Biophys Acta 2015;1852:816-25. [PMID: 25555992 DOI: 10.1016/j.bbadis.2014.12.015] [Cited by in Crossref: 29] [Cited by in F6Publishing: 26] [Article Influence: 4.1] [Reference Citation Analysis]
71 Buettner N, Thimme R. Sexual dimorphism in hepatitis B and C and hepatocellular carcinoma. Semin Immunopathol 2019;41:203-11. [PMID: 30498927 DOI: 10.1007/s00281-018-0727-4] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
72 Wang H, Lafdil F, Kong X, Gao B. Signal transducer and activator of transcription 3 in liver diseases: a novel therapeutic target. Int J Biol Sci. 2011;7:536-550. [PMID: 21552420 DOI: 10.7150/ijbs.7.536] [Cited by in Crossref: 164] [Cited by in F6Publishing: 164] [Article Influence: 16.4] [Reference Citation Analysis]
73 Gilbert LA, Hemann MT. Chemotherapeutic resistance: surviving stressful situations. Cancer Res 2011;71:5062-6. [PMID: 21771909 DOI: 10.1158/0008-5472.CAN-11-0277] [Cited by in Crossref: 40] [Cited by in F6Publishing: 23] [Article Influence: 4.0] [Reference Citation Analysis]
74 Lee C, Kim J, Jung Y. Potential Therapeutic Application of Estrogen in Gender Disparity of Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis. Cells 2019;8:E1259. [PMID: 31619023 DOI: 10.3390/cells8101259] [Cited by in Crossref: 20] [Cited by in F6Publishing: 13] [Article Influence: 10.0] [Reference Citation Analysis]
75 Rodríguez Y, Novelli L, Rojas M, De Santis M, Acosta-Ampudia Y, Monsalve DM, Ramírez-Santana C, Costanzo A, Ridgway WM, Ansari AA, Gershwin ME, Selmi C, Anaya JM. Autoinflammatory and autoimmune conditions at the crossroad of COVID-19. J Autoimmun 2020;114:102506. [PMID: 32563547 DOI: 10.1016/j.jaut.2020.102506] [Cited by in Crossref: 83] [Cited by in F6Publishing: 64] [Article Influence: 83.0] [Reference Citation Analysis]
76 Nagashima T, Maruyama A, Kamata Y, Minota S. Unchanged serum viral load and liver function during tocilizumab treatment in a patient with rheumatoid arthritis and hepatitis C virus infection. Rheumatol Int 2012;32:2231-2. [DOI: 10.1007/s00296-011-2060-2] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.4] [Reference Citation Analysis]
77 Feng H, Yu Z, Tian Y, Lee YY, Li MS, Go MY, Cheung YS, Lai PB, Chan AM, To KF, Chan HL, Sung JJ, Cheng AS. A CCRK-EZH2 epigenetic circuitry drives hepatocarcinogenesis and associates with tumor recurrence and poor survival of patients. J Hepatol 2015;62:1100-11. [PMID: 25500144 DOI: 10.1016/j.jhep.2014.11.040] [Cited by in Crossref: 41] [Cited by in F6Publishing: 37] [Article Influence: 5.9] [Reference Citation Analysis]
78 Van Overmeire E, Laoui D, Keirsse J, Van Ginderachter JA, Sarukhan A. Mechanisms driving macrophage diversity and specialization in distinct tumor microenvironments and parallelisms with other tissues. Front Immunol 2014;5:127. [PMID: 24723924 DOI: 10.3389/fimmu.2014.00127] [Cited by in Crossref: 87] [Cited by in F6Publishing: 90] [Article Influence: 12.4] [Reference Citation Analysis]
79 Rebouissou S, Amessou M, Couchy G, Poussin K, Imbeaud S, Pilati C, Izard T, Balabaud C, Bioulac-Sage P, Zucman-Rossi J. Frequent in-frame somatic deletions activate gp130 in inflammatory hepatocellular tumours. Nature. 2009;457:200-204. [PMID: 19020503 DOI: 10.1038/nature07475] [Cited by in Crossref: 354] [Cited by in F6Publishing: 304] [Article Influence: 27.2] [Reference Citation Analysis]
80 Della Torre S. Non-alcoholic Fatty Liver Disease as a Canonical Example of Metabolic Inflammatory-Based Liver Disease Showing a Sex-Specific Prevalence: Relevance of Estrogen Signaling. Front Endocrinol (Lausanne) 2020;11:572490. [PMID: 33071979 DOI: 10.3389/fendo.2020.572490] [Cited by in Crossref: 11] [Cited by in F6Publishing: 3] [Article Influence: 11.0] [Reference Citation Analysis]
81 Schwabe RF, Jobin C. The microbiome and cancer. Nat Rev Cancer 2013;13:800-12. [PMID: 24132111 DOI: 10.1038/nrc3610] [Cited by in Crossref: 765] [Cited by in F6Publishing: 667] [Article Influence: 95.6] [Reference Citation Analysis]
82 Kiziltas S. Toll-like receptors in pathophysiology of liver diseases. World J Hepatol. 2016;8:1354-1369. [PMID: 27917262 DOI: 10.4254/wjh.v8.i32.1354] [Cited by in Crossref: 55] [Cited by in F6Publishing: 45] [Article Influence: 11.0] [Reference Citation Analysis]
83 Kassam I, Wu Y, Yang J, Visscher PM, McRae AF. Tissue-specific sex differences in human gene expression. Hum Mol Genet 2019;28:2976-86. [PMID: 31044242 DOI: 10.1093/hmg/ddz090] [Cited by in Crossref: 18] [Cited by in F6Publishing: 11] [Article Influence: 18.0] [Reference Citation Analysis]
84 Chen VL, Le AK, Podlaha O, Estevez J, Li B, Vutien P, Chang ET, Rosenberg-Hasson Y, Pflanz S, Jiang Z, Ge D, Gaggar A, Nguyen MH. Soluble intercellular adhesion molecule-1 is associated with hepatocellular carcinoma risk: multiplex analysis of serum markers. Sci Rep. 2017;7:11169. [PMID: 28894136 DOI: 10.1038/s41598-017-10498-5] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
85 Lepiller Q, Tripathy MK, Di Martino V, Kantelip B, Herbein G. Increased HCMV seroprevalence in patients with hepatocellular carcinoma. Virol J. 2011;8:485. [PMID: 22032643 DOI: 10.1186/1743-422x-8-485] [Cited by in Crossref: 24] [Cited by in F6Publishing: 16] [Article Influence: 2.4] [Reference Citation Analysis]
86 Langlet C, Springael C, Johnson J, Thomas S, Flamand V, Leitges M, Goldman M, Aksoy E, Willems F. PKC-α controls MYD88-dependent TLR/IL-1R signaling and cytokine production in mouse and human dendritic cells. Eur J Immunol 2010;40:505-15. [DOI: 10.1002/eji.200939391] [Cited by in Crossref: 39] [Cited by in F6Publishing: 39] [Article Influence: 3.5] [Reference Citation Analysis]
87 Li Z, Tuteja G, Schug J, Kaestner KH. Foxa1 and Foxa2 are essential for sexual dimorphism in liver cancer. Cell. 2012;148:72-83. [PMID: 22265403 DOI: 10.1016/j.cell.2011.11.026] [Cited by in Crossref: 216] [Cited by in F6Publishing: 198] [Article Influence: 24.0] [Reference Citation Analysis]
88 Başaran-küçükgergin C, Bingül İ, Tekkeşin MS, Olgaç V, Doğru-abbasoğlu S, Uysal M. Effects of carnosine, taurine, and betaine pretreatments on diethylnitrosamine-induced oxidative stress and tissue injury in rat liver. Toxicol Ind Health 2016;32:1405-13. [DOI: 10.1177/0748233714563432] [Cited by in Crossref: 13] [Cited by in F6Publishing: 8] [Article Influence: 1.9] [Reference Citation Analysis]
89 Van Ginderachter JA, Movahedi K, Van den Bossche J, De Baetselier P. Macrophages, PPARs, and Cancer. PPAR Res 2008;2008:169414. [PMID: 18615187 DOI: 10.1155/2008/169414] [Cited by in Crossref: 36] [Cited by in F6Publishing: 26] [Article Influence: 3.6] [Reference Citation Analysis]
90 Buchert M, Burns CJ, Ernst M. Targeting JAK kinase in solid tumors: emerging opportunities and challenges. Oncogene 2016;35:939-51. [DOI: 10.1038/onc.2015.150] [Cited by in Crossref: 129] [Cited by in F6Publishing: 113] [Article Influence: 21.5] [Reference Citation Analysis]
91 Peychal SE, Bilger A, Pitot HC, Drinkwater NR. Predominant modifier of extreme liver cancer susceptibility in C57BR/cdJ female mice localized to 6 Mb on chromosome 17. Carcinogenesis 2009;30:879-85. [PMID: 19255062 DOI: 10.1093/carcin/bgp054] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
92 Tian Y, Wong VW, Chan HL, Cheng AS. Epigenetic regulation of hepatocellular carcinoma in non-alcoholic fatty liver disease. Semin Cancer Biol. 2013;23:471-482. [PMID: 24018165 DOI: 10.1016/j.semcancer.2013.08.010] [Cited by in Crossref: 51] [Cited by in F6Publishing: 42] [Article Influence: 6.4] [Reference Citation Analysis]
93 Morton PM, Schafer MH, Ferraro KF. Does childhood misfortune increase cancer risk in adulthood? J Aging Health 2012;24:948-84. [PMID: 22764155 DOI: 10.1177/0898264312449184] [Cited by in Crossref: 41] [Cited by in F6Publishing: 31] [Article Influence: 4.6] [Reference Citation Analysis]
94 Li S, Mo C, Huang S, Yang S, Lu Y, Peng Q, Wang J, Deng Y, Qin X, Liu Y. Over-expressed Testis-specific Protein Y-encoded 1 as a novel biomarker for male hepatocellular carcinoma. PLoS One 2014;9:e89219. [PMID: 24586606 DOI: 10.1371/journal.pone.0089219] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
95 Bayram S, Akkız H, Bekar A, Akgöllü E, Yıldırım S. The significance of Exonuclease 1 K589E polymorphism on hepatocellular carcinoma susceptibility in the Turkish population: a case-control study. Mol Biol Rep 2012;39:5943-51. [PMID: 22205538 DOI: 10.1007/s11033-011-1406-x] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 1.9] [Reference Citation Analysis]
96 Gao B, Wang H, Lafdil F, Feng D. STAT proteins - key regulators of anti-viral responses, inflammation, and tumorigenesis in the liver. J Hepatol. 2012;57:430-441. [PMID: 22504331 DOI: 10.1016/j.jhep.2012.01.029] [Cited by in Crossref: 90] [Cited by in F6Publishing: 87] [Article Influence: 10.0] [Reference Citation Analysis]
97 Friedman SL. Focus. Journal of Hepatology 2011;55:1-2. [DOI: 10.1016/j.jhep.2011.03.001] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
98 Yu H, Li M, He R, Fang P, Wang Q, Yi Y, Wang F, Zhou L, Zhang Y, Chen A, Peng N, Liu D, Trilling M, Broering R, Wiemer EAC, Lu M, Zhu Y, Liu S. Major Vault Protein Promotes Hepatocellular Carcinoma Through Targeting Interferon Regulatory Factor 2 and Decreasing p53 Activity. Hepatology 2020;72:518-34. [PMID: 31758709 DOI: 10.1002/hep.31045] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
99 Xu J, Ji B, Wen G, Yang Y, Jin H, Liu X, Xie R, Song W, Song P, Dong H, Tuo B. Na+/H+ exchanger 1, Na+/Ca2+ exchanger 1 and calmodulin complex regulates interleukin 6-mediated cellular behavior of human hepatocellular carcinoma. Carcinogenesis. 2016;37:290-300. [PMID: 26775040 DOI: 10.1093/carcin/bgw004] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 4.0] [Reference Citation Analysis]
100 Wang S, Zhang Q, Wang Q, Shen Q, Chen X, Li Z, Zhou Y, Hou J, Xu B, Li N, Cao X. NEAT1 paraspeckle promotes human hepatocellular carcinoma progression by strengthening IL-6/STAT3 signaling. Oncoimmunology 2018;7:e1503913. [PMID: 30377567 DOI: 10.1080/2162402X.2018.1503913] [Cited by in Crossref: 28] [Cited by in F6Publishing: 11] [Article Influence: 9.3] [Reference Citation Analysis]
101 Wakiya T, Sanada Y, Urahashi T, Ihara Y, Yamada N, Okada N, Hirata Y, Hakamada K, Yasuda Y, Mizuta K. Impact of the serum ferritin concentration in liver transplantation: Impact of Serum Ferritin in LT. Liver Transpl 2015;21:1419-27. [DOI: 10.1002/lt.24222] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
102 Chan MK, Ocampo-Hafalla MT, Vartanian V, Jaruga P, Kirkali G, Koenig KL, Brown S, Lloyd RS, Dizdaroglu M, Teebor GW. Targeted deletion of the genes encoding NTH1 and NEIL1 DNA N-glycosylases reveals the existence of novel carcinogenic oxidative damage to DNA. DNA Repair (Amst). 2009;8:786-794. [PMID: 19346169 DOI: 10.1016/j.dnarep.2009.03.001] [Cited by in Crossref: 86] [Cited by in F6Publishing: 74] [Article Influence: 7.2] [Reference Citation Analysis]
103 Scully EP, Haverfield J, Ursin RL, Tannenbaum C, Klein SL. Considering how biological sex impacts immune responses and COVID-19 outcomes. Nat Rev Immunol. 2020;20:442-447. [PMID: 32528136 DOI: 10.1038/s41577-020-0348-8] [Cited by in Crossref: 250] [Cited by in F6Publishing: 176] [Article Influence: 250.0] [Reference Citation Analysis]
104 Lonardo A, Suzuki A. Sexual Dimorphism of NAFLD in Adults. Focus on Clinical Aspects and Implications for Practice and Translational Research. J Clin Med 2020;9:E1278. [PMID: 32354182 DOI: 10.3390/jcm9051278] [Cited by in Crossref: 26] [Cited by in F6Publishing: 20] [Article Influence: 26.0] [Reference Citation Analysis]
105 Zaremba T, Thomas HD, Cole M, Coulthard SA, Plummer ER, Curtin NJ. Poly(ADP-ribose) polymerase-1 (PARP-1) pharmacogenetics, activity and expression analysis in cancer patients and healthy volunteers. Biochem J 2011;436:671-9. [PMID: 21434873 DOI: 10.1042/BJ20101723] [Cited by in Crossref: 47] [Cited by in F6Publishing: 25] [Article Influence: 4.7] [Reference Citation Analysis]
106 Lim YM, Kim H, Lim SK, Yoo J, Lee JY, Eom IC, Yoon BI, Kim P, Yu SD, Shim I. In Vitro and In Vivo Evaluation of the Toxic Effects of Dodecylguanidine Hydrochloride. Toxics 2020;8:E76. [PMID: 32971939 DOI: 10.3390/toxics8030076] [Reference Citation Analysis]
107 Kim JH, Sohn BH, Lee HS, Kim SB, Yoo JE, Park YY, Jeong W, Lee SS, Park ES, Kaseb A. Genomic predictors for recurrence patterns of hepatocellular carcinoma: model derivation and validation. PLoS Med. 2014;11:e1001770. [PMID: 25536056 DOI: 10.1371/journal.pmed.1001770] [Cited by in Crossref: 58] [Cited by in F6Publishing: 55] [Article Influence: 8.3] [Reference Citation Analysis]
108 Karatayli E, Hall RA, Weber SN, Dooley S, Lammert F. Effect of alcohol on the interleukin 6-mediated inflammatory response in a new mouse model of acute-on-chronic liver injury. Biochim Biophys Acta Mol Basis Dis 2019;1865:298-307. [PMID: 30447270 DOI: 10.1016/j.bbadis.2018.11.008] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
109 Sander LE, Blander JM. Inflammasome and toll-like receptor 9: Partners in crime in toxic liver injury. Hepatology 2009;49:2119-21. [PMID: 19479796 DOI: 10.1002/hep.23022] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
110 Naugler WE, Karin M. The wolf in sheep's clothing: the role of interleukin-6 in immunity, inflammation and cancer. Trends Mol Med. 2008;14:109-119. [PMID: 18261959 DOI: 10.1016/j.molmed.2007.12.007] [Cited by in Crossref: 462] [Cited by in F6Publishing: 440] [Article Influence: 35.5] [Reference Citation Analysis]
111 Gilbert LA, Hemann MT. DNA damage-mediated induction of a chemoresistant niche. Cell. 2010;143:355-366. [PMID: 21029859 DOI: 10.1016/j.cell.2010.09.043] [Cited by in Crossref: 287] [Cited by in F6Publishing: 254] [Article Influence: 26.1] [Reference Citation Analysis]
112 Memon A, Pyao Y, Jung Y, Lee JI, Lee WK. A Modified Protocol of Diethylnitrosamine Administration in Mice to Model Hepatocellular Carcinoma. Int J Mol Sci 2020;21:E5461. [PMID: 32751728 DOI: 10.3390/ijms21155461] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
113 Amr S, Iarocci EA, Nasr GR, Saleh D, Blancato J, Shetty K, Loffredo CA. Multiple pregnancies, hepatitis C, and risk for hepatocellular carcinoma in Egyptian women. BMC Cancer 2014;14:893. [PMID: 25432765 DOI: 10.1186/1471-2407-14-893] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
114 Li Z, White P, Tuteja G, Rubins N, Sackett S, Kaestner KH. Foxa1 and Foxa2 regulate bile duct development in mice. J Clin Invest. 2009;119:1537-1545. [PMID: 19436110 DOI: 10.1172/jci38201] [Cited by in Crossref: 93] [Cited by in F6Publishing: 60] [Article Influence: 7.8] [Reference Citation Analysis]
115 Allavena P, Sica A, Garlanda C, Mantovani A. The Yin-Yang of tumor-associated macrophages in neoplastic progression and immune surveillance. Immunol Rev. 2008;222:155-161. [PMID: 18364000 DOI: 10.1111/j.1600-065x.2008.00607.x] [Cited by in Crossref: 396] [Cited by in F6Publishing: 217] [Article Influence: 33.0] [Reference Citation Analysis]
116 Dobos J, Mohos A, Tóvári J, Rásó E, Lőrincz T, Zádori G, Tímár J, Ladányi A. Sex-dependent liver colonization of human melanoma in SCID mice--role of host defense mechanisms. Clin Exp Metastasis 2013;30:497-506. [PMID: 23203681 DOI: 10.1007/s10585-012-9554-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
117 Lujambio A, Akkari L, Simon J, Grace D, Tschaharganeh DF, Bolden JE, Zhao Z, Thapar V, Joyce JA, Krizhanovsky V. Non-cell-autonomous tumor suppression by p53. Cell. 2013;153:449-460. [PMID: 23562644 DOI: 10.1016/j.cell.2013.03.020] [Cited by in Crossref: 411] [Cited by in F6Publishing: 378] [Article Influence: 51.4] [Reference Citation Analysis]
118 Park O, Wang H, Weng H, Feigenbaum L, Li H, Yin S, Ki SH, Yoo SH, Dooley S, Wang FS. In vivo consequences of liver-specific interleukin-22 expression in mice: Implications for human liver disease progression. Hepatology. 2011;54:252-261. [PMID: 21465510 DOI: 10.1002/hep.24339] [Cited by in Crossref: 153] [Cited by in F6Publishing: 152] [Article Influence: 15.3] [Reference Citation Analysis]
119 Qiu B, Wang J, Yu Y, Zhen C, Gu J, Liu W, Wen Y, Chen L, Gao Y, Xia Q, Kong X. DJ-1 promotes development of DEN-induced hepatocellular carcinoma and proliferation of liver cancer cells. Oncotarget 2017;8:8499-511. [PMID: 28036277 DOI: 10.18632/oncotarget.14293] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 4.7] [Reference Citation Analysis]
120 Guo J, Ma Q, Zhou X, Fan P, Shan T, Miao D. Inactivation of p27kip1 promotes chemical hepatocarcinogenesis through enhancing inflammatory cytokine secretion and STAT3 signaling activation. J Cell Physiol 2013;228:1967-76. [PMID: 23460367 DOI: 10.1002/jcp.24357] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
121 Huang X, Shu C, Chen L, Yao B. Impact of sex, body mass index and initial pathologic diagnosis age on the incidence and prognosis of different types of cancer. Oncol Rep 2018;40:1359-69. [PMID: 29956810 DOI: 10.3892/or.2018.6529] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
122 Kohoutková M, Korimová A, Brázda V, Kohoutek J, Dubový P. Early inflammatory profiling of schwannoma cells induced by lipopolysaccharide. Histochem Cell Biol 2017;148:607-15. [DOI: 10.1007/s00418-017-1601-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
123 Sinclair M, Grossmann M, Gow PJ, Angus PW. Testosterone in men with advanced liver disease: Abnormalities and implications: Testosterone in men with liver disease. J Gastroenterol Hepatol 2015;30:244-51. [DOI: 10.1111/jgh.12695] [Cited by in Crossref: 57] [Cited by in F6Publishing: 37] [Article Influence: 9.5] [Reference Citation Analysis]
124 Imtiyaz HZ, Williams EP, Hickey MM, Patel SA, Durham AC, Yuan LJ, Hammond R, Gimotty PA, Keith B, Simon MC. Hypoxia-inducible factor 2alpha regulates macrophage function in mouse models of acute and tumor inflammation. J Clin Invest 2010;120:2699-714. [PMID: 20644254 DOI: 10.1172/JCI39506] [Cited by in Crossref: 273] [Cited by in F6Publishing: 188] [Article Influence: 24.8] [Reference Citation Analysis]
125 Pedersen KB, Pulliam CF, Patel A, Del Piero F, Watanabe TTN, Wankhade UD, Shankar K, Hicks C, Ronis MJ. Liver tumorigenesis is promoted by a high saturated fat diet specifically in male mice and is associated with hepatic expression of the proto-oncogene Agap2 and enrichment of the intestinal microbiome with Coprococcus. Carcinogenesis 2019;40:349-59. [PMID: 30325408 DOI: 10.1093/carcin/bgy141] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
126 Hetzler KL, Hardee JP, LaVoie HA, Murphy EA, Carson JA. Ovarian function's role during cancer cachexia progression in the female mouse. Am J Physiol Endocrinol Metab 2017;312:E447-59. [PMID: 28292759 DOI: 10.1152/ajpendo.00294.2016] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 3.5] [Reference Citation Analysis]
127 Chew V, Chen J, Lee D, Loh E, Lee J, Lim KH, Weber A, Slankamenac K, Poon RT, Yang H, Ooi LL, Toh HC, Heikenwalder M, Ng IO, Nardin A, Abastado JP. Chemokine-driven lymphocyte infiltration: an early intratumoural event determining long-term survival in resectable hepatocellular carcinoma. Gut. 2012;61:427-438. [PMID: 21930732 DOI: 10.1136/gutjnl-2011-300509] [Cited by in Crossref: 192] [Cited by in F6Publishing: 176] [Article Influence: 19.2] [Reference Citation Analysis]
128 Sales ML, Schreiber R, Ferreira-Sae MC, Fernandes MN, Piveta CS, Cipolli JA, Cardoso CC, Matos-Souza JR, Geloneze B, Franchini KG, Nadruz W Jr. Toll-like receptor 6 Ser249Pro polymorphism is associated with lower left ventricular wall thickness and inflammatory response in hypertensive women. Am J Hypertens 2010;23:649-54. [PMID: 20224557 DOI: 10.1038/ajh.2010.24] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 1.8] [Reference Citation Analysis]
129 Shang N, Arteaga M, Chitsike L, Wang F, Viswakarma N, Breslin P, Qiu W. FAK deletion accelerates liver regeneration after two-thirds partial hepatectomy. Sci Rep 2016;6:34316. [PMID: 27677358 DOI: 10.1038/srep34316] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
130 Zhou A, Tang L, Zeng S, Lei Y, Yang S, Tang B. Gut microbiota: A new piece in understanding hepatocarcinogenesis. Cancer Lett 2020;474:15-22. [PMID: 31917160 DOI: 10.1016/j.canlet.2020.01.002] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 11.0] [Reference Citation Analysis]
131 Silver JS, Hunter CA. gp130 at the nexus of inflammation, autoimmunity, and cancer. J Leukoc Biol. 2010;88:1145-1156. [PMID: 20610800 DOI: 10.1189/jlb.0410217] [Cited by in Crossref: 159] [Cited by in F6Publishing: 149] [Article Influence: 14.5] [Reference Citation Analysis]
132 Zhang L, Rahbari R, He M, Kebebew E. CDC23 regulates cancer cell phenotype and is overexpressed in papillary thyroid cancer. Endocr Relat Cancer 2011;18:731-42. [PMID: 21990323 DOI: 10.1530/ERC-11-0181] [Cited by in Crossref: 11] [Cited by in F6Publishing: 3] [Article Influence: 1.1] [Reference Citation Analysis]
133 Bremer J, Heikenwalder M, Haybaeck J, Tiberi C, Krautler NJ, Kurrer MO, Aguzzi A. Repetitive immunization enhances the susceptibility of mice to peripherally administered prions. PLoS One 2009;4:e7160. [PMID: 19779609 DOI: 10.1371/journal.pone.0007160] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 1.7] [Reference Citation Analysis]
134 Mosteiro L, Pantoja C, de Martino A, Serrano M. Senescence promotes in vivo reprogramming through p16INK4a and IL-6. Aging Cell. 2018;17. [PMID: 29280266 DOI: 10.1111/acel.12711] [Cited by in Crossref: 75] [Cited by in F6Publishing: 55] [Article Influence: 18.8] [Reference Citation Analysis]
135 Dong H, Xu J, Li W, Gan J, Lin W, Ke J, Jiang J, Du L, Chen Y, Zhong X, Zhang D, Yeung SJ, Li X, Zhang H. Reciprocal androgen receptor/interleukin-6 crosstalk drives oesophageal carcinoma progression and contributes to patient prognosis. J Pathol 2017;241:448-62. [PMID: 27801498 DOI: 10.1002/path.4839] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 6.0] [Reference Citation Analysis]
136 Lee SR, Kwon SW, Lee YH, Kaya P, Kim JM, Ahn C, Jung EM, Lee GS, An BS, Jeung EB, Park BK, Hong EJ. Dietary intake of genistein suppresses hepatocellular carcinoma through AMPK-mediated apoptosis and anti-inflammation. BMC Cancer 2019;19:6. [PMID: 30606143 DOI: 10.1186/s12885-018-5222-8] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 10.0] [Reference Citation Analysis]
137 Wu WY, Li J, Wu ZS, Zhang CL, Meng XL. STAT3 activation in monocytes accelerates liver cancer progression. BMC Cancer 2011;11:506. [PMID: 22136659 DOI: 10.1186/1471-2407-11-506] [Cited by in Crossref: 46] [Cited by in F6Publishing: 44] [Article Influence: 4.6] [Reference Citation Analysis]
138 Souza CLSE, Barbosa CD, Coelho HILN, Santos Júnior MN, Barbosa EN, Queiroz ÉC, Teles MF, Dos Santos DC, Bittencourt RS, Soares TJ, Oliveira MV, Timenetsky J, Campos GB, Marques LM. Effects of 17β-Estradiol on Monocyte/Macrophage Response to Staphylococcus aureus: An In Vitro Study. Front Cell Infect Microbiol 2021;11:701391. [PMID: 34336722 DOI: 10.3389/fcimb.2021.701391] [Reference Citation Analysis]
139 Yang J, Li M, Zheng QC. Emerging role of Toll-like receptor 4 in hepatocellular carcinoma. J Hepatocell Carcinoma 2015;2:11-7. [PMID: 27508190 DOI: 10.2147/JHC.S44515] [Cited by in Crossref: 3] [Cited by in F6Publishing: 10] [Article Influence: 0.5] [Reference Citation Analysis]
140 Murakami S, Ninomiya W, Sakamoto E, Shibata T, Akiyama H, Tashiro F. SRY and OCT4 Are Required for the Acquisition of Cancer Stem Cell-Like Properties and Are Potential Differentiation Therapy Targets. Stem Cells. 2015;33:2652-2663. [PMID: 26013162 DOI: 10.1002/stem.2059] [Cited by in Crossref: 39] [Cited by in F6Publishing: 38] [Article Influence: 6.5] [Reference Citation Analysis]
141 Tolba R, Kraus T, Liedtke C, Schwarz M, Weiskirchen R. Diethylnitrosamine (DEN)-induced carcinogenic liver injury in mice. Lab Anim 2015;49:59-69. [DOI: 10.1177/0023677215570086] [Cited by in Crossref: 102] [Cited by in F6Publishing: 86] [Article Influence: 17.0] [Reference Citation Analysis]
142 Cheng CW, Su JL, Lin CW, Su CW, Shih CH, Yang SF, Chien MH. Effects of NFKB1 and NFKBIA gene polymorphisms on hepatocellular carcinoma susceptibility and clinicopathological features. PLoS One 2013;8:e56130. [PMID: 23457512 DOI: 10.1371/journal.pone.0056130] [Cited by in Crossref: 28] [Cited by in F6Publishing: 28] [Article Influence: 3.5] [Reference Citation Analysis]
143 Chen GG, Leung J, Liang NC, Li L, Wu K, Chan UP, Leung BC, Li M, Du J, Deng YF, Gong X, Lv Y, Chak EC, Lai PB. Ent-11α-hydroxy-15-oxo-kaur-16-en-19-oic-acid inhibits hepatocellular carcinoma in vitro and in vivo via stabilizing IkBα. Invest New Drugs 2012;30:2210-8. [PMID: 22227815 DOI: 10.1007/s10637-011-9791-5] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
144 Henstridge DC, Abildgaard J, Lindegaard B, Febbraio MA. Metabolic control and sex: A focus on inflammatory-linked mediators. Br J Pharmacol 2019;176:4193-207. [PMID: 30820935 DOI: 10.1111/bph.14642] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
145 Cussigh A, Falleti E, Fabris C, Bitetto D, Cmet S, Fontanini E, Bignulin S, Fornasiere E, Fumolo E, Minisini R, Pirisi M, Toniutto P. Interleukin 6 promoter polymorphisms influence the outcome of chronic hepatitis C. Immunogenetics. 2011;63:33-41. [PMID: 21072509 DOI: 10.1007/s00251-010-0491-7] [Cited by in Crossref: 44] [Cited by in F6Publishing: 39] [Article Influence: 4.0] [Reference Citation Analysis]
146 de Lope CR, Tremosini S, Forner A, Reig M, Bruix J. Management of HCC. Journal of Hepatology 2012;56:S75-87. [DOI: 10.1016/s0168-8278(12)60009-9] [Cited by in Crossref: 363] [Cited by in F6Publishing: 192] [Article Influence: 40.3] [Reference Citation Analysis]
147 Zhang H, Han J, Xing H, Li Z, Schwartz ME, Zhou Y, Chen T, Wang H, Gu W, Lau WY, Wu H, Wu M, Shen F, Yang T. Sex difference in recurrence and survival after liver resection for hepatocellular carcinoma: A multicenter study. Surgery 2019;165:516-24. [DOI: 10.1016/j.surg.2018.08.031] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]
148 Fekry B, Ribas-Latre A, Baumgartner C, Mohamed AMT, Kolonin MG, Sladek FM, Younes M, Eckel-Mahan KL. HNF4α-Deficient Fatty Liver Provides a Permissive Environment for Sex-Independent Hepatocellular Carcinoma. Cancer Res 2019;79:5860-73. [PMID: 31575546 DOI: 10.1158/0008-5472.CAN-19-1277] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 4.5] [Reference Citation Analysis]
149 Lee JK, Bettencourt R, Brenner D, Le TA, Barrett-Connor E, Loomba R. Association between serum interleukin-6 concentrations and mortality in older adults: the Rancho Bernardo study. PLoS One 2012;7:e34218. [PMID: 22514624 DOI: 10.1371/journal.pone.0034218] [Cited by in Crossref: 44] [Cited by in F6Publishing: 44] [Article Influence: 4.9] [Reference Citation Analysis]
150 Laguna JC, Alegret M, Roglans N. Simple sugar intake and hepatocellular carcinoma: epidemiological and mechanistic insight. Nutrients 2014;6:5933-54. [PMID: 25533006 DOI: 10.3390/nu6125933] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 3.1] [Reference Citation Analysis]
151 Gao Y, Zhang Y, Yao Y, Guan X, Liu Y, Qi X, Wang Y, Liu C, Zhang Y, Gao H, Nair V, Wang X, Gao Y. Avian leukosis virus subgroup J induces VEGF expression via NF-κB/PI3K-dependent IL-6 production. Oncotarget 2016;7:80275-87. [PMID: 27852059 DOI: 10.18632/oncotarget.13282] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
152 Li YX, Ren YL, Fu HJ, Zou L, Yang Y, Chen Z. Hepatitis B Virus Middle Protein Enhances IL-6 Production via p38 MAPK/NF-κB Pathways in an ER Stress-Dependent Manner. PLoS One 2016;11:e0159089. [PMID: 27434097 DOI: 10.1371/journal.pone.0159089] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 2.2] [Reference Citation Analysis]
153 Phillips JM, Burgoon LD, Goodman JI. The constitutive active/androstane receptor facilitates unique phenobarbital-induced expression changes of genes involved in key pathways in precancerous liver and liver tumors. Toxicol Sci 2009;110:319-33. [PMID: 19482888 DOI: 10.1093/toxsci/kfp108] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 2.0] [Reference Citation Analysis]
154 Luedde T, Trautwein C. A molecular link between inflammation and fibrogenesis: the bacterial microflora influences hepatic fibrosis via toll-like receptor 4-dependent modification of transforming growth factor-beta signaling in hepatic stellate cells. Hepatology. 2008;47:1089-1091. [PMID: 18306215 DOI: 10.1002/hep.22232] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
155 Shanmugam MK, Rane G, Kanchi MM, Arfuso F, Chinnathambi A, Zayed ME, Alharbi SA, Tan BK, Kumar AP, Sethi G. The multifaceted role of curcumin in cancer prevention and treatment. Molecules 2015;20:2728-69. [PMID: 25665066 DOI: 10.3390/molecules20022728] [Cited by in Crossref: 228] [Cited by in F6Publishing: 191] [Article Influence: 38.0] [Reference Citation Analysis]
156 Mencin A, Kluwe J, Schwabe RF. Toll-like receptors as targets in chronic liver diseases. Gut. 2009;58:704-720. [PMID: 19359436 DOI: 10.1136/gut.2008.156307] [Cited by in Crossref: 225] [Cited by in F6Publishing: 218] [Article Influence: 18.8] [Reference Citation Analysis]
157 Bollrath J, Greten FR. IKK/NF-kappaB and STAT3 pathways: central signalling hubs in inflammation-mediated tumour promotion and metastasis. EMBO Rep. 2009;10:1314-1319. [PMID: 19893576 DOI: 10.1038/embor.2009.243] [Cited by in Crossref: 277] [Cited by in F6Publishing: 248] [Article Influence: 23.1] [Reference Citation Analysis]
158 Maeda S, Shibata W. Nuclear Factor-Kappa B Actions During the Development of Hepatocellular Carcinoma. Liver Pathophysiology. Elsevier; 2017. pp. 289-93. [DOI: 10.1016/b978-0-12-804274-8.00022-9] [Cited by in Crossref: 3] [Article Influence: 0.8] [Reference Citation Analysis]
159 Font-Burgada J, Sun B, Karin M. Obesity and Cancer: The Oil that Feeds the Flame. Cell Metab. 2016;23:48-62. [PMID: 26771116 DOI: 10.1016/j.cmet.2015.12.015] [Cited by in Crossref: 197] [Cited by in F6Publishing: 163] [Article Influence: 39.4] [Reference Citation Analysis]
160 Kamachi S, Mizuta T, Otsuka T, Nakashita S, Ide Y, Miyoshi A, Kitahara K, Eguchi Y, Ozaki I, Anzai K. Sarcopenia is a risk factor for the recurrence of hepatocellular carcinoma after curative treatment. Hepatol Res 2016;46:201-8. [PMID: 26223826 DOI: 10.1111/hepr.12562] [Cited by in Crossref: 41] [Cited by in F6Publishing: 39] [Article Influence: 6.8] [Reference Citation Analysis]
161 Wang M, Cai J, Huang F, Zhu M, Zhang Q, Yang T, Zhang X, Qian H, Xu W. Pre-treatment of human umbilical cord-derived mesenchymal stem cells with interleukin-6 abolishes their growth-promoting effect on gastric cancer cells. Int J Mol Med 2015;35:367-75. [PMID: 25483835 DOI: 10.3892/ijmm.2014.2019] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 2.1] [Reference Citation Analysis]
162 Luisier R, Unterberger EB, Goodman JI, Schwarz M, Moggs J, Terranova R, van Nimwegen E. Computational modeling identifies key gene regulatory interactions underlying phenobarbital-mediated tumor promotion. Nucleic Acids Res 2014;42:4180-95. [PMID: 24464994 DOI: 10.1093/nar/gkt1415] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 2.3] [Reference Citation Analysis]
163 Neyrolles O, Quintana-Murci L. Sexual inequality in tuberculosis. PLoS Med 2009;6:e1000199. [PMID: 20027210 DOI: 10.1371/journal.pmed.1000199] [Cited by in Crossref: 197] [Cited by in F6Publishing: 169] [Article Influence: 16.4] [Reference Citation Analysis]
164 Zhang LJ, Xiong Y, Nilubol N, He M, Bommareddi S, Zhu X, Jia L, Xiao Z, Park JW, Xu X, Patel D, Willingham MC, Cheng SY, Kebebew E. Testosterone regulates thyroid cancer progression by modifying tumor suppressor genes and tumor immunity. Carcinogenesis 2015;36:420-8. [PMID: 25576159 DOI: 10.1093/carcin/bgv001] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.3] [Reference Citation Analysis]
165 Delire B, Henriet P, Lemoine P, Leclercq IA, Stärkel P. Chronic liver injury promotes hepatocarcinoma cell seeding and growth, associated with infiltration by macrophages. Cancer Sci 2018;109:2141-52. [PMID: 29727510 DOI: 10.1111/cas.13628] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.7] [Reference Citation Analysis]
166 Liu J, Zhang X, Wang H, Zhang M, Peng Y, Li M, Xie L, Jiang F, Gong Y, Zhao Q, Zhou P. Implication of myeloid differentiation factor 88 inhibitor TJ-M2010-5 for therapeutic intervention of hepatocellular carcinoma. Hepatol Res 2019;49:1182-94. [PMID: 31074165 DOI: 10.1111/hepr.13359] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
167 Balaha M, Kandeel S, Barakat W. Carvedilol suppresses circulating and hepatic IL-6 responsible for hepatocarcinogenesis of chronically damaged liver in rats. Toxicology and Applied Pharmacology 2016;311:1-11. [DOI: 10.1016/j.taap.2016.10.012] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
168 Bartel DP. MicroRNAs: target recognition and regulatory functions. Cell. 2009;136:215-233. [PMID: 19167326 DOI: 10.1016/j] [Cited by in F6Publishing: 105] [Reference Citation Analysis]
169 Song H, Yu Z, Sun X, Feng J, Yu Q, Khan H, Zhu X, Huang L, Li M, Mok MTS, Cheng ASL, Gao Y, Feng H. Androgen receptor drives hepatocellular carcinogenesis by activating enhancer of zeste homolog 2-mediated Wnt/β-catenin signaling. EBioMedicine 2018;35:155-66. [PMID: 30150059 DOI: 10.1016/j.ebiom.2018.08.043] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 4.7] [Reference Citation Analysis]
170 Ding J, Wu W, Fang J, Zhao J, Jiang L. Male sex is associated with aggressive behaviour and poor prognosis in Chinese papillary thyroid carcinoma. Sci Rep 2020;10:4141. [PMID: 32139703 DOI: 10.1038/s41598-020-60199-9] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
171 Harada K, Hirohara J, Ueno Y, Nakano T, Kakuda Y, Tsubouchi H, Ichida T, Nakanuma Y. Incidence of and risk factors for hepatocellular carcinoma in primary biliary cirrhosis: national data from Japan. Hepatology. 2013;57:1942-1949. [PMID: 23197466 DOI: 10.1002/hep.26176] [Cited by in Crossref: 55] [Cited by in F6Publishing: 39] [Article Influence: 6.9] [Reference Citation Analysis]
172 Huang JL, Zhang YL, Wang CC, Zhou JR, Ma Q, Wang X, Shen XH, Jiang CL. Enhanced phosphorylation of MAPKs by NE promotes TNF-α production by macrophage through α adrenergic receptor. Inflammation 2012;35:527-34. [PMID: 21590324 DOI: 10.1007/s10753-011-9342-4] [Cited by in Crossref: 27] [Cited by in F6Publishing: 25] [Article Influence: 3.0] [Reference Citation Analysis]
173 Yamada S, Okumura N, Wei L, Fuchs BC, Fujii T, Sugimoto H, Nomoto S, Takeda S, Tanabe KK, Kodera Y. Epithelial to mesenchymal transition is associated with shorter disease-free survival in hepatocellular carcinoma. Ann Surg Oncol 2014;21:3882-90. [PMID: 24833103 DOI: 10.1245/s10434-014-3779-2] [Cited by in Crossref: 43] [Cited by in F6Publishing: 33] [Article Influence: 6.1] [Reference Citation Analysis]
174 Taniguchi K, Karin M. IL-6 and related cytokines as the critical lynchpins between inflammation and cancer. Seminars in Immunology. 2014;26:54-74. [PMID: 24552665 DOI: 10.1016/j.smim.2014.01.001] [Cited by in Crossref: 319] [Cited by in F6Publishing: 274] [Article Influence: 45.6] [Reference Citation Analysis]
175 Fox JG, Feng Y, Theve EJ, Raczynski AR, Fiala JL, Doernte AL, Williams M, McFaline JL, Essigmann JM, Schauer DB, Tannenbaum SR, Dedon PC, Weinman SA, Lemon SM, Fry RC, Rogers AB. Gut microbes define liver cancer risk in mice exposed to chemical and viral transgenic hepatocarcinogens. Gut 2010;59:88-97. [PMID: 19850960 DOI: 10.1136/gut.2009.183749] [Cited by in Crossref: 157] [Cited by in F6Publishing: 132] [Article Influence: 14.3] [Reference Citation Analysis]
176 Zhong L, Kong JN, Dinkins MB, Leanhart S, Zhu Z, Spassieva SD, Qin H, Lin HP, Elsherbini A, Wang R, Jiang X, Nikolova-Karakashian M, Wang G, Bieberich E. Increased liver tumor formation in neutral sphingomyelinase-2-deficient mice. J Lipid Res 2018;59:795-804. [PMID: 29567647 DOI: 10.1194/jlr.M080879] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 2.7] [Reference Citation Analysis]
177 Matsuda M, Seki E. Hepatic Stellate Cell-Macrophage Crosstalk in Liver Fibrosis and Carcinogenesis. Semin Liver Dis 2020;40:307-20. [PMID: 32242330 DOI: 10.1055/s-0040-1708876] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 8.0] [Reference Citation Analysis]
178 Qi J, Tan CK, Hashimi SM, Zulfiker AH, Good D, Wei MQ. Toad glandular secretions and skin extractions as anti-inflammatory and anticancer agents. Evid Based Complement Alternat Med 2014;2014:312684. [PMID: 24734105 DOI: 10.1155/2014/312684] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 3.4] [Reference Citation Analysis]
179 Mitchell J, Tinkey PT, Avritscher R, Van Pelt C, Eskandari G, Konnath George S, Xiao L, Cressman E, Morris JS, Rashid A, Kaseb AO, Amin HM, Uthamanthil R. Validation of a Preclinical Model of Diethylnitrosamine-Induced Hepatic Neoplasia in Yucatan Miniature Pigs. Oncology 2016;91:90-100. [PMID: 27305144 DOI: 10.1159/000446074] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.4] [Reference Citation Analysis]
180 Ding H, Liu J, Wang C, Su Y. NONO promotes hepatocellular carcinoma progression by enhancing fatty acids biosynthesis through interacting with ACLY mRNA. Cancer Cell Int 2020;20:425. [PMID: 32884448 DOI: 10.1186/s12935-020-01520-4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
181 El Sabeh R, Bonnet M, Le Corf K, Lang K, Kfoury A, Badran B, Hussein N, Virard F, Treilleux I, Le Romancer M, Lebecque S, Manie S, Coste I, Renno T. A Gender-Dependent Molecular Switch of Inflammation via MyD88/Estrogen Receptor-Alpha Interaction. J Inflamm Res 2021;14:2149-56. [PMID: 34045885 DOI: 10.2147/JIR.S306805] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
182 Brandon-Warner E, Walling TL, Schrum LW, McKillop IH. Chronic ethanol feeding accelerates hepatocellular carcinoma progression in a sex-dependent manner in a mouse model of hepatocarcinogenesis. Alcohol Clin Exp Res. 2012;36:641-653. [PMID: 22017344 DOI: 10.1111/j.1530-0277.2011.01660.x] [Cited by in Crossref: 50] [Cited by in F6Publishing: 53] [Article Influence: 5.0] [Reference Citation Analysis]
183 Yang JD, Roberts LR. Hepatocellular carcinoma: A global view. Nat Rev Gastroenterol Hepatol 2010;7:448-58. [PMID: 20628345 DOI: 10.1038/nrgastro.2010.100] [Cited by in Crossref: 810] [Cited by in F6Publishing: 766] [Article Influence: 73.6] [Reference Citation Analysis]
184 Tarocchi M, Hannivoort R, Hoshida Y, Lee UE, Vetter D, Narla G, Villanueva A, Oren M, Llovet JM, Friedman SL. Carcinogen-induced hepatic tumors in KLF6+/- mice recapitulate aggressive human hepatocellular carcinoma associated with p53 pathway deregulation. Hepatology. 2011;54:522-531. [PMID: 21563203 DOI: 10.1002/hep.24413] [Cited by in Crossref: 31] [Cited by in F6Publishing: 33] [Article Influence: 3.1] [Reference Citation Analysis]
185 Wang N, Zheng Y, Yu X, Lin W, Chen Y, Jiang Q. Sex-Modified Effect of Hepatitis B Virus Infection on Mortality From Primary Liver Cancer. American Journal of Epidemiology 2009;169:990-5. [DOI: 10.1093/aje/kwn418] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 1.4] [Reference Citation Analysis]
186 Bruchard M, Mignot G, Derangère V, Chalmin F, Chevriaux A, Végran F, Boireau W, Simon B, Ryffel B, Connat JL. Chemotherapy-triggered cathepsin B release in myeloid-derived suppressor cells activates the Nlrp3 inflammasome and promotes tumor growth. Nat Med. 2013;19:57-64. [PMID: 23202296 DOI: 10.1038/nm.2999] [Cited by in Crossref: 431] [Cited by in F6Publishing: 396] [Article Influence: 47.9] [Reference Citation Analysis]
187 Mank JE, Nam K, Brunström B, Ellegren H. Ontogenetic complexity of sexual dimorphism and sex-specific selection. Mol Biol Evol 2010;27:1570-8. [PMID: 20142440 DOI: 10.1093/molbev/msq042] [Cited by in Crossref: 75] [Cited by in F6Publishing: 61] [Article Influence: 6.8] [Reference Citation Analysis]
188 Pergola C, Dodt G, Rossi A, Neunhoeffer E, Lawrenz B, Northoff H, Samuelsson B, Rådmark O, Sautebin L, Werz O. ERK-mediated regulation of leukotriene biosynthesis by androgens: a molecular basis for gender differences in inflammation and asthma. Proc Natl Acad Sci U S A 2008;105:19881-6. [PMID: 19064924 DOI: 10.1073/pnas.0809120105] [Cited by in Crossref: 134] [Cited by in F6Publishing: 121] [Article Influence: 10.3] [Reference Citation Analysis]
189 Lee SA, Kim H, Won YS, Seok SH, Na Y, Shin HB, Inn KS, Kim BJ. Male-specific hepatitis B virus large surface protein variant W4P potentiates tumorigenicity and induces gender disparity. Mol Cancer. 2015;14:23. [PMID: 25645622 DOI: 10.1186/s12943-015-0303-7] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 3.0] [Reference Citation Analysis]
190 Hu B, Yang XB, Sang XT. Molecular subtypes based on immune-related genes predict the prognosis for hepatocellular carcinoma patients. Int Immunopharmacol 2021;90:107164. [PMID: 33172741 DOI: 10.1016/j.intimp.2020.107164] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
191 Li N, Jiang J, Fu J, Yu T, Wang B, Qin W, Xu A, Wu M, Chen Y, Wang H. Targeting interleukin-1 receptor-associated kinase 1 for human hepatocellular carcinoma. J Exp Clin Cancer Res 2016;35. [DOI: 10.1186/s13046-016-0413-0] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 1.2] [Reference Citation Analysis]
192 Johnson C, Han Y, Hughart N, McCarra J, Alpini G, Meng F. Interleukin-6 and its receptor, key players in hepatobiliary inflammation and cancer. Transl Gastrointest Cancer 2012;1:58-70. [PMID: 22724089 DOI: 10.3978/j.issn.2224-4778.2011.11.02] [Cited by in F6Publishing: 60] [Reference Citation Analysis]
193 Ao J, Meng J, Zhu L, Nie H, Yang C, Li J, Gu J, Lin Q, Long W, Dong X. Activation of androgen receptor induces ID1 and promotes hepatocellular carcinoma cell migration and invasion. Mol Oncol. 2012;6:507-515. [PMID: 22819717 DOI: 10.1016/j.molonc.2012.06.005] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 2.3] [Reference Citation Analysis]
194 Tokushige K, Hashimoto E, Kodama K, Tobari M, Matsushita N, Kogiso T, Taniai M, Torii N, Shiratori K, Nishizaki Y, Ohga T, Ohashi Y, Sato T. Serum metabolomic profile and potential biomarkers for severity of fibrosis in nonalcoholic fatty liver disease. J Gastroenterol 2013;48:1392-400. [PMID: 23478936 DOI: 10.1007/s00535-013-0766-5] [Cited by in Crossref: 37] [Cited by in F6Publishing: 33] [Article Influence: 4.6] [Reference Citation Analysis]
195 Swann JB, Vesely MD, Silva A, Sharkey J, Akira S, Schreiber RD, Smyth MJ. Demonstration of inflammation-induced cancer and cancer immunoediting during primary tumorigenesis. Proc Natl Acad Sci U S A. 2008;105:652-656. [PMID: 18178624 DOI: 10.1073/pnas.0708594105] [Cited by in Crossref: 216] [Cited by in F6Publishing: 191] [Article Influence: 16.6] [Reference Citation Analysis]
196 Zhang XF, Yang X, Jia HL, Zhu WW, Lu L, Shi W, Zhang H, Chen JH, Tao YF, Wang ZX, Yang J, Wang LX, Lu M, Zheng Y, Zhao J, Dong QZ, Qin LX. Bcl-2 expression is a poor predictor for hepatocellular carcinoma prognosis of andropause-age patients. Cancer Biol Med 2016;13:459-68. [PMID: 28154777 DOI: 10.20892/j.issn.2095-3941.2016.0077] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
197 Wang FJ, Wang P, Chen LY, Geng YW, Chen H, Meng ZQ, Liu LM, Chen Z. TAM Infiltration Differences in "Tumor-First" and " ZHENG-First" Models and the Underlying Inflammatory Molecular Mechanism in Pancreatic Cancer. Integr Cancer Ther 2018;17:707-16. [PMID: 29681184 DOI: 10.1177/1534735418771193] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
198 Ji J, Shi J, Budhu A, Yu Z, Forgues M, Roessler S, Ambs S, Chen Y, Meltzer PS, Croce CM, Qin LX, Man K, Lo CM, Lee J, Ng IO, Fan J, Tang ZY, Sun HC, Wang XW. MicroRNA expression, survival, and response to interferon in liver cancer. N Engl J Med 2009;361:1437-47. [PMID: 19812400 DOI: 10.1056/NEJMoa0901282] [Cited by in Crossref: 591] [Cited by in F6Publishing: 319] [Article Influence: 49.3] [Reference Citation Analysis]
199 Chen Y, Song X, Valanejad L, Vasilenko A, More V, Qiu X, Chen W, Lai Y, Slitt A, Stoner M. Bile salt export pump is dysregulated with altered farnesoid X receptor isoform expression in patients with hepatocellular carcinoma. Hepatology. 2013;57:1530-1541. [PMID: 23213087 DOI: 10.1002/hep.26187] [Cited by in Crossref: 48] [Cited by in F6Publishing: 38] [Article Influence: 6.0] [Reference Citation Analysis]
200 Pérez-Hernández AI, Catalán V, Gómez-Ambrosi J, Rodríguez A, Frühbeck G. Mechanisms linking excess adiposity and carcinogenesis promotion. Front Endocrinol (Lausanne) 2014;5:65. [PMID: 24829560 DOI: 10.3389/fendo.2014.00065] [Cited by in Crossref: 20] [Cited by in F6Publishing: 44] [Article Influence: 2.9] [Reference Citation Analysis]
201 Mitchell C, Willenbring H. A reproducible and well-tolerated method for 2/3 partial hepatectomy in mice. Nat Protoc 2008;3:1167-70. [PMID: 18600221 DOI: 10.1038/nprot.2008.80] [Cited by in Crossref: 298] [Cited by in F6Publishing: 273] [Article Influence: 22.9] [Reference Citation Analysis]
202 Capece D, Verzella D, Tessitore A, Alesse E, Capalbo C, Zazzeroni F. Cancer secretome and inflammation: The bright and the dark sides of NF-κB. Semin Cell Dev Biol 2018;78:51-61. [PMID: 28779979 DOI: 10.1016/j.semcdb.2017.08.004] [Cited by in Crossref: 35] [Cited by in F6Publishing: 39] [Article Influence: 8.8] [Reference Citation Analysis]
203 Siracusa MC, Overstreet MG, Housseau F, Scott AL, Klein SL. 17beta-estradiol alters the activity of conventional and IFN-producing killer dendritic cells. J Immunol 2008;180:1423-31. [PMID: 18209037 DOI: 10.4049/jimmunol.180.3.1423] [Cited by in Crossref: 67] [Cited by in F6Publishing: 67] [Article Influence: 5.2] [Reference Citation Analysis]
204 Li N, Yamamoto G, Fuji H, Kisseleva T. Interleukin-17 in Liver Disease Pathogenesis. Semin Liver Dis 2021. [PMID: 34130335 DOI: 10.1055/s-0041-1730926] [Reference Citation Analysis]
205 Seshadri S, Kannan Y, Mitra S, Parker-Barnes J, Wewers MD. MAIL regulates human monocyte IL-6 production. J Immunol 2009;183:5358-68. [PMID: 19783680 DOI: 10.4049/jimmunol.0802736] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 2.1] [Reference Citation Analysis]
206 Bakiri L, Wagner EF. Mouse models for liver cancer. Mol Oncol 2013;7:206-23. [PMID: 23428636 DOI: 10.1016/j.molonc.2013.01.005] [Cited by in Crossref: 107] [Cited by in F6Publishing: 92] [Article Influence: 13.4] [Reference Citation Analysis]
207 Khazali AS, Clark AM, Wells A. A Pathway to Personalizing Therapy for Metastases Using Liver-on-a-Chip Platforms. Stem Cell Rev Rep 2017;13:364-80. [PMID: 28425064 DOI: 10.1007/s12015-017-9735-3] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
208 Huang FY, Wong DK, Seto WK, Lai CL, Yuen MF. Estradiol induces apoptosis via activation of miRNA-23a and p53: implication for gender difference in liver cancer development. Oncotarget. 2015;6:34941-34952. [PMID: 26439986 DOI: 10.18632/oncotarget.5472] [Cited by in Crossref: 30] [Cited by in F6Publishing: 27] [Article Influence: 6.0] [Reference Citation Analysis]
209 Hammerich L, Tacke F. Interleukins in chronic liver disease: lessons learned from experimental mouse models. Clin Exp Gastroenterol. 2014;7:297-306. [PMID: 25214799 DOI: 10.2147/ceg.s43737] [Cited by in Crossref: 29] [Cited by in F6Publishing: 39] [Article Influence: 4.1] [Reference Citation Analysis]
210 Li Y, Kang K, Krahn JM, Croutwater N, Lee K, Umbach DM, Li L. A comprehensive genomic pan-cancer classification using The Cancer Genome Atlas gene expression data. BMC Genomics 2017;18:508. [PMID: 28673244 DOI: 10.1186/s12864-017-3906-0] [Cited by in Crossref: 66] [Cited by in F6Publishing: 42] [Article Influence: 16.5] [Reference Citation Analysis]
211 Stubbins RE, Najjar K, Holcomb VB, Hong J, Núñez NP. Oestrogen alters adipocyte biology and protects female mice from adipocyte inflammation and insulin resistance. Diabetes Obes Metab 2012;14:58-66. [PMID: 21834845 DOI: 10.1111/j.1463-1326.2011.01488.x] [Cited by in Crossref: 118] [Cited by in F6Publishing: 106] [Article Influence: 11.8] [Reference Citation Analysis]
212 Lin J, Pu X, Wang W, Matin S, Tannir NM, Wood CG, Wu X. Case-control analysis of nucleotide excision repair pathway and the risk of renal cell carcinoma. Carcinogenesis 2008;29:2112-9. [PMID: 18711149 DOI: 10.1093/carcin/bgn189] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
213 Wei T, Chen W, Wen L, Zhang J, Zhang Q, Yang J, Liu H, Chen BW, Zhou Y, Feng X, Yang Q, Bai X, Liang T. G protein-coupled estrogen receptor deficiency accelerates liver tumorigenesis by enhancing inflammation and fibrosis. Cancer Letters 2016;382:195-202. [DOI: 10.1016/j.canlet.2016.08.012] [Cited by in Crossref: 30] [Cited by in F6Publishing: 26] [Article Influence: 6.0] [Reference Citation Analysis]
214 Bingül İ, Başaran-Küçükgergin C, Tekkeşin MS, Olgaç V, Doğru-Abbasoğlu S, Uysal M. Effect of blueberry pretreatment on diethylnitrosamine-induced oxidative stress and liver injury in rats. Environ Toxicol Pharmacol 2013;36:529-38. [PMID: 23811110 DOI: 10.1016/j.etap.2013.05.014] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 2.3] [Reference Citation Analysis]
215 Kao JH, Chen PJ, Chen DS. Recent advances in the research of hepatitis B virus-related hepatocellular carcinoma: epidemiologic and molecular biological aspects. Adv Cancer Res. 2010;108:21-72. [PMID: 21034965 DOI: 10.1016/b978-0-12-380888-2.00002-9] [Cited by in Crossref: 61] [Cited by in F6Publishing: 27] [Article Influence: 6.1] [Reference Citation Analysis]
216 McLoughlin MR, Orlicky DJ, Prigge JR, Krishna P, Talago EA, Cavigli IR, Eriksson S, Miller CG, Kundert JA, Sayin VI, Sabol RA, Heinemann J, Brandenberger LO, Iverson SV, Bothner B, Papagiannakopoulos T, Shearn CT, Arnér ESJ, Schmidt EE. TrxR1, Gsr, and oxidative stress determine hepatocellular carcinoma malignancy. Proc Natl Acad Sci U S A 2019;116:11408-17. [PMID: 31097586 DOI: 10.1073/pnas.1903244116] [Cited by in Crossref: 21] [Cited by in F6Publishing: 16] [Article Influence: 10.5] [Reference Citation Analysis]
217 Tobari M, Hashimoto E. Characteristic Features of Nonalcoholic Fatty Liver Disease in Japan with a Focus on the Roles of Age, Sex and Body Mass Index. Gut Liver 2020;14:537-45. [PMID: 31887811 DOI: 10.5009/gnl19236] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 13.0] [Reference Citation Analysis]
218 Meng Z, Wang X, Gan Y, Zhang Y, Zhou H, Ness CV, Wu J, Lou G, Yu H, He C, Xu R, Huang W. Deletion of IFNγ enhances hepatocarcinogenesis in FXR knockout mice. J Hepatol 2012;57:1004-12. [PMID: 22728874 DOI: 10.1016/j.jhep.2012.06.016] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 2.3] [Reference Citation Analysis]
219 Kido T, Lau YC. The Y-linked proto-oncogene TSPY contributes to poor prognosis of the male hepatocellular carcinoma patients by promoting the pro-oncogenic and suppressing the anti-oncogenic gene expression. Cell Biosci 2019;9:22. [PMID: 30867900 DOI: 10.1186/s13578-019-0287-x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
220 Athuluri-Divakar SK, Hoshida Y. Generic chemoprevention of hepatocellular carcinoma. Ann N Y Acad Sci 2019;1440:23-35. [PMID: 30221358 DOI: 10.1111/nyas.13971] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
221 Liu Y, Li PK, Li C, Lin J. Inhibition of STAT3 signaling blocks the anti-apoptotic activity of IL-6 in human liver cancer cells. J Biol Chem 2010;285:27429-39. [PMID: 20562100 DOI: 10.1074/jbc.M110.142752] [Cited by in Crossref: 112] [Cited by in F6Publishing: 62] [Article Influence: 10.2] [Reference Citation Analysis]
222 Keng VW, Villanueva A, Chiang DY, Dupuy AJ, Ryan BJ, Matise I, Silverstein KA, Sarver A, Starr TK, Akagi K, Tessarollo L, Collier LS, Powers S, Lowe SW, Jenkins NA, Copeland NG, Llovet JM, Largaespada DA. A conditional transposon-based insertional mutagenesis screen for genes associated with mouse hepatocellular carcinoma. Nat Biotechnol 2009;27:264-74. [PMID: 19234449 DOI: 10.1038/nbt.1526] [Cited by in Crossref: 156] [Cited by in F6Publishing: 140] [Article Influence: 13.0] [Reference Citation Analysis]
223 Chen CL, Kuo MJ, Yen AM, Yang WS, Kao JH, Chen PJ, Chen HH. Gender Difference in the Association Between Metabolic Factors and Hepatocellular Carcinoma. JNCI Cancer Spectr 2020;4:pkaa036. [PMID: 33134821 DOI: 10.1093/jncics/pkaa036] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
224 Ma M, Zhou Y, Sun R, Shi J, Tan Y, Yang H, Zhang M, Shen R, Xu L, Wang Z, Fei J. STAT3 and AKT signaling pathways mediate oncogenic role of NRSF in hepatocellular carcinoma. Acta Biochim Biophys Sin (Shanghai) 2020;52:1063-70. [PMID: 32556117 DOI: 10.1093/abbs/gmaa069] [Reference Citation Analysis]
225 Fu Y, Cai L, Lei X, Wang D. Circular RNA ABCB10 promotes hepatocellular carcinoma progression by increasing HMG20A expression by sponging miR-670-3p. Cancer Cell Int 2019;19:338. [PMID: 31889891 DOI: 10.1186/s12935-019-1055-z] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 6.0] [Reference Citation Analysis]
226 Blechacz B, Mishra L. Hepatocellular carcinoma biology. Recent Results Cancer Res. 2013;190:1-20. [PMID: 22941010 DOI: 10.1007/978-3-642-16037-0_1] [Cited by in Crossref: 30] [Cited by in F6Publishing: 36] [Article Influence: 3.8] [Reference Citation Analysis]
227 Kim M, Park SW, Kim M, D'Agati VD, Lee HT. Isoflurane activates intestinal sphingosine kinase to protect against renal ischemia-reperfusion-induced liver and intestine injury. Anesthesiology 2011;114:363-73. [PMID: 21245730 DOI: 10.1097/ALN.0b013e3182070c3a] [Cited by in Crossref: 26] [Cited by in F6Publishing: 18] [Article Influence: 2.6] [Reference Citation Analysis]
228 Ernst M, Najdovska M, Grail D, Lundgren-May T, Buchert M, Tye H, Matthews VB, Armes J, Bhathal PS, Hughes NR, Marcusson EG, Karras JG, Na S, Sedgwick JD, Hertzog PJ, Jenkins BJ. STAT3 and STAT1 mediate IL-11-dependent and inflammation-associated gastric tumorigenesis in gp130 receptor mutant mice. J Clin Invest 2008;118:1727-38. [PMID: 18431520 DOI: 10.1172/JCI34944] [Cited by in Crossref: 31] [Cited by in F6Publishing: 130] [Article Influence: 2.4] [Reference Citation Analysis]
229 Kim S, Karin M. Role of TLR2-dependent inflammation in metastatic progression. Ann N Y Acad Sci 2011;1217:191-206. [PMID: 21276007 DOI: 10.1111/j.1749-6632.2010.05882.x] [Cited by in Crossref: 42] [Cited by in F6Publishing: 40] [Article Influence: 4.2] [Reference Citation Analysis]
230 Li W, Lebrun DG, Li M. The expression and functions of microRNAs in pancreatic adenocarcinoma and hepatocellular carcinoma. Chin J Cancer. 2011;30:540-550. [PMID: 21801602 DOI: 10.5732/cjc.011.10197] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
231 Sander LE, Trautwein C, Liedtke C. Is interleukin-6 a gender-specific risk factor for liver cancer? Hepatology 2007;46:1304-5. [PMID: 17896415 DOI: 10.1002/hep.21982] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 1.4] [Reference Citation Analysis]
232 Rustemoglu A, Erkol Inal E, Inanir A, Ekinci D, Gul U, Yigit S, Ates O, Karakus N. Clinical significance of NCOA5 gene rs2903908 polymorphism in Behçet's disease. EXCLI J 2017;16:609-17. [PMID: 28694762 DOI: 10.17179/excli2017-189] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
233 Koch KS, Maeda S, He G, Karin M, Leffert HL. Targeted deletion of hepatocyte Ikkbeta confers growth advantages. Biochem Biophys Res Commun 2009;380:349-54. [PMID: 19171122 DOI: 10.1016/j.bbrc.2009.01.085] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 1.1] [Reference Citation Analysis]
234 Mauer J, Denson JL, Brüning JC. Versatile functions for IL-6 in metabolism and cancer. Trends Immunol 2015;36:92-101. [PMID: 25616716 DOI: 10.1016/j.it.2014.12.008] [Cited by in Crossref: 196] [Cited by in F6Publishing: 162] [Article Influence: 32.7] [Reference Citation Analysis]
235 Okayasu I, Ohnishi H, Sarandi I, Shojima J, Komatsu J, Oritsu M, Sasabe M, Nanami KO, Matsuura M, Azumi J, Ito S, Fujiwara M. Significant increase of prostaglandin E-major urinary metabolite in male smokers: a screening study of age and gender differences using a simple radioimmunoassay. J Clin Lab Anal 2014;28:32-41. [PMID: 24375858 DOI: 10.1002/jcla.21640] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 2.0] [Reference Citation Analysis]
236 Srivastava J, Robertson CL, Ebeid K, Dozmorov M, Rajasekaran D, Mendoza R, Siddiq A, Akiel MA, Jariwala N, Shen XN, Windle JJ, Subler MA, Mukhopadhyay ND, Giashuddin S, Ghosh S, Lai Z, Chen Y, Fisher PB, Salem AK, Sanyal AJ, Sarkar D. A novel role of astrocyte elevated gene-1 (AEG-1) in regulating nonalcoholic steatohepatitis (NASH). Hepatology 2017;66:466-80. [PMID: 28437865 DOI: 10.1002/hep.29230] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 3.3] [Reference Citation Analysis]
237 Rubin JB, Lagas JS, Broestl L, Sponagel J, Rockwell N, Rhee G, Rosen SF, Chen S, Klein RS, Imoukhuede P, Luo J. Sex differences in cancer mechanisms. Biol Sex Differ 2020;11:17. [PMID: 32295632 DOI: 10.1186/s13293-020-00291-x] [Cited by in Crossref: 42] [Cited by in F6Publishing: 27] [Article Influence: 42.0] [Reference Citation Analysis]
238 Weigert A, Sekar D, Brüne B. Tumor-associated macrophages as targets for tumor immunotherapy. Immunotherapy 2009;1:83-95. [PMID: 20635976 DOI: 10.2217/1750743X.1.1.83] [Cited by in Crossref: 33] [Cited by in F6Publishing: 14] [Article Influence: 3.3] [Reference Citation Analysis]
239 Dalwadi DA, Torrens L, Abril-Fornaguera J, Pinyol R, Willoughby C, Posey J, Llovet JM, Lanciault C, Russell DW, Grompe M, Naugler WE. Liver Injury Increases the Incidence of HCC following AAV Gene Therapy in Mice. Mol Ther 2021;29:680-90. [PMID: 33554867 DOI: 10.1016/j.ymthe.2020.10.018] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
240 Señarís RM, Trujillo ML, Navia B, Comes G, Ferrer B, Giralt M, Hidalgo J. Interleukin-6 Regulates the Expression of Hypothalamic Neuropeptides Involved in Body Weight in a Gender-Dependent Way: IL-6 and hypothalamic neuropeptides. Journal of Neuroendocrinology 2011;23:675-86. [DOI: 10.1111/j.1365-2826.2011.02158.x] [Cited by in Crossref: 44] [Cited by in F6Publishing: 38] [Article Influence: 4.4] [Reference Citation Analysis]
241 Rando G, Wahli W. Sex differences in nuclear receptor-regulated liver metabolic pathways. Biochim Biophys Acta 2011;1812:964-73. [PMID: 21211563 DOI: 10.1016/j.bbadis.2010.12.023] [Cited by in Crossref: 45] [Cited by in F6Publishing: 38] [Article Influence: 4.5] [Reference Citation Analysis]
242 Biswas SK, Lewis CE. NF-κB as a central regulator of macrophage function in tumors. J Leukoc Biol 2010;88:877-84. [PMID: 20573802 DOI: 10.1189/jlb.0310153] [Cited by in Crossref: 85] [Cited by in F6Publishing: 80] [Article Influence: 7.7] [Reference Citation Analysis]
243 Vilar-gomez E, Calzadilla-bertot L, Wai-sun Wong V, Castellanos M, Aller-de la Fuente R, Metwally M, Eslam M, Gonzalez-fabian L, Alvarez-quiñones Sanz M, Conde-martin AF, De Boer B, Mcleod D, Hung Chan AW, Chalasani N, George J, Adams LA, Romero-gomez M. Fibrosis Severity as a Determinant of Cause-Specific Mortality in Patients With Advanced Nonalcoholic Fatty Liver Disease: A Multi-National Cohort Study. Gastroenterology 2018;155:443-457.e17. [DOI: 10.1053/j.gastro.2018.04.034] [Cited by in Crossref: 235] [Cited by in F6Publishing: 209] [Article Influence: 78.3] [Reference Citation Analysis]
244 Yeh H, Chiang CC, Yen TH. Hepatocellular carcinoma in patients with renal dysfunction: Pathophysiology, prognosis, and treatment challenges. World J Gastroenterol 2021;27:4104-42. [PMID: 34326614 DOI: 10.3748/wjg.v27.i26.4104] [Reference Citation Analysis]
245 Liu C, Ren YF, Dong J, Ke MY, Ma F, Monga SPS, Wu R, Lv Y, Zhang XF. Activation of SRY accounts for male-specific hepatocarcinogenesis: Implication in gender disparity of hepatocellular carcinoma. Cancer Lett 2017;410:20-31. [PMID: 28942012 DOI: 10.1016/j.canlet.2017.09.013] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
246 Khan S, Zaki H. Crosstalk between NLRP12 and JNK during Hepatocellular Carcinoma. Int J Mol Sci 2020;21:E496. [PMID: 31941025 DOI: 10.3390/ijms21020496] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
247 Wang Z, Yan J, Lin H, Hua F, Wang X, Liu H, Lv X, Yu J, Mi S, Wang J, Hu ZW. Toll-like receptor 4 activity protects against hepatocellular tumorigenesis and progression by regulating expression of DNA repair protein Ku70 in mice. Hepatology 2013;57:1869-81. [PMID: 23299825 DOI: 10.1002/hep.26234] [Cited by in Crossref: 48] [Cited by in F6Publishing: 32] [Article Influence: 6.0] [Reference Citation Analysis]
248 Fujii M, Shibazaki Y, Wakamatsu K, Honda Y, Kawauchi Y, Suzuki K, Arumugam S, Watanabe K, Ichida T, Asakura H. A murine model for non-alcoholic steatohepatitis showing evidence of association between diabetes and hepatocellular carcinoma. Med Mol Morphol. 2013;46:141-152. [PMID: 23430399 DOI: 10.1007/s00795-013-0016-1] [Cited by in Crossref: 166] [Cited by in F6Publishing: 152] [Article Influence: 20.8] [Reference Citation Analysis]
249 Iyer JK, Kalra M, Kaul A, Payton ME, Kaul R. Estrogen receptor expression in chronic hepatitis C and hepatocellular carcinoma pathogenesis. World J Gastroenterol. 2017;23:6802-6816. [PMID: 29085224 DOI: 10.3748/wjg.v23.i37.6802] [Cited by in CrossRef: 28] [Cited by in F6Publishing: 24] [Article Influence: 9.3] [Reference Citation Analysis]
250 Iorns E, Lord CJ, Grigoriadis A, McDonald S, Fenwick K, Mackay A, Mein CA, Natrajan R, Savage K, Tamber N, Reis-Filho JS, Turner NC, Ashworth A. Integrated functional, gene expression and genomic analysis for the identification of cancer targets. PLoS One. 2009;4:e5120. [PMID: 19357772 DOI: 10.1371/journal.pone.0005120] [Cited by in Crossref: 78] [Cited by in F6Publishing: 67] [Article Influence: 6.5] [Reference Citation Analysis]
251 Bergmann J, Müller M, Baumann N, Reichert M, Heneweer C, Bolik J, Lücke K, Gruber S, Carambia A, Boretius S, Leuschner I, Becker T, Rabe B, Herkel J, Wunderlich FT, Mittrücker HW, Rose-John S, Schmidt-Arras D. IL-6 trans-signaling is essential for the development of hepatocellular carcinoma in mice. Hepatology 2017;65:89-103. [PMID: 27770462 DOI: 10.1002/hep.28874] [Cited by in Crossref: 71] [Cited by in F6Publishing: 69] [Article Influence: 14.2] [Reference Citation Analysis]
252 Yang H, Xuefeng Y, Jianhua X. Systematic review of the roles of interleukins in hepatocellular carcinoma. Clin Chim Acta 2020;506:33-43. [PMID: 32142718 DOI: 10.1016/j.cca.2020.03.001] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
253 Hashimoto E, Tokushige K. Prevalence, gender, ethnic variations, and prognosis of NASH. J Gastroenterol 2011;46:63-9. [DOI: 10.1007/s00535-010-0311-8] [Cited by in Crossref: 152] [Cited by in F6Publishing: 131] [Article Influence: 13.8] [Reference Citation Analysis]
254 Dufour JF. C-reactive protein, a prognostic marker in hepatocellular carcinoma. Hepatology 2013;57:2103-5. [PMID: 23315964 DOI: 10.1002/hep.26250] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
255 Weber SN, Bohner A, Dapito DH, Schwabe RF, Lammert F. TLR4 Deficiency Protects against Hepatic Fibrosis and Diethylnitrosamine-Induced Pre-Carcinogenic Liver Injury in Fibrotic Liver. PLoS One. 2016;11:e0158819. [PMID: 27391331 DOI: 10.1371/journal.pone.0158819] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 2.2] [Reference Citation Analysis]
256 Mendy M, Walton R. Molecular pathogenesis and early detection of hepatocellular carcinoma--perspectives from West Africa. Cancer Lett. 2009;286:44-51. [PMID: 19523756 DOI: 10.1016/j.canlet.2009.04.039] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
257 Oberley CC, Bilger A, Drinkwater NR. Genetic background determines if Stat5b suppresses or enhances murine hepatocarcinogenesis. Mol Carcinog 2015;54:959-70. [PMID: 24838184 DOI: 10.1002/mc.22165] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
258 Afum C, Cudjoe L, Hills J, Hunt R, Padilla LA, Elmore S, Afriyie A, Opare-Sem O, Phillips T, Jolly PE. Association between Aflatoxin M₁ and Liver Disease in HBV/HCV Infected Persons in Ghana. Int J Environ Res Public Health 2016;13:377. [PMID: 27043586 DOI: 10.3390/ijerph13040377] [Cited by in Crossref: 21] [Cited by in F6Publishing: 14] [Article Influence: 4.2] [Reference Citation Analysis]
259 Karin M. New insights into the pathogenesis and treatment of non-viral hepatocellular carcinoma: a balancing act between immunosuppression and immunosurveillance. Precis Clin Med. 2018;1:21-28. [PMID: 30687560 DOI: 10.1093/pcmedi/pby005] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 2.3] [Reference Citation Analysis]
260 Harada K, Nakanuma Y. Prevalence and risk factors of hepatocellular carcinoma in Japanese patients with primary biliary cirrhosis. Hepatol Res. 2014;44:133-140. [PMID: 24102868 DOI: 10.1111/hepr.12242] [Cited by in Crossref: 10] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
261 Takakura K, Oikawa T, Nakano M, Saeki C, Torisu Y, Kajihara M, Saruta M. Recent Insights Into the Multiple Pathways Driving Non-alcoholic Steatohepatitis-Derived Hepatocellular Carcinoma.Front Oncol. 2019;9:762. [PMID: 31456946 DOI: 10.3389/fonc.2019.00762] [Cited by in Crossref: 12] [Cited by in F6Publishing: 15] [Article Influence: 6.0] [Reference Citation Analysis]
262 Chikada H, Ida K, Ando E, Inagaki Y, Sakamoto A, Kamiya A. Establishment and analysis of a mouse model that regulates sex-related differences in liver drug metabolism. Lab Invest 2018;98:1500-11. [PMID: 29968852 DOI: 10.1038/s41374-018-0088-6] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
263 Wang S, Sugamori KS, Tung A, McPherson JP, Grant DM. N-hydroxylation of 4-aminobiphenyl by CYP2E1 produces oxidative stress in a mouse model of chemically induced liver cancer. Toxicol Sci 2015;144:393-405. [PMID: 25601990 DOI: 10.1093/toxsci/kfv006] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
264 Kim E, Viatour P. Hepatocellular carcinoma: old friends and new tricks. Exp Mol Med. 2020;52:1898-1907. [PMID: 33268834 DOI: 10.1038/s12276-020-00527-1] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 11.0] [Reference Citation Analysis]
265 Woo LL, Egner PA, Belanger CL, Wattanawaraporn R, Trudel LJ, Croy RG, Groopman JD, Essigmann JM, Wogan GN, Bouhenguel JT. Aflatoxin B1-DNA adduct formation and mutagenicity in livers of neonatal male and female B6C3F1 mice. Toxicol Sci 2011;122:38-44. [PMID: 21507988 DOI: 10.1093/toxsci/kfr087] [Cited by in Crossref: 44] [Cited by in F6Publishing: 40] [Article Influence: 4.4] [Reference Citation Analysis]
266 Erreni M, Mantovani A, Allavena P. Tumor-associated Macrophages (TAM) and Inflammation in Colorectal Cancer. Cancer Microenviron. 2011;4:141-154. [PMID: 21909876 DOI: 10.1007/s12307-010-0052-5] [Cited by in Crossref: 205] [Cited by in F6Publishing: 193] [Article Influence: 18.6] [Reference Citation Analysis]
267 Hurwitz AA, Watkins SK. Immune suppression in the tumor microenvironment: a role for dendritic cell-mediated tolerization of T cells. Cancer Immunol Immunother 2012;61:289-93. [PMID: 22237887 DOI: 10.1007/s00262-011-1181-5] [Cited by in Crossref: 60] [Cited by in F6Publishing: 50] [Article Influence: 6.7] [Reference Citation Analysis]
268 Öcal O, Kupčinskas J, Morkunas E, Amthauer H, Schütte K, Malfertheiner P, Klümpen HJ, Sengel C, Benckert J, Seidensticker R, Sangro B, Wildgruber M, Pech M, Bartenstein P, Ricke J, Seidensticker M. Prognostic value of baseline interleukin 6 levels in liver decompensation and survival in HCC patients undergoing radioembolization. EJNMMI Res 2021;11:51. [PMID: 34080071 DOI: 10.1186/s13550-021-00791-w] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
269 Sutti S, Tacke F. Liver inflammation and regeneration in drug-induced liver injury: sex matters! Clin Sci (Lond) 2018;132:609-13. [PMID: 29545336 DOI: 10.1042/CS20171313] [Cited by in Crossref: 11] [Cited by in F6Publishing: 5] [Article Influence: 3.7] [Reference Citation Analysis]
270 Germano G, Allavena P, Mantovani A. Cytokines as a key component of cancer-related inflammation. Cytokine. 2008;43:374-379. [PMID: 18701317 DOI: 10.1016/j.cyto.2008.07.014] [Cited by in Crossref: 198] [Cited by in F6Publishing: 191] [Article Influence: 15.2] [Reference Citation Analysis]
271 Wang RF, Miyahara Y, Wang HY. Toll-like receptors and immune regulation: implications for cancer therapy. Oncogene. 2008;27:181-189. [PMID: 18176599 DOI: 10.1038/sj.onc.1210906] [Cited by in Crossref: 94] [Cited by in F6Publishing: 86] [Article Influence: 7.2] [Reference Citation Analysis]
272 Michalak EM, Vandenberg CJ, Delbridge AR, Wu L, Scott CL, Adams JM, Strasser A. Apoptosis-promoted tumorigenesis: gamma-irradiation-induced thymic lymphomagenesis requires Puma-driven leukocyte death. Genes Dev 2010;24:1608-13. [PMID: 20679396 DOI: 10.1101/gad.1940110] [Cited by in Crossref: 90] [Cited by in F6Publishing: 86] [Article Influence: 8.2] [Reference Citation Analysis]
273 Hanna D, Riedmaier AE, Sugamori KS, Grant DM. Influence of sex and developmental stage on acute hepatotoxic and inflammatory responses to liver procarcinogens in the mouse. Toxicology 2016;373:30-40. [PMID: 27746196 DOI: 10.1016/j.tox.2016.10.006] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
274 Erdman SE, Rao VP, Olipitz W, Taylor CL, Jackson EA, Levkovich T, Lee CW, Horwitz BH, Fox JG, Ge Z. Unifying roles for regulatory T cells and inflammation in cancer. Int J Cancer. 2010;126:1651-1665. [PMID: 19795459 DOI: 10.1002/ijc.24923] [Cited by in Crossref: 17] [Cited by in F6Publishing: 42] [Article Influence: 1.5] [Reference Citation Analysis]
275 Yao M, Brummer G, Acevedo D, Cheng N. Cytokine Regulation of Metastasis and Tumorigenicity. Adv Cancer Res. 2016;132:265-367. [PMID: 27613135 DOI: 10.1016/bs.acr.2016.05.005] [Cited by in Crossref: 37] [Cited by in F6Publishing: 34] [Article Influence: 7.4] [Reference Citation Analysis]
276 Kassam I, Lloyd-Jones L, Holloway A, Small KS, Zeng B, Bakshi A, Metspalu A, Gibson G, Spector TD, Esko T, Montgomery GW, Powell JE, Yang J, Visscher PM, McRae AF. Autosomal genetic control of human gene expression does not differ across the sexes. Genome Biol 2016;17:248. [PMID: 27908293 DOI: 10.1186/s13059-016-1111-0] [Cited by in Crossref: 11] [Cited by in F6Publishing: 5] [Article Influence: 2.2] [Reference Citation Analysis]
277 Missiha SB, Ostrowski M, Heathcote EJ. Disease Progression in Chronic Hepatitis C: Modifiable and Nonmodifiable Factors. Gastroenterology 2008;134:1699-714. [DOI: 10.1053/j.gastro.2008.02.069] [Cited by in Crossref: 152] [Cited by in F6Publishing: 126] [Article Influence: 11.7] [Reference Citation Analysis]
278 Mittal D, Saccheri F, Vénéreau E, Pusterla T, Bianchi ME, Rescigno M. TLR4-mediated skin carcinogenesis is dependent on immune and radioresistant cells. EMBO J 2010;29:2242-52. [PMID: 20526283 DOI: 10.1038/emboj.2010.94] [Cited by in Crossref: 116] [Cited by in F6Publishing: 107] [Article Influence: 10.5] [Reference Citation Analysis]
279 Khajeh Alizadeh Attar M, Anwar MA, Eskian M, Keshavarz-Fathi M, Choi S, Rezaei N. Basic understanding and therapeutic approaches to target toll-like receptors in cancerous microenvironment and metastasis. Med Res Rev 2018;38:1469-84. [PMID: 29283184 DOI: 10.1002/med.21480] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
280 Maeda S, Omata M. Inflammation and cancer: role of nuclear factor-kappaB activation. Cancer science. 2008;99:836-842. [PMID: 18294278 DOI: 10.1111/j.1349-7006.2008.00763.x] [Cited by in Crossref: 157] [Cited by in F6Publishing: 141] [Article Influence: 12.1] [Reference Citation Analysis]
281 Pollutri D, Gramantieri L, Bolondi L, Fornari F. TP53/MicroRNA Interplay in Hepatocellular Carcinoma. Int J Mol Sci. 2016;17. [PMID: 27918441 DOI: 10.3390/ijms17122029] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 4.4] [Reference Citation Analysis]
282 Peng W, Chen Y, Jiang Q, Zheng Y. Spatial analysis of hepatocellular carcinoma and socioeconomic status in China from a population-based cancer registry. Cancer Epidemiol 2010;34:29-33. [PMID: 20075018 DOI: 10.1016/j.canep.2009.12.013] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
283 Han X, Liu A, Zhao X, Li Y, Zheng G, Zhang G. Immunizing Effects of Cocultures of H22 Hepatocarcinoma Cells and Cartilage Polysaccharide on Murine H22 Hepatocarcinoma. Journal of Food Science 2010;75:H265-73. [DOI: 10.1111/j.1750-3841.2009.01509.x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
284 Singh AK, Kumar R, Pandey AK. Hepatocellular Carcinoma: Causes, Mechanism of Progression and Biomarkers. Curr Chem Genom Transl Med. 2018;12:9-26. [PMID: 30069430 DOI: 10.2174/2213988501812010009] [Cited by in Crossref: 52] [Cited by in F6Publishing: 45] [Article Influence: 17.3] [Reference Citation Analysis]
285 Xiang P, He R, Liu R, Li K, Gao P, Cui X, Li H, Liu Y, Ma LQ. Cellular responses of normal (HL-7702) and cancerous (HepG2) hepatic cells to dust extract exposure. Chemosphere 2018;193:1189-97. [DOI: 10.1016/j.chemosphere.2017.11.123] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 5.3] [Reference Citation Analysis]
286 Ghosh S, Dungdung SR, Choudhury ST, Chakraborty S, Das N. Mitochondria protection with ginkgolide B-loaded polymeric nanocapsules prevents diethylnitrosamine-induced hepatocarcinoma in rats. Nanomedicine 2014;9:441-56. [DOI: 10.2217/nnm.13.56] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.7] [Reference Citation Analysis]
287 Mu Y, She R, Zhang H, Dong B, Huang C, Lin W, Li D, Li X. Effects of estrogen and androgen deprivation on the progression of non-alcoholic steatohepatitis (NASH) in male Sprague-Dawley rats. Hepatol Res 2009;39:910-20. [PMID: 19453544 DOI: 10.1111/j.1872-034X.2009.00512.x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 4] [Article Influence: 0.9] [Reference Citation Analysis]
288 Kennedy GD, Nukaya M, Moran SM, Glover E, Weinberg S, Balbo S, Hecht SS, Pitot HC, Drinkwater NR, Bradfield CA. Liver tumor promotion by 2,3,7,8-tetrachlorodibenzo-p-dioxin is dependent on the aryl hydrocarbon receptor and TNF/IL-1 receptors. Toxicol Sci 2014;140:135-43. [PMID: 24718703 DOI: 10.1093/toxsci/kfu065] [Cited by in Crossref: 31] [Cited by in F6Publishing: 24] [Article Influence: 4.4] [Reference Citation Analysis]
289 Tu S, Bhagat G, Cui G, Takaishi S, Kurt-Jones EA, Rickman B, Betz KS, Penz-Oesterreicher M, Bjorkdahl O, Fox JG. Overexpression of interleukin-1beta induces gastric inflammation and cancer and mobilizes myeloid-derived suppressor cells in mice. Cancer Cell. 2008;14:408-419. [PMID: 18977329 DOI: 10.1016/j.ccr] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
290 Chikada H, Ida K, Nishikawa Y, Inagaki Y, Kamiya A. Liver-specific knockout of B cell lymphoma 6 suppresses progression of non-alcoholic steatohepatitis in mice. Sci Rep 2020;10:9704. [PMID: 32546802 DOI: 10.1038/s41598-020-66539-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
291 Schumacher N, Rose-John S, Schmidt-Arras D. ADAM-Mediated Signalling Pathways in Gastrointestinal Cancer Formation. Int J Mol Sci 2020;21:E5133. [PMID: 32698506 DOI: 10.3390/ijms21145133] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
292 Liu Y, Lin J. Blocking the IL-6-STAT3 signaling pathway: potential liver cancer therapy. Future Oncol 2011;7:161-4. [PMID: 21345134 DOI: 10.2217/fon.10.183] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
293 Yang Q, Yan C, Gong Z. Activation of liver stromal cells is associated with male-biased liver tumor initiation in xmrk and Myc transgenic zebrafish. Sci Rep 2017;7:10315. [PMID: 28871112 DOI: 10.1038/s41598-017-10529-1] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 2.8] [Reference Citation Analysis]
294 Clocchiatti A, Cora E, Zhang Y, Dotto GP. Sexual dimorphism in cancer. Nat Rev Cancer 2016;16:330-9. [PMID: 27079803 DOI: 10.1038/nrc.2016.30] [Cited by in Crossref: 117] [Cited by in F6Publishing: 99] [Article Influence: 23.4] [Reference Citation Analysis]
295 Laoui D, Van Overmeire E, Movahedi K, Van den Bossche J, Schouppe E, Mommer C, Nikolaou A, Morias Y, De Baetselier P, Van Ginderachter JA. Mononuclear phagocyte heterogeneity in cancer: different subsets and activation states reaching out at the tumor site. Immunobiology 2011;216:1192-202. [PMID: 21803441 DOI: 10.1016/j.imbio.2011.06.007] [Cited by in Crossref: 56] [Cited by in F6Publishing: 52] [Article Influence: 5.6] [Reference Citation Analysis]
296 Svinarenko M, Katz SF, Tharehalli U, Mulaw MA, Maier HJ, Sunami Y, Fischer SK, Chen Y, Heurich S, Erkert L, Tannapfel A, Wirth T, Schirmbeck R, Seufferlein T, Lechel A. An IKK/NF-κB Activation/p53 Deletion Sequence Drives Liver Carcinogenesis and Tumor Differentiation. Cancers (Basel) 2019;11:E1410. [PMID: 31546614 DOI: 10.3390/cancers11101410] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
297 Zheng B, Zhu YJ, Wang HY, Chen L. Gender disparity in hepatocellular carcinoma (HCC): multiple underlying mechanisms. Sci China Life Sci. 2017;60:575-584. [PMID: 28547581 DOI: 10.1007/s11427-016-9043-9] [Cited by in Crossref: 29] [Cited by in F6Publishing: 30] [Article Influence: 7.3] [Reference Citation Analysis]
298 Yang W, Lu Y, Xu Y, Xu L, Zheng W, Wu Y, Li L, Shen P. Estrogen represses hepatocellular carcinoma (HCC) growth via inhibiting alternative activation of tumor-associated macrophages (TAMs). J Biol Chem. 2012;287:40140-40149. [PMID: 22908233 DOI: 10.1074/jbc.M112.348763] [Cited by in Crossref: 64] [Cited by in F6Publishing: 39] [Article Influence: 7.1] [Reference Citation Analysis]
299 Merle P, Trepo C. Molecular mechanisms underlying hepatocellular carcinoma. Viruses. 2009;1:852-872. [PMID: 21994573 DOI: 10.3390/v1030852] [Cited by in Crossref: 29] [Cited by in F6Publishing: 21] [Article Influence: 2.4] [Reference Citation Analysis]
300 Xie L, Jiang FC, Zhang LM, He WT, Liu JH, Li MQ, Zhang X, Xing S, Guo H, Zhou P. Targeting of MyD88 Homodimerization by Novel Synthetic Inhibitor TJ-M2010-5 in Preventing Colitis-Associated Colorectal Cancer. J Natl Cancer Inst 2016;108:djv364. [PMID: 26712311 DOI: 10.1093/jnci/djv364] [Cited by in Crossref: 32] [Cited by in F6Publishing: 27] [Article Influence: 5.3] [Reference Citation Analysis]
301 van Zijl F, Krupitza G, Mikulits W. Initial steps of metastasis: cell invasion and endothelial transmigration. Mutat Res 2011;728:23-34. [PMID: 21605699 DOI: 10.1016/j.mrrev.2011.05.002] [Cited by in Crossref: 396] [Cited by in F6Publishing: 355] [Article Influence: 39.6] [Reference Citation Analysis]
302 Dawood RM, Salum GM, Abd El-Meguid M, Shemis M, Abdel Aziz AO, El Awady MK. Recipient interleukin 6 gene polymorphism and expression predict HCV recurrence post liver transplantation. Gene 2020;754:144887. [PMID: 32534059 DOI: 10.1016/j.gene.2020.144887] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
303 Wang SH, Yeh SH, Chen PJ. Unique Features of Hepatitis B Virus-Related Hepatocellular Carcinoma in Pathogenesis and Clinical Significance. Cancers (Basel) 2021;13:2454. [PMID: 34070067 DOI: 10.3390/cancers13102454] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
304 Cui J, Chen Y, Wang HY, Wang RF. Mechanisms and pathways of innate immune activation and regulation in health and cancer. Hum Vaccin Immunother. 2014;10:3270-3285. [PMID: 25625930 DOI: 10.4161/21645515.2014.979640] [Cited by in Crossref: 121] [Cited by in F6Publishing: 110] [Article Influence: 20.2] [Reference Citation Analysis]
305 Nevzorova YA, Liedtke C. Sh(i)pping signals protect against Stat3-driven liver cancer. Hepatology. 2012;55:322-324. [PMID: 22190379 DOI: 10.1002/hep.24742] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
306 Mathew S, Ali A, Abdel-hafiz H, Fatima K, Suhail M, Archunan G, Begum N, Jahangir S, Ilyas M, Chaudhary AG, Al Qahtani M, Mohamad Bazarah S, Qadri I. Biomarkers for virus-induced hepatocellular carcinoma (HCC). Infection, Genetics and Evolution 2014;26:327-39. [DOI: 10.1016/j.meegid.2014.06.014] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 2.3] [Reference Citation Analysis]
307 Koh MY, Gagea M, Sargis T, Lemos R Jr, Grandjean G, Charbono A, Bekiaris V, Sedy J, Kiriakova G, Liu X, Roberts LR, Ware C, Powis G. A new HIF-1α/RANTES-driven pathway to hepatocellular carcinoma mediated by germline haploinsufficiency of SART1/HAF in mice. Hepatology 2016;63:1576-91. [PMID: 26799785 DOI: 10.1002/hep.28468] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 4.6] [Reference Citation Analysis]
308 Soares JB, Pimentel-Nunes P, Roncon-Albuquerque R, Leite-Moreira A. The role of lipopolysaccharide/toll-like receptor 4 signaling in chronic liver diseases. Hepatol Int. 2010;4:659-672. [PMID: 21286336 DOI: 10.1007/s12072-010-9219-x] [Cited by in Crossref: 147] [Cited by in F6Publishing: 134] [Article Influence: 13.4] [Reference Citation Analysis]
309 Saito K, Negishi M, James Squires E. Sexual dimorphisms in zonal gene expression in mouse liver. Biochem Biophys Res Commun. 2013;436:730-735. [PMID: 23791742 DOI: 10.1016/j.bbrc.2013.06.025] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 2.0] [Reference Citation Analysis]
310 Lai MW, Chu YD, Lin CL, Chien RN, Yeh TS, Pan TL, Ke PY, Lin KH, Yeh CT. Is there a sex difference in postoperative prognosis of hepatocellular carcinoma? BMC Cancer 2019;19:250. [PMID: 30894157 DOI: 10.1186/s12885-019-5453-3] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
311 El-Fattah MA, Aboelmagd M, Elhamouly M. Prognostic factors of hepatocellular carcinoma survival after radiofrequency ablation: A US population-based study. United European Gastroenterol J 2017;5:227-35. [PMID: 28344790 DOI: 10.1177/2050640616659024] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 3.4] [Reference Citation Analysis]
312 Abolarinwa BA, Ibrahim RB, Huang YH. Conceptual Development of Immunotherapeutic Approaches to Gastrointestinal Cancer. Int J Mol Sci 2019;20:E4624. [PMID: 31540435 DOI: 10.3390/ijms20184624] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
313 Stender JD, Nwachukwu JC, Kastrati I, Kim Y, Strid T, Yakir M, Srinivasan S, Nowak J, Izard T, Rangarajan ES, Carlson KE, Katzenellenbogen JA, Yao XQ, Grant BJ, Leong HS, Lin CY, Frasor J, Nettles KW, Glass CK. Structural and Molecular Mechanisms of Cytokine-Mediated Endocrine Resistance in Human Breast Cancer Cells. Mol Cell 2017;65:1122-1135.e5. [PMID: 28306507 DOI: 10.1016/j.molcel.2017.02.008] [Cited by in Crossref: 62] [Cited by in F6Publishing: 49] [Article Influence: 15.5] [Reference Citation Analysis]
314 Zhou TY, Zhou YL, Qian MJ, Fang YZ, Ye S, Xin WX, Yang XC, Wu HH. Interleukin-6 induced by YAP in hepatocellular carcinoma cells recruits tumor-associated macrophages. J Pharmacol Sci 2018;138:89-95. [PMID: 30340922 DOI: 10.1016/j.jphs.2018.07.013] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 6.3] [Reference Citation Analysis]
315 Yu H, Pardoll D, Jove R. STATs in cancer inflammation and immunity: a leading role for STAT3. Nat Rev Cancer. 2009;9:798-809. [PMID: 19851315 DOI: 10.1038/nrc2734] [Cited by in Crossref: 2500] [Cited by in F6Publishing: 2300] [Article Influence: 208.3] [Reference Citation Analysis]
316 Xu H, Wei Y, Zhang Y, Xu Y, Li F, Liu J, Zhang W, Han X, Tan R, Shen P. Oestrogen attenuates tumour progression in hepatocellular carcinoma. J Pathol 2012;228:216-29. [PMID: 22374713 DOI: 10.1002/path.4009] [Cited by in Crossref: 34] [Cited by in F6Publishing: 32] [Article Influence: 3.8] [Reference Citation Analysis]
317 Ruggieri A, Barbati C, Malorni W. Cellular and molecular mechanisms involved in hepatocellular carcinoma gender disparity. Int J Cancer. 2010;127:499-504. [PMID: 20201099 DOI: 10.1002/ijc.25298] [Cited by in Crossref: 53] [Cited by in F6Publishing: 51] [Article Influence: 4.8] [Reference Citation Analysis]
318 Sheppard S, Ferry A, Guedes J, Guerra N. The Paradoxical Role of NKG2D in Cancer Immunity. Front Immunol 2018;9:1808. [PMID: 30150983 DOI: 10.3389/fimmu.2018.01808] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 8.0] [Reference Citation Analysis]
319 Molina-sánchez P, Lujambio A. Experimental Models for Preclinical Research in Hepatocellular Carcinoma. In: Hoshida Y, editor. Hepatocellular Carcinoma. Cham: Springer International Publishing; 2019. pp. 333-58. [DOI: 10.1007/978-3-030-21540-8_16] [Cited by in Crossref: 4] [Article Influence: 2.0] [Reference Citation Analysis]
320 Kuo TM, Hu CP, Chen YL, Hong MH, Jeng KS, Liang CC, Chen ML, Chang C. HBV replication is significantly reduced by IL-6. J Biomed Sci. 2009;16:41. [PMID: 19374779 DOI: 10.1186/1423-0127-16-41] [Cited by in Crossref: 38] [Cited by in F6Publishing: 40] [Article Influence: 3.2] [Reference Citation Analysis]
321 Chin AI, Miyahira AK, Covarrubias A, Teague J, Guo B, Dempsey PW, Cheng G. Toll-like receptor 3-mediated suppression of TRAMP prostate cancer shows the critical role of type I interferons in tumor immune surveillance. Cancer Res. 2010;70:2595-2603. [PMID: 20233880 DOI: 10.1158/0008-5472.can-09-1162] [Cited by in Crossref: 76] [Cited by in F6Publishing: 43] [Article Influence: 6.9] [Reference Citation Analysis]
322 Dougan M, Li D, Neuberg D, Mihm M, Googe P, Wong KK, Dranoff G. A dual role for the immune response in a mouse model of inflammation-associated lung cancer. J Clin Invest 2011;121:2436-46. [PMID: 21537082 DOI: 10.1172/JCI44796] [Cited by in Crossref: 64] [Cited by in F6Publishing: 42] [Article Influence: 6.4] [Reference Citation Analysis]
323 Ropelle ER, Flores MB, Cintra DE, Rocha GZ, Pauli JR, Morari J, de Souza CT, Moraes JC, Prada PO, Guadagnini D, Marin RM, Oliveira AG, Augusto TM, Carvalho HF, Velloso LA, Saad MJ, Carvalheira JB. IL-6 and IL-10 anti-inflammatory activity links exercise to hypothalamic insulin and leptin sensitivity through IKKbeta and ER stress inhibition. PLoS Biol 2010;8:e1000465. [PMID: 20808781 DOI: 10.1371/journal.pbio.1000465] [Cited by in Crossref: 214] [Cited by in F6Publishing: 195] [Article Influence: 19.5] [Reference Citation Analysis]
324 Villa E. Role of estrogen in liver cancer. Womens Health (Lond Engl). 2008;4:41-50. [PMID: 19072450 DOI: 10.2217/17455057.4.1.41] [Cited by in Crossref: 30] [Cited by in F6Publishing: 26] [Article Influence: 2.5] [Reference Citation Analysis]
325 Giannitrapani L, Soresi M, Giacalone A, Campagna ME, Marasà M, Cervello M, Marasà S, Montalto G. IL-6 -174G/C polymorphism and IL-6 serum levels in patients with liver cirrhosis and hepatocellular carcinoma. OMICS. 2011;15:183-186. [PMID: 21329460 DOI: 10.1089/omi.2010.0093] [Cited by in Crossref: 33] [Cited by in F6Publishing: 28] [Article Influence: 3.3] [Reference Citation Analysis]
326 Tsuei DJ, Lee PH, Peng HY, Lu HL, Su DS, Jeng YM, Hsu HC, Hsu SH, Wu JF, Ni YH, Chang MH. Male germ cell-specific RNA binding protein RBMY: a new oncogene explaining male predominance in liver cancer. PLoS One 2011;6:e26948. [PMID: 22073224 DOI: 10.1371/journal.pone.0026948] [Cited by in Crossref: 20] [Cited by in F6Publishing: 23] [Article Influence: 2.0] [Reference Citation Analysis]
327 Maeda S, Hikiba Y, Sakamoto K, Nakagawa H, Hirata Y, Hayakawa Y, Yanai A, Ogura K, Karin M, Omata M. Ikappa B kinasebeta/nuclear factor-kappaB activation controls the development of liver metastasis by way of interleukin-6 expression. Hepatology. 2009;50:1851-1860. [PMID: 19821485 DOI: 10.1002/hep.23199] [Cited by in Crossref: 51] [Cited by in F6Publishing: 45] [Article Influence: 4.3] [Reference Citation Analysis]
328 Torres-Hernandez A, Wang W, Nikiforov Y, Tejada K, Torres L, Kalabin A, Wu Y, Haq MIU, Khan MY, Zhao Z, Su W, Camargo J, Hundeyin M, Diskin B, Adam S, Rossi JAK, Kurz E, Aykut B, Shadaloey SAA, Leinwand J, Miller G. Targeting SYK signaling in myeloid cells protects against liver fibrosis and hepatocarcinogenesis. Oncogene. 2019;38:4512-4526. [PMID: 30742098 DOI: 10.1038/s41388-019-0734-5] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
329 Scotland RS, Stables MJ, Madalli S, Watson P, Gilroy DW. Sex differences in resident immune cell phenotype underlie more efficient acute inflammatory responses in female mice. Blood 2011;118:5918-27. [PMID: 21911834 DOI: 10.1182/blood-2011-03-340281] [Cited by in Crossref: 148] [Cited by in F6Publishing: 132] [Article Influence: 14.8] [Reference Citation Analysis]
330 Vom Steeg LG, Klein SL. Sex Steroids Mediate Bidirectional Interactions Between Hosts and Microbes. Horm Behav 2017;88:45-51. [PMID: 27816626 DOI: 10.1016/j.yhbeh.2016.10.016] [Cited by in Crossref: 37] [Cited by in F6Publishing: 30] [Article Influence: 7.4] [Reference Citation Analysis]
331 Sun N, Zhong X, Wang S, Zeng K, Sun H, Sun G, Zou R, Liu W, Liu W, Lin L, Song H, Lv C, Wang C, Zhao Y. ATXN7L3 positively regulates SMAD7 transcription in hepatocellular carcinoma with growth inhibitory function. EBioMedicine 2020;62:103108. [PMID: 33186807 DOI: 10.1016/j.ebiom.2020.103108] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
332 Wu Y, Yao N, Feng Y, Tian Z, Yang Y, Zhao Y. Identification and characterization of sexual dimorphism‑linked gene expression profile in hepatocellular carcinoma. Oncol Rep 2019;42:937-52. [PMID: 31322260 DOI: 10.3892/or.2019.7217] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
333 Li H, Lu JW, Huo X, Li Y, Li Z, Gong Z. Effects of sex hormones on liver tumor progression and regression in Myc/xmrk double oncogene transgenic zebrafish. Gen Comp Endocrinol 2019;277:112-21. [PMID: 30926469 DOI: 10.1016/j.ygcen.2019.03.018] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
334 Lei J, Chen S, Zhong S. Abnormal expression of TFIIIB subunits and RNA Pol III genes is associated with hepatocellular carcinoma. Liver Res 2017;1:112-20. [PMID: 29276645 DOI: 10.1016/j.livres.2017.08.005] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
335 Wu S, Rhee KJ, Albesiano E, Rabizadeh S, Wu X, Yen HR, Huso DL, Brancati FL, Wick E, McAllister F, Housseau F, Pardoll DM, Sears CL. A human colonic commensal promotes colon tumorigenesis via activation of T helper type 17 T cell responses. Nat Med. 2009;15:1016-1022. [PMID: 19701202 DOI: 10.1038/nm.2015] [Cited by in Crossref: 957] [Cited by in F6Publishing: 859] [Article Influence: 79.8] [Reference Citation Analysis]
336 Fan Y, Boivin GP, Knudsen ES, Nebert DW, Xia Y, Puga A. The aryl hydrocarbon receptor functions as a tumor suppressor of liver carcinogenesis. Cancer Res 2010;70:212-20. [PMID: 19996281 DOI: 10.1158/0008-5472.CAN-09-3090] [Cited by in Crossref: 117] [Cited by in F6Publishing: 69] [Article Influence: 9.8] [Reference Citation Analysis]
337 Hoste E, Arwert EN, Lal R, South AP, Salas-Alanis JC, Murrell DF, Donati G, Watt FM. Innate sensing of microbial products promotes wound-induced skin cancer. Nat Commun. 2015;6:5932. [PMID: 25575023 DOI: 10.1038/ncomms6932] [Cited by in Crossref: 67] [Cited by in F6Publishing: 59] [Article Influence: 11.2] [Reference Citation Analysis]
338 Zhou C, Bi F, Yuan J, Yang F, Sun S. Gain of UBE2D1 facilitates hepatocellular carcinoma progression and is associated with DNA damage caused by continuous IL-6. J Exp Clin Cancer Res 2018;37:290. [PMID: 30482241 DOI: 10.1186/s13046-018-0951-8] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 3.7] [Reference Citation Analysis]
339 Macpherson AJ, Heikenwalder M, Ganal-Vonarburg SC. The Liver at the Nexus of Host-Microbial Interactions. Cell Host Microbe 2016;20:561-71. [PMID: 27832587 DOI: 10.1016/j.chom.2016.10.016] [Cited by in Crossref: 50] [Cited by in F6Publishing: 40] [Article Influence: 12.5] [Reference Citation Analysis]
340 Wang S, Sugamori KS, Brenneman D, Hsu I, Calce A, Grant DM. Influence of arylamine N-acetyltransferase, sex, and age on 4-aminobiphenyl-induced in vivo mutant frequencies and spectra in mouse liver. Environ Mol Mutagen. 2012;53:350-357. [PMID: 22508569 DOI: 10.1002/em.21695] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
341 Kalra M, Mayes J, Assefa S, Kaul AK, Kaul R. Role of sex steroid receptors in pathobiology of hepatocellular carcinoma. World J Gastroenterol. 2008;14:5945-5961. [PMID: 18932272 DOI: 10.3748/wjg.14.5945] [Cited by in CrossRef: 88] [Cited by in F6Publishing: 79] [Article Influence: 7.3] [Reference Citation Analysis]
342 Braconi C, Swenson E, Kogure T, Huang N, Patel T. Targeting the IL-6 dependent phenotype can identify novel therapies for cholangiocarcinoma. PLoS One 2010;5:e15195. [PMID: 21179572 DOI: 10.1371/journal.pone.0015195] [Cited by in Crossref: 23] [Cited by in F6Publishing: 15] [Article Influence: 2.1] [Reference Citation Analysis]
343 Kim M, Park SW, Kim M, D'Agati VD, Lee HT. Isoflurane activates intestinal sphingosine kinase to protect against bilateral nephrectomy-induced liver and intestine dysfunction. Am J Physiol Renal Physiol 2011;300:F167-76. [PMID: 20962114 DOI: 10.1152/ajprenal.00467.2010] [Cited by in Crossref: 22] [Cited by in F6Publishing: 16] [Article Influence: 2.0] [Reference Citation Analysis]
344 Zaynagetdinov R, Sherrill TP, Polosukhin VV, Han W, Ausborn JA, McLoed AG, McMahon FB, Gleaves LA, Degryse AL, Stathopoulos GT, Yull FE, Blackwell TS. A critical role for macrophages in promotion of urethane-induced lung carcinogenesis. J Immunol 2011;187:5703-11. [PMID: 22048774 DOI: 10.4049/jimmunol.1100558] [Cited by in Crossref: 84] [Cited by in F6Publishing: 80] [Article Influence: 8.4] [Reference Citation Analysis]
345 Liu W, Crott JW, Lyu L, Pfalzer AC, Li J, Choi SW, Yang Y, Mason JB, Liu Z. Diet- and Genetically-induced Obesity Produces Alterations in the Microbiome, Inflammation and Wnt Pathway in the Intestine of Apc+/1638N Mice: Comparisons and Contrasts. J Cancer 2016;7:1780-90. [PMID: 27698916 DOI: 10.7150/jca.15792] [Cited by in Crossref: 28] [Cited by in F6Publishing: 23] [Article Influence: 5.6] [Reference Citation Analysis]
346 [DOI: 10.1101/2020.06.25.172635] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
347 Febbraio MA, Rose-john S, Pedersen BK. Is Interleukin-6 Receptor Blockade the Holy Grail for Inflammatory Diseases? Clin Pharmacol Ther 2010;87:396-8. [DOI: 10.1038/clpt.2010.1] [Cited by in Crossref: 42] [Cited by in F6Publishing: 41] [Article Influence: 3.8] [Reference Citation Analysis]
348 Muhammad JS, Bajbouj K, Shafarin J, Hamad M. Estrogen-induced epigenetic silencing of FTH1 and TFRC genes reduces liver cancer cell growth and survival. Epigenetics 2020;15:1302-18. [PMID: 32476555 DOI: 10.1080/15592294.2020.1770917] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 6.0] [Reference Citation Analysis]
349 Huang M, Wang H, Hu X, Cao X. lncRNA MALAT1 binds chromatin remodeling subunit BRG1 to epigenetically promote inflammation-related hepatocellular carcinoma progression. Oncoimmunology 2019;8:e1518628. [PMID: 30546959 DOI: 10.1080/2162402X.2018.1518628] [Cited by in Crossref: 31] [Cited by in F6Publishing: 17] [Article Influence: 10.3] [Reference Citation Analysis]
350 Marcus NY, Brunt EM, Blomenkamp K, Ali F, Rudnick DA, Ahmad M, Teckman JH. Characteristics of hepatocellular carcinoma in a murine model of alpha-1-antitrypsin deficiency. Hepatol Res. 2010;40:641-653. [PMID: 20618460 DOI: 10.1111/j.1872-034x.2010.00663.x] [Cited by in Crossref: 31] [Cited by in F6Publishing: 14] [Article Influence: 3.1] [Reference Citation Analysis]
351 Ladenheim MR, Kim NG, Nguyen P, Le A, Stefanick ML, Garcia G, Nguyen MH. Sex differences in disease presentation, treatment and clinical outcomes of patients with hepatocellular carcinoma: a single-centre cohort study. BMJ Open Gastroenterol 2016;3:e000107. [PMID: 27493763 DOI: 10.1136/bmjgast-2016-000107] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.8] [Reference Citation Analysis]
352 Mishra D, Richard JE, Maric I, Porteiro B, Häring M, Kooijman S, Musovic S, Eerola K, López-Ferreras L, Peris E, Grycel K, Shevchouk OT, Micallef P, Olofsson CS, Wernstedt Asterholm I, Grill HJ, Nogueiras R, Skibicka KP. Parabrachial Interleukin-6 Reduces Body Weight and Food Intake and Increases Thermogenesis to Regulate Energy Metabolism. Cell Rep 2019;26:3011-3026.e5. [PMID: 30865890 DOI: 10.1016/j.celrep.2019.02.044] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 15.0] [Reference Citation Analysis]
353 Rakoff-Nahoum S, Medzhitov R. Role of toll-like receptors in tissue repair and tumorigenesis. Biochemistry (Mosc). 2008;73:555-561. [PMID: 18605980 DOI: 10.1134/s0006297908050088] [Cited by in Crossref: 60] [Cited by in F6Publishing: 37] [Article Influence: 4.6] [Reference Citation Analysis]
354 Nartey YA, Awuku YA, Agyei-Nkansah A, Duah A, Bampoh SA, Ayawin J, Asibey SO, Björkström NK, Ye W, Afihene MY, Roberts LR, Plymoth A. Ambulatory end-stage liver disease in Ghana; patient profile and utility of alpha fetoprotein and aspartate aminotransferase: platelet ratio index. BMC Gastroenterol 2020;20:428. [PMID: 33357229 DOI: 10.1186/s12876-020-01581-9] [Reference Citation Analysis]
355 Baglieri J, Zhang C, Liang S, Liu X, Nishio T, Rosenthal SB, Dhar D, Su H, Cong M, Jia J, Hosseini M, Karin M, Kisseleva T, Brenner DA. Nondegradable Collagen Increases Liver Fibrosis but Not Hepatocellular Carcinoma in Mice. Am J Pathol 2021;191:1564-79. [PMID: 34119473 DOI: 10.1016/j.ajpath.2021.05.019] [Reference Citation Analysis]
356 Hassan MM, Botrus G, Abdel-Wahab R, Wolff RA, Li D, Tweardy D, Phan AT, Hawk E, Javle M, Lee JS, Torres HA, Rashid A, Lenzi R, Hassabo HM, Abaza Y, Shalaby AS, Lacin S, Morris J, Patt YZ, Amos CI, Khaderi SA, Goss JA, Jalal PK, Kaseb AO. Estrogen Replacement Reduces Risk and Increases Survival Times of Women With Hepatocellular Carcinoma. Clin Gastroenterol Hepatol 2017;15:1791-9. [PMID: 28579181 DOI: 10.1016/j.cgh.2017.05.036] [Cited by in Crossref: 40] [Cited by in F6Publishing: 37] [Article Influence: 10.0] [Reference Citation Analysis]
357 Sheh A, Ge Z, Parry NM, Muthupalani S, Rager JE, Raczynski AR, Mobley MW, McCabe AF, Fry RC, Wang TC. 17β-estradiol and tamoxifen prevent gastric cancer by modulating leukocyte recruitment and oncogenic pathways in Helicobacter pylori-infected INS-GAS male mice. Cancer Prev Res (Phila). 2011;4:1426-1435. [PMID: 21680705 DOI: 10.1158/1940-6207.capr-11-0219] [Cited by in Crossref: 51] [Cited by in F6Publishing: 35] [Article Influence: 5.1] [Reference Citation Analysis]
358 Riehle KJ, Campbell JS, McMahan RS, Johnson MM, Beyer RP, Bammler TK, Fausto N. Regulation of liver regeneration and hepatocarcinogenesis by suppressor of cytokine signaling 3. J Exp Med. 2008;205:91-103. [PMID: 18158318 DOI: 10.1084/jem.20070820] [Cited by in Crossref: 115] [Cited by in F6Publishing: 107] [Article Influence: 8.2] [Reference Citation Analysis]
359 Hatting M, Spannbauer M, Peng J, Al Masaoudi M, Sellge G, Nevzorova YA, Gassler N, Liedtke C, Cubero FJ, Trautwein C. Lack of gp130 expression in hepatocytes attenuates tumor progression in the DEN model. Cell Death Dis 2015;6:e1667. [PMID: 25741592 DOI: 10.1038/cddis.2014.590] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 2.8] [Reference Citation Analysis]
360 Kim KI, Chung HK, Park JH, Lee YJ, Kang JH. Alpha-fetoprotein-targeted reporter gene expression imaging in hepatocellular carcinoma. World J Gastroenterol. 2016;22:6127-6134. [PMID: 27468205 DOI: 10.3748/wjg.v22.i27.6127] [Cited by in CrossRef: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.5] [Reference Citation Analysis]
361 Dolicka D, Sobolewski C, Gjorgjieva M, Correia de Sousa M, Berthou F, De Vito C, Colin DJ, Bejuy O, Fournier M, Maeder C, Blackshear PJ, Rubbia-Brandt L, Foti M. Tristetraprolin Promotes Hepatic Inflammation and Tumor Initiation but Restrains Cancer Progression to Malignancy. Cell Mol Gastroenterol Hepatol 2021;11:597-621. [PMID: 32987153 DOI: 10.1016/j.jcmgh.2020.09.012] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
362 Lu P, Cai X, Guo Y, Xu M, Tian J, Locker J, Xie W. Constitutive Activation of the Human Aryl Hydrocarbon Receptor in Mice Promotes Hepatocarcinogenesis Independent of Its Coactivator Gadd45b. Toxicol Sci 2019;167:581-92. [PMID: 30346592 DOI: 10.1093/toxsci/kfy263] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
363 Quetier I, Brezillon N, Revaud J, Ahodantin J, DaSilva L, Soussan P, Kremsdorf D. C-terminal-truncated hepatitis B virus X protein enhances the development of diethylnitrosamine-induced hepatocellular carcinogenesis. J Gen Virol 2015;96:614-25. [PMID: 25519169 DOI: 10.1099/vir.0.070680-0] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 2.7] [Reference Citation Analysis]
364 Pedersen L, Idorn M, Olofsson GH, Lauenborg B, Nookaew I, Hansen RH, Johannesen HH, Becker JC, Pedersen KS, Dethlefsen C, Nielsen J, Gehl J, Pedersen BK, Thor Straten P, Hojman P. Voluntary Running Suppresses Tumor Growth through Epinephrine- and IL-6-Dependent NK Cell Mobilization and Redistribution. Cell Metab 2016;23:554-62. [PMID: 26895752 DOI: 10.1016/j.cmet.2016.01.011] [Cited by in Crossref: 336] [Cited by in F6Publishing: 254] [Article Influence: 67.2] [Reference Citation Analysis]
365 Tsai WT, Lo YC, Wu MS, Li CY, Kuo YP, Lai YH, Tsai Y, Chen KC, Chuang TH, Yao CH, Lee JC, Hsu LC, Hsu JT, Yu GY. Mycotoxin Patulin Suppresses Innate Immune Responses by Mitochondrial Dysfunction and p62/Sequestosome-1-dependent Mitophagy. J Biol Chem 2016;291:19299-311. [PMID: 27458013 DOI: 10.1074/jbc.M115.686683] [Cited by in Crossref: 22] [Cited by in F6Publishing: 9] [Article Influence: 4.4] [Reference Citation Analysis]
366 Jia RJ, Cao L, Zhang L, Jing W, Chen R, Zhu MH, Guo SW, Wu GB, Fan XY, Wang H, Zhang YY, Zhou XY, Zhao J, Guo YJ. Enhanced myeloid differentiation factor 88 promotes tumor metastasis via induction of epithelial-mesenchymal transition in human hepatocellular carcinoma. Cell Death Dis 2014;5:e1103. [PMID: 24603331 DOI: 10.1038/cddis.2014.71] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 1.7] [Reference Citation Analysis]
367 Lamas-Paz A, Morán L, Peng J, Salinas B, López-Alcántara N, Sydor S, Vilchez-Vargas R, Asensio I, Hao F, Zheng K, Martín-Adrados B, Moreno L, Cogolludo A, Gómez Del Moral M, Bechmann L, Martínez-Naves E, Vaquero J, Bañares R, Nevzorova YA, Cubero FJ. Intestinal Epithelial Cell-Derived Extracellular Vesicles Modulate Hepatic Injury via the Gut-Liver Axis During Acute Alcohol Injury. Front Pharmacol 2020;11:603771. [PMID: 33408632 DOI: 10.3389/fphar.2020.603771] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
368 Lu X, Ma P, Shi Y, Yao M, Hou L, Zhang P, Jiang L. NF-κB increased expression of 17β-hydroxysteroid dehydrogenase 4 promotes HepG2 proliferation via inactivating estradiol. Mol Cell Endocrinol 2015;401:1-11. [PMID: 25448063 DOI: 10.1016/j.mce.2014.11.016] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
369 Xu J, Liu X, Gao B, Karin M, Tsukamoto H, Brenner D, Kisseleva T. New Approaches for Studying Alcoholic Liver Disease. Curr Pathobiol Rep 2014;2:171-83. [PMID: 26594598 DOI: 10.1007/s40139-014-0053-z] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
370 Balistreri CR, Candore G, Lio D, Carruba G. Prostate cancer: from the pathophysiologic implications of some genetic risk factors to translation in personalized cancer treatments. Cancer Gene Ther 2014;21:2-11. [DOI: 10.1038/cgt.2013.77] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 1.7] [Reference Citation Analysis]
371 Ahmed A, Redmond HP, Wang JH. Links between Toll-like receptor 4 and breast cancer. Oncoimmunology 2013;2:e22945. [PMID: 23526132 DOI: 10.4161/onci.22945] [Cited by in Crossref: 31] [Cited by in F6Publishing: 29] [Article Influence: 4.4] [Reference Citation Analysis]
372 Pandey S, Singh S, Anang V, Bhatt AN, Natarajan K, Dwarakanath BS. Pattern Recognition Receptors in Cancer Progression and Metastasis. Cancer Growth Metastasis 2015;8:25-34. [PMID: 26279628 DOI: 10.4137/CGM.S24314] [Cited by in Crossref: 41] [Cited by in F6Publishing: 28] [Article Influence: 6.8] [Reference Citation Analysis]
373 Kim Y, Fiel MI, Albanis E, Chou HI, Zhang W, Khitrov G, Friedman SL. Anti-fibrotic activity and enhanced interleukin-6 production by hepatic stellate cells in response to imatinib mesylate. Liver Int 2012;32:1008-17. [PMID: 22507133 DOI: 10.1111/j.1478-3231.2012.02806.x] [Cited by in Crossref: 33] [Cited by in F6Publishing: 26] [Article Influence: 3.7] [Reference Citation Analysis]
374 Jiao Z, Li L, Zhao Z, Liu D, Lin B, Li H. Aqueous extracts of Ocimum grasstimum inhibits lipopolysaccharide-induced interleukin-6 and interleukin-8 expression in airway epithelial cell BEAS-2B. Chin J Integr Med 2013;19:741-8. [DOI: 10.1007/s11655-012-1251-3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
375 Sakurai T, He G, Matsuzawa A, Yu GY, Maeda S, Hardiman G, Karin M. Hepatocyte necrosis induced by oxidative stress and IL-1 alpha release mediate carcinogen-induced compensatory proliferation and liver tumorigenesis. Cancer Cell. 2008;14:156-165. [PMID: 18691550 DOI: 10.1016/j.ccr.2008.06.016] [Cited by in Crossref: 320] [Cited by in F6Publishing: 304] [Article Influence: 24.6] [Reference Citation Analysis]
376 Wang EL, Qian ZR, Nakasono M, Tanahashi T, Yoshimoto K, Bando Y, Kudo E, Shimada M, Sano T. High expression of Toll-like receptor 4/myeloid differentiation factor 88 signals correlates with poor prognosis in colorectal cancer. Br J Cancer. 2010;102:908-915. [PMID: 20145615 DOI: 10.1038/sj.bjc.6605558] [Cited by in Crossref: 151] [Cited by in F6Publishing: 146] [Article Influence: 13.7] [Reference Citation Analysis]
377 Prieto J. Inflammation, HCC and sex: IL-6 in the centre of the triangle. J Hepatol. 2008;48:380-381. [PMID: 18093689 DOI: 10.1016/j.jhep.2007.11.007] [Cited by in Crossref: 73] [Cited by in F6Publishing: 71] [Article Influence: 5.2] [Reference Citation Analysis]
378 Kim SY, Song HK, Lee SK, Kim SG, Woo HG, Yang J, Noh HJ, Kim YS, Moon A. Sex-Biased Molecular Signature for Overall Survival of Liver Cancer Patients. Biomol Ther (Seoul) 2020;28:491-502. [PMID: 33077700 DOI: 10.4062/biomolther.2020.157] [Reference Citation Analysis]
379 Zhang HL, Yu LX, Yang W, Tang L, Lin Y, Wu H, Zhai B, Tan YX, Shan L, Liu Q. Profound impact of gut homeostasis on chemically-induced pro-tumorigenic inflammation and hepatocarcinogenesis in rats. J Hepatol. 2012;57:803-812. [PMID: 22727732 DOI: 10.1016/j.jhep.2012.06.011] [Cited by in Crossref: 127] [Cited by in F6Publishing: 117] [Article Influence: 14.1] [Reference Citation Analysis]
380 Javaid N, Choi S. Toll-like Receptors from the Perspective of Cancer Treatment. Cancers (Basel) 2020;12:E297. [PMID: 32012718 DOI: 10.3390/cancers12020297] [Cited by in Crossref: 14] [Cited by in F6Publishing: 8] [Article Influence: 14.0] [Reference Citation Analysis]
381 Yao KF, Ma M, Ding GY, Li ZM, Chen HL, Han B, Chen Q, Jiang XQ, Wang LS. Meta-analysis reveals gender difference in the association of liver cancer incidence and excess BMI. Oncotarget 2017;8:72959-71. [PMID: 29069840 DOI: 10.18632/oncotarget.20127] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
382 Jewell R, Elliott F, Laye J, Nsengimana J, Davies J, Walker C, Conway C, Mitra A, Harland M, Cook MG, Boon A, Storr S, Safuan S, Martin SG, Jirström K, Olsson H, Ingvar C, Lauss M, Bishop T, Jönsson G, Newton-Bishop J. The clinicopathological and gene expression patterns associated with ulceration of primary melanoma. Pigment Cell Melanoma Res 2015;28:94-104. [PMID: 25220403 DOI: 10.1111/pcmr.12315] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 3.1] [Reference Citation Analysis]
383 Kitazume S, Oka R, Ogawa K, Futakawa S, Hagiwara Y, Takikawa H, Kato M, Kasahara A, Miyoshi E, Taniguchi N, Hashimoto Y. Molecular insights into beta-galactoside alpha2,6-sialyltransferase secretion in vivo. Glycobiology 2009;19:479-87. [PMID: 19150807 DOI: 10.1093/glycob/cwp003] [Cited by in Crossref: 29] [Cited by in F6Publishing: 29] [Article Influence: 2.4] [Reference Citation Analysis]
384 Cao L, Li WJ, Yang JH, Wang Y, Hua ZJ, Liu D, Chen YQ, Zhang HM, Zhang R, Zhao JS, Cheng SJ, Zhang Q. Inflammatory cytokine-induced expression of MASTL is involved in hepatocarcinogenesis by regulating cell cycle progression. Oncol Lett 2019;17:3163-72. [PMID: 30867746 DOI: 10.3892/ol.2019.9983] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
385 Tang S, Liu Z, Zhang Y, He Y, Pan D, Liu Y, Liu Q, Zhang Z, Yuan Y. Rather than Rs1800796 polymorphism, expression of interleukin-6 is associated with disease progression of chronic HBV infection in a Chinese Han population. Dis Markers 2013;35:799-805. [PMID: 24371367 DOI: 10.1155/2013/508023] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
386 Liao R, Fu YP, Wang T, Deng ZG, Li DW, Fan J, Zhou J, Feng GS, Qiu SJ, Du CY. Metavir and FIB-4 scores are associated with patient prognosis after curative hepatectomy in hepatitis B virus-related hepatocellular carcinoma: a retrospective cohort study at two centers in China. Oncotarget 2017;8:1774-87. [PMID: 27662665 DOI: 10.18632/oncotarget.12152] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 2.7] [Reference Citation Analysis]
387 Hassanipour S, Vali M, Gaffari-Fam S, Nikbakht HA, Abdzadeh E, Joukar F, Pourshams A, Shafaghi A, Malakoutikhah M, Arab-Zozani M, Salehiniya H, Mansour-Ghanaei F. The survival rate of hepatocellular carcinoma in Asian countries: a systematic review and meta-analysis. EXCLI J 2020;19:108-30. [PMID: 32038120 DOI: 10.17179/excli2019-1842] [Cited by in F6Publishing: 7] [Reference Citation Analysis]
388 Dorak MT, Karpuzoglu E. Gender differences in cancer susceptibility: an inadequately addressed issue. Front Genet 2012;3:268. [PMID: 23226157 DOI: 10.3389/fgene.2012.00268] [Cited by in Crossref: 189] [Cited by in F6Publishing: 171] [Article Influence: 21.0] [Reference Citation Analysis]
389 Ramakrishna G, Rastogi A, Trehanpati N, Sen B, Khosla R, Sarin SK. From cirrhosis to hepatocellular carcinoma: new molecular insights on inflammation and cellular senescence. Liver Cancer. 2013;2:367-383. [PMID: 24400224 DOI: 10.1159/000343852] [Cited by in Crossref: 95] [Cited by in F6Publishing: 72] [Article Influence: 13.6] [Reference Citation Analysis]
390 Aljumah AA, Kuriry H, AlZunaitan M, Al Ghobain M, Al Muaikeel M, Al Olayan A, Azzumeea F, Almutairi B, AlAlwan A, AlGhamdi H. Clinical Presentation, Risk Factors, and Treatment Modalities of Hepatocellular Carcinoma: A Single Tertiary Care Center Experience. Gastroenterol Res Pract 2016;2016:1989045. [PMID: 27525001 DOI: 10.1155/2016/1989045] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.6] [Reference Citation Analysis]
391 Ali MA, Lacin S, Abdel-Wahab R, Uemura M, Hassan M, Rashid A, Duda DG, Kaseb AO. Nonalcoholic steatohepatitis-related hepatocellular carcinoma: is there a role for the androgen receptor pathway? Onco Targets Ther 2017;10:1403-12. [PMID: 28424556 DOI: 10.2147/OTT.S111681] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
392 Wang PR, Xu M, Toffanin S, Li Y, Llovet JM, Russell DW. Induction of hepatocellular carcinoma by in vivo gene targeting. Proc Natl Acad Sci U S A 2012;109:11264-9. [PMID: 22733778 DOI: 10.1073/pnas.1117032109] [Cited by in Crossref: 64] [Cited by in F6Publishing: 58] [Article Influence: 7.1] [Reference Citation Analysis]
393 Li Y, Wang J, Song K, Liu S, Zhang H, Wang F, Ni C, Zhai W, Liang J, Qin Z, Zhang J. S100A4 promotes hepatocellular carcinogenesis by intensifying fibrosis-associated cancer cell stemness. Oncoimmunology 2020;9:1725355. [PMID: 32117590 DOI: 10.1080/2162402X.2020.1725355] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
394 Burra P, De Martin E, Gitto S, Villa E. Influence of age and gender before and after liver transplantation. Liver Transpl. 2013;19:122-134. [PMID: 23172830 DOI: 10.1002/lt.23574] [Cited by in Crossref: 34] [Cited by in F6Publishing: 28] [Article Influence: 4.3] [Reference Citation Analysis]
395 Berasain C, Castillo J, Perugorria MJ, Latasa MU, Prieto J, Avila MA. Inflammation and liver cancer: new molecular links . Ann N Y Acad Sci. 2009;1155:206-221. [PMID: 19250206 DOI: 10.1111/j.1749-6632.2009.03704.x] [Cited by in Crossref: 266] [Cited by in F6Publishing: 235] [Article Influence: 22.2] [Reference Citation Analysis]
396 Riordan JD, Nadeau JH. Modeling progressive non-alcoholic fatty liver disease in the laboratory mouse. Mamm Genome 2014;25:473-86. [PMID: 24802098 DOI: 10.1007/s00335-014-9521-3] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 3.1] [Reference Citation Analysis]
397 Ben-batalla I, Vargas-delgado ME, Meier L, Loges S. Sexual dimorphism in solid and hematological malignancies. Semin Immunopathol 2019;41:251-63. [DOI: 10.1007/s00281-018-0724-7] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
398 Ledda C, Loreto C, Zammit C, Marconi A, Fago L, Matera S, Costanzo V, Fuccio Sanzà G, Palmucci S, Ferrante M, Costa C, Fenga C, Biondi A, Pomara C, Rapisarda V. Non‑infective occupational risk factors for hepatocellular carcinoma: A review (Review). Mol Med Rep 2017;15:511-33. [PMID: 28000892 DOI: 10.3892/mmr.2016.6046] [Cited by in Crossref: 36] [Cited by in F6Publishing: 30] [Article Influence: 7.2] [Reference Citation Analysis]
399 Bromberg J, Wang TC. Inflammation and cancer: IL-6 and STAT3 complete the link. Cancer Cell. 2009;15:79-80. [PMID: 19185839 DOI: 10.1016/j.ccr.2009.01.009] [Cited by in Crossref: 358] [Cited by in F6Publishing: 334] [Article Influence: 29.8] [Reference Citation Analysis]
400 Bedossa P, Paradis V. Hepatocellular Carcinoma. Practical Hepatic Pathology: A Diagnostic Approach. Elsevier; 2011. pp. 489-501. [DOI: 10.1016/b978-0-443-06803-4.00035-6] [Cited by in Crossref: 2] [Article Influence: 0.2] [Reference Citation Analysis]
401 Kim JY, He F, Karin M. From Liver Fat to Cancer: Perils of the Western Diet. Cancers (Basel) 2021;13:1095. [PMID: 33806428 DOI: 10.3390/cancers13051095] [Reference Citation Analysis]
402 Koch KS, Leffert HL. Hypothesis: Targeted Ikkβ deletion upregulates MIF signaling responsiveness and MHC class II expression in mouse hepatocytes. Hepat Med 2010;2010:39-47. [PMID: 23997575 DOI: 10.2147/HMER.S7208] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
403 Lonardo A, Loria P. Potential for statins in the chemoprevention and management of hepatocellular carcinoma. J Gastroenterol Hepatol. 2012;27:1654-1664. [PMID: 22849701 DOI: 10.1111/j.1440-1746.2012.07232.x] [Cited by in Crossref: 44] [Cited by in F6Publishing: 43] [Article Influence: 5.5] [Reference Citation Analysis]
404 Salcedo R, Worschech A, Cardone M, Jones Y, Gyulai Z, Dai RM, Wang E, Ma W, Haines D, O’hUigin C. MyD88-mediated signaling prevents development of adenocarcinomas of the colon: role of interleukin 18. J Exp Med. 2010;207:1625-1636. [PMID: 20624890 DOI: 10.1084/jem.20100199] [Cited by in Crossref: 293] [Cited by in F6Publishing: 260] [Article Influence: 26.6] [Reference Citation Analysis]
405 Han S, Yang JD, Sinn DH, Kim JM, Choi GS, Jung G, Ahn JH, Kim S, Ko JS, Gwak MS, Kwon CHD, Leise MD, Gwak G, Heimbach JK, Kim GS. Risk of Post-transplant Hepatocellular Carcinoma Recurrence Is Higher in Recipients of Livers From Male Than Female Living Donors. Annals of Surgery 2018;268:1043-50. [DOI: 10.1097/sla.0000000000002318] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
406 Chalmers SA, Eidelman AS, Ewer JC, Ricca JM, Serrano A, Tucker KC, Vail CM, Kurt RA. A role for HMGB1, HSP60 and Myd88 in growth of murine mammary carcinoma in vitro. Cell Immunol 2013;282:136-45. [PMID: 23770722 DOI: 10.1016/j.cellimm.2013.04.014] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 1.8] [Reference Citation Analysis]
407 Li D, Hu M, Liu Y, Ye P, Du P, Li CS, Cheng L, Liu P, Jiang J, Su L, Wang S, Zheng P, Liu Y. CD24-p53 axis suppresses diethylnitrosamine-induced hepatocellular carcinogenesis by sustaining intrahepatic macrophages. Cell Discov 2018;4:6. [PMID: 29423273 DOI: 10.1038/s41421-017-0007-9] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
408 Xie CR, Wang F, Zhang S, Wang FQ, Zheng S, Li Z, Lv J, Qi HQ, Fang QL, Wang XM, Yin ZY. Long Noncoding RNA HCAL Facilitates the Growth and Metastasis of Hepatocellular Carcinoma by Acting as a ceRNA of LAPTM4B. Mol Ther Nucleic Acids 2017;9:440-51. [PMID: 29246322 DOI: 10.1016/j.omtn.2017.10.018] [Cited by in Crossref: 49] [Cited by in F6Publishing: 53] [Article Influence: 12.3] [Reference Citation Analysis]
409 McGlynn KA, Sahasrabuddhe VV, Campbell PT, Graubard BI, Chen J, Schwartz LM, Petrick JL, Alavanja MC, Andreotti G, Boggs DA. Reproductive factors, exogenous hormone use and risk of hepatocellular carcinoma among US women: results from the Liver Cancer Pooling Project. Br J Cancer. 2015;112:1266-1272. [PMID: 25742475 DOI: 10.1038/bjc.2015.58] [Cited by in Crossref: 40] [Cited by in F6Publishing: 29] [Article Influence: 6.7] [Reference Citation Analysis]
410 Zhang WN, Wang L, Wang Q, Luo X, Fang DF, Chen Y, Pan X, Man JH, Xia Q, Jin BF, Li WH, Li T, Liang B, Chen L, Gong WL, Yu M, Li AL, Zhou T, Li HY. CUEDC2 (CUE domain-containing 2) and SOCS3 (suppressors of cytokine signaling 3) cooperate to negatively regulate Janus kinase 1/signal transducers and activators of transcription 3 signaling. J Biol Chem 2012;287:382-92. [PMID: 22084247 DOI: 10.1074/jbc.M111.276832] [Cited by in Crossref: 18] [Cited by in F6Publishing: 13] [Article Influence: 1.8] [Reference Citation Analysis]
411 Akkız H, Bayram S, Bekar A, Akgöllü E, Ulger Y. A functional polymorphism in pre-microRNA-196a-2 contributes to the susceptibility of hepatocellular carcinoma in a Turkish population: a case-control study. J Viral Hepat 2011;18:e399-407. [PMID: 21692953 DOI: 10.1111/j.1365-2893.2010.01414.x] [Cited by in Crossref: 76] [Cited by in F6Publishing: 75] [Article Influence: 6.9] [Reference Citation Analysis]
412 Christensen LP. Bioactive C17 and C18 Acetylenic Oxylipins from Terrestrial Plants as Potential Lead Compounds for Anticancer Drug Development. Molecules 2020;25:E2568. [PMID: 32486470 DOI: 10.3390/molecules25112568] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 8.0] [Reference Citation Analysis]
413 Chen JG, Kensler TW. Changing rates for liver and lung cancers in Qidong, China. Chem Res Toxicol 2014;27:3-6. [PMID: 24215631 DOI: 10.1021/tx400313j] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 2.9] [Reference Citation Analysis]
414 Ribeiro D, Planchon S, Leclercq C, Raundrup K, Alves S, Bessa R, Renaut J, Almeida A. The muscular, hepatic and adipose tissues proteomes in muskox (Ovibos moschatus): Differences between males and females. Journal of Proteomics 2019;208:103480. [DOI: 10.1016/j.jprot.2019.103480] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
415 Dorak MT. Cancer. Principles of Gender-Specific Medicine. Elsevier; 2017. pp. 401-16. [DOI: 10.1016/b978-0-12-803506-1.00007-3] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
416 Khan MGM, Ghosh A, Variya B, Santharam MA, Kandhi R, Ramanathan S, Ilangumaran S. Hepatocyte growth control by SOCS1 and SOCS3. Cytokine. 2019;121:154733. [PMID: 31154249 DOI: 10.1016/j.cyto.2019.154733] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
417 Chen J, Xia D, Xu M, Su R, Lin W, Guo D, Chen G, Liu S. Expression and Significance of MyD88 in Patients With Gastric Cardia Cancer in a High-Incidence Area of China. Front Oncol 2020;10:559. [PMID: 32477927 DOI: 10.3389/fonc.2020.00559] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
418 Davis MB, Vasquez-Dunddel D, Fu J, Albesiano E, Pardoll D, Kim YJ. Intratumoral administration of TLR4 agonist absorbed into a cellular vector improves antitumor responses. Clin Cancer Res 2011;17:3984-92. [PMID: 21543518 DOI: 10.1158/1078-0432.CCR-10-3262] [Cited by in Crossref: 40] [Cited by in F6Publishing: 22] [Article Influence: 4.0] [Reference Citation Analysis]
419 Mank JE, Hultin-Rosenberg L, Webster MT, Ellegren H. The unique genomic properties of sex-biased genes: insights from avian microarray data. BMC Genomics 2008;9:148. [PMID: 18377635 DOI: 10.1186/1471-2164-9-148] [Cited by in Crossref: 63] [Cited by in F6Publishing: 54] [Article Influence: 4.8] [Reference Citation Analysis]
420 Shalini S, Nikolic A, Wilson CH, Puccini J, Sladojevic N, Finnie J, Dorstyn L, Kumar S. Caspase-2 deficiency accelerates chemically induced liver cancer in mice. Cell Death Differ 2016;23:1727-36. [PMID: 27518436 DOI: 10.1038/cdd.2016.81] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 5.0] [Reference Citation Analysis]
421 Li N, Zhou ZS, Shen Y, Xu J, Miao HH, Xiong Y, Xu F, Li BL, Luo J, Song BL. Inhibition of the sterol regulatory element-binding protein pathway suppresses hepatocellular carcinoma by repressing inflammation in mice. Hepatology 2017;65:1936-47. [PMID: 28027595 DOI: 10.1002/hep.29018] [Cited by in Crossref: 35] [Cited by in F6Publishing: 36] [Article Influence: 8.8] [Reference Citation Analysis]
422 Liu C, Kuo F, Hu H, Chen C, Huang Y, Cheng K, Yokoyama KK, Wu D, Hsieh S, Kuo C. 17β-Estradiol inhibition of IL-6–Src and Cas and paxillin pathway suppresses human mesenchymal stem cells–mediated gastric cancer cell motility. Translational Research 2014;164:232-43. [DOI: 10.1016/j.trsl.2014.04.009] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
423 Lee CH, Hsieh SY, Lin JL, Liu MS, Yen TH. Hepatocellular carcinoma in patients with chronic kidney disease. World J Gastroenterol 2013;19:2466-72. [PMID: 23674847 DOI: 10.3748/wjg.v19.i16.2466] [Cited by in CrossRef: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
424 Yoshikawa Y, Miyashita T, Higuchi S, Tsuneyama K, Endo S, Tsukui T, Toyoda Y, Fukami T, Nakajima M, Yokoi T. Mechanisms of the hepatoprotective effects of tamoxifen against drug-induced and chemical-induced acute liver injuries. Toxicol Appl Pharmacol 2012;264:42-50. [PMID: 22841776 DOI: 10.1016/j.taap.2012.06.023] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 1.8] [Reference Citation Analysis]
425 Grivennikov SI, Karin M. Dangerous liaisons: STAT3 and NF-kappaB collaboration and crosstalk in cancer. Cytokine Growth Factor Rev. 2010;21:11-19. [PMID: 20018552 DOI: 10.1016/j.cytogfr.2009.11.005] [Cited by in Crossref: 674] [Cited by in F6Publishing: 628] [Article Influence: 56.2] [Reference Citation Analysis]
426 Schmidt-Arras D, Galun E, Rose-John S. The two facets of gp130 signalling in liver tumorigenesis. Semin Immunopathol 2021. [PMID: 34047814 DOI: 10.1007/s00281-021-00861-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
427 Hong J, Stubbins RE, Smith RR, Harvey AE, Núñez NP. Differential susceptibility to obesity between male, female and ovariectomized female mice. Nutr J 2009;8:11. [PMID: 19220919 DOI: 10.1186/1475-2891-8-11] [Cited by in Crossref: 158] [Cited by in F6Publishing: 140] [Article Influence: 13.2] [Reference Citation Analysis]
428 Cullaro G, Rubin J, Mehta N, Yao F, Verna EC, Lai JC. Sex-Based Disparities in Hepatocellular Carcinoma Recurrence After Liver Transplantation. Transplantation 2020. [PMID: 33323764 DOI: 10.1097/TP.0000000000003575] [Reference Citation Analysis]
429 Klopstock N, Katzenellenbogen M, Pappo O, Sklair-Levy M, Olam D, Mizrahi L, Potikha T, Galun E, Goldenberg D. HCV tumor promoting effect is dependent on host genetic background. PLoS One. 2009;4:e5025. [PMID: 19340302 DOI: 10.1371/journal.pone.0005025] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 1.8] [Reference Citation Analysis]
430 Ji H, Lu Y, Shi Y. Seeds in the liver. Acta Histochem 2017;119:349-56. [PMID: 28389020 DOI: 10.1016/j.acthis.2017.03.006] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
431 Shariff MI, Cox IJ, Gomaa AI, Khan SA, Gedroyc W, Taylor-robinson SD. Hepatocellular carcinoma: current trends in worldwide epidemiology, risk factors, diagnosis and therapeutics. Expert Review of Gastroenterology & Hepatology 2014;3:353-67. [DOI: 10.1586/egh.09.35] [Cited by in Crossref: 197] [Cited by in F6Publishing: 187] [Article Influence: 28.1] [Reference Citation Analysis]
432 Balkwill F, Mantovani A. Cancer and inflammation: implications for pharmacology and therapeutics. Clin Pharmacol Ther. 2010;87:401-406. [PMID: 20200512 DOI: 10.1038/clpt.2009.312] [Cited by in Crossref: 172] [Cited by in F6Publishing: 162] [Article Influence: 15.6] [Reference Citation Analysis]
433 Schmidt-Arras D, Rose-John S. IL-6 pathway in the liver: From physiopathology to therapy. J Hepatol. 2016;64:1403-1415. [PMID: 26867490 DOI: 10.1016/j.jhep.2016.02.004] [Cited by in Crossref: 305] [Cited by in F6Publishing: 275] [Article Influence: 61.0] [Reference Citation Analysis]
434 Rokavec M, Öner MG, Hermeking H. lnflammation-induced epigenetic switches in cancer. Cell Mol Life Sci 2016;73:23-39. [DOI: 10.1007/s00018-015-2045-5] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 4.3] [Reference Citation Analysis]
435 Tsai WC, Hsu SD, Hsu CS, Lai TC, Chen SJ, Shen R, Huang Y, Chen HC, Lee CH, Tsai TF, Hsu MT, Wu JC, Huang HD, Shiao MS, Hsiao M, Tsou AP. MicroRNA-122 plays a critical role in liver homeostasis and hepatocarcinogenesis. J Clin Invest 2012;122:2884-97. [PMID: 22820290 DOI: 10.1172/JCI63455] [Cited by in Crossref: 562] [Cited by in F6Publishing: 333] [Article Influence: 62.4] [Reference Citation Analysis]
436 Rassouli A, Saliba J, Castano R, Hier M, Zeitouni AG. Systemic inflammatory markers as independent prognosticators of head and neck squamous cell carcinoma: Inflammatory Markers in Head and Neck Malignancies. Head Neck 2015;37:103-10. [DOI: 10.1002/hed.23567] [Cited by in Crossref: 87] [Cited by in F6Publishing: 84] [Article Influence: 12.4] [Reference Citation Analysis]
437 Bigsby RM, Caperell-Grant A. The role for estrogen receptor-alpha and prolactin receptor in sex-dependent DEN-induced liver tumorigenesis. Carcinogenesis 2011;32:1162-6. [PMID: 21606321 DOI: 10.1093/carcin/bgr094] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 1.9] [Reference Citation Analysis]
438 Lee S, Lee M, Kim JB, Jo A, Cho EJ, Yu SJ, Lee JH, Yoon JH, Kim YJ. 17β-estradiol exerts anticancer effects in anoikis-resistant hepatocellular carcinoma cell lines by targeting IL-6/STAT3 signaling. Biochem Biophys Res Commun 2016;473:1247-54. [PMID: 27091428 DOI: 10.1016/j.bbrc.2016.04.049] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 2.6] [Reference Citation Analysis]
439 Li BZ, Zhang HY, Pan HF, Ye DQ. Identification of MFG-E8 as a novel therapeutic target for diseases. Expert Opin Ther Targets 2013;17:1275-85. [PMID: 23972256 DOI: 10.1517/14728222.2013.829455] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 2.5] [Reference Citation Analysis]
440 Lepiller Q, Abbas W, Kumar A, Tripathy MK, Herbein G. HCMV activates the IL-6-JAK-STAT3 axis in HepG2 cells and primary human hepatocytes. PLoS One 2013;8:e59591. [PMID: 23555719 DOI: 10.1371/journal.pone.0059591] [Cited by in Crossref: 38] [Cited by in F6Publishing: 39] [Article Influence: 4.8] [Reference Citation Analysis]
441 Wang AG, Lee DS, Moon HB, Kim JM, Cho KH, Choi SH, Ha HL, Han YH, Kim DG, Hwang SB. Non-structural 5A protein of hepatitis C virus induces a range of liver pathology in transgenic mice. J Pathol. 2009;219:253-262. [PMID: 19621337 DOI: 10.1002/path.2592] [Cited by in Crossref: 47] [Cited by in F6Publishing: 41] [Article Influence: 3.9] [Reference Citation Analysis]
442 Ploeger C, Waldburger N, Fraas A, Goeppert B, Pusch S, Breuhahn K, Wang XW, Schirmacher P, Roessler S. Chromosome 8p tumor suppressor genes SH2D4A and SORBS3 cooperate to inhibit interleukin-6 signaling in hepatocellular carcinoma. Hepatology 2016;64:828-42. [PMID: 27311882 DOI: 10.1002/hep.28684] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 3.6] [Reference Citation Analysis]
443 Egunsola AT, Zawislak CL, Akuffo AA, Chalmers SA, Ewer JC, Vail CM, Lombardo JC, Perez DN, Kurt RA. Growth, metastasis, and expression of CCL2 and CCL5 by murine mammary carcinomas are dependent upon Myd88. Cell Immunol 2012;272:220-9. [PMID: 22088941 DOI: 10.1016/j.cellimm.2011.10.008] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 1.7] [Reference Citation Analysis]
444 Mantovani A, Garlanda C, Allavena P. Molecular pathways and targets in cancer-related inflammation. Ann Med. 2010;42:161-170. [PMID: 20384432 DOI: 10.3109/07853890903405753] [Cited by in Crossref: 123] [Cited by in F6Publishing: 103] [Article Influence: 11.2] [Reference Citation Analysis]
445 McGlynn KA, Hagberg K, Chen J, Braunlin M, Graubard BI, Suneja N, Jick S, Sahasrabuddhe VV. Menopausal hormone therapy use and risk of primary liver cancer in the clinical practice research datalink. Int J Cancer 2016;138:2146-53. [PMID: 26662112 DOI: 10.1002/ijc.29960] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
446 Gao S, Li A, Liu F, Chen F, Williams M, Zhang C, Kelley Z, Wu CL, Luo R, Xiao H. NCOA5 haploinsufficiency results in glucose intolerance and subsequent hepatocellular carcinoma. Cancer Cell. 2013;24:725-737. [PMID: 24332041 DOI: 10.1016/j.ccr.2013.11.005] [Cited by in Crossref: 32] [Cited by in F6Publishing: 35] [Article Influence: 4.6] [Reference Citation Analysis]
447 Muhimpundu S, Conway RBN, Warren Andersen S, Lipworth L, Steinwandel MD, Blot WJ, Shu XO, Sudenga SL. Racial Differences in Hepatocellular Carcinoma Incidence and Risk Factors among a Low Socioeconomic Population. Cancers (Basel) 2021;13:3710. [PMID: 34359611 DOI: 10.3390/cancers13153710] [Reference Citation Analysis]
448 Mohs A, Kuttkat N, Otto T, Youssef SA, De Bruin A, Trautwein C. MyD88-dependent signaling in non-parenchymal cells promotes liver carcinogenesis. Carcinogenesis 2020;41:171-81. [PMID: 30770929 DOI: 10.1093/carcin/bgy173] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
449 Svinka J, Mikulits W, Eferl R. STAT3 in hepatocellular carcinoma: new perspectives. Hepatic Oncol. 2013;1:107-120. [PMID: 30190945 DOI: 10.2217/hep.13.7] [Cited by in Crossref: 25] [Cited by in F6Publishing: 19] [Article Influence: 3.1] [Reference Citation Analysis]
450 Romualdo GR, Prata GB, da Silva TC, Fernandes AAH, Moreno FS, Cogliati B, Barbisan LF. Fibrosis-associated hepatocarcinogenesis revisited: Establishing standard medium-term chemically-induced male and female models. PLoS One 2018;13:e0203879. [PMID: 30212575 DOI: 10.1371/journal.pone.0203879] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 2.7] [Reference Citation Analysis]
451 Xiao Y, Liu G, Sun Y, Gao Y, Ouyang X, Chang C, Gong L, Yeh S. Targeting the estrogen receptor alpha (ERα)-mediated circ-SMG1.72/miR-141-3p/Gelsolin signaling to better suppress the HCC cell invasion. Oncogene 2020;39:2493-508. [PMID: 31996784 DOI: 10.1038/s41388-019-1150-6] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 14.0] [Reference Citation Analysis]
452 Navarro FC, Herrnreiter C, Nowak L, Watkins SK. Estrogen Regulation of T-Cell Function and Its Impact on the Tumor Microenvironment. Gender and the Genome 2018;2:81-91. [DOI: 10.1177/2470289718801379] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
453 Hartwell HJ, Petrosky KY, Fox JG, Horseman ND, Rogers AB. Prolactin prevents hepatocellular carcinoma by restricting innate immune activation of c-Myc in mice. Proc Natl Acad Sci USA. 2014;111:11455-11460. [PMID: 25049387 DOI: 10.1073/pnas.1404267111] [Cited by in Crossref: 46] [Cited by in F6Publishing: 40] [Article Influence: 6.6] [Reference Citation Analysis]
454 Jinushi M, Sato M, Kanamoto A, Itoh A, Nagai S, Koyasu S, Dranoff G, Tahara H. Milk fat globule epidermal growth factor-8 blockade triggers tumor destruction through coordinated cell-autonomous and immune-mediated mechanisms. J Exp Med 2009;206:1317-26. [PMID: 19433619 DOI: 10.1084/jem.20082614] [Cited by in Crossref: 68] [Cited by in F6Publishing: 63] [Article Influence: 5.7] [Reference Citation Analysis]
455 Gubernatorova EO, Gorshkova EA, Polinova AI, Drutskaya MS. IL-6: Relevance for immunopathology of SARS-CoV-2.Cytokine Growth Factor Rev. 2020;53:13-24. [PMID: 32475759 DOI: 10.1016/j.cytogfr.2020.05.009] [Cited by in Crossref: 89] [Cited by in F6Publishing: 69] [Article Influence: 89.0] [Reference Citation Analysis]
456 Barshop NJ, Sirlin CB, Schwimmer JB, Lavine JE. Review article: epidemiology, pathogenesis and potential treatments of paediatric non-alcoholic fatty liver disease: REVIEW: PAEDIATRIC NON-ALCOHOLIC FATTY LIVER DISEASE. Alimentary Pharmacology & Therapeutics 2008;28:13-24. [DOI: 10.1111/j.1365-2036.2008.03703.x] [Cited by in Crossref: 89] [Cited by in F6Publishing: 90] [Article Influence: 6.8] [Reference Citation Analysis]
457 Chen C, Chang M. HEPATITIS B AND PREGNANCY, THE SCIENTIFIC BASIS FOR PERINATAL PREVENTION. Fet Matern Med Rev 2010;21:89-113. [DOI: 10.1017/s0965539510000021] [Cited by in Crossref: 2] [Article Influence: 0.2] [Reference Citation Analysis]
458 Alahari SV, Dong S, Alahari SK. Are macrophages in tumors good targets for novel therapeutic approaches? Mol Cells 2015;38:95-104. [PMID: 25518927 DOI: 10.14348/molcells.2015.2298] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
459 Liu F, Yuan JH, Huang JF, Yang F, Wang TT, Ma JZ, Zhang L, Zhou CC, Wang F, Yu J. Long noncoding RNA FTX inhibits hepatocellular carcinoma proliferation and metastasis by binding MCM2 and miR-374a. Oncogene. 2016;35:5422-5434. [PMID: 27065331 DOI: 10.1038/onc.2016.80] [Cited by in Crossref: 102] [Cited by in F6Publishing: 111] [Article Influence: 20.4] [Reference Citation Analysis]
460 Xin G, Qin S, Wang S, Wang X, Zhang Y, Wang J. Sex hormone affects the severity of non-alcoholic steatohepatitis through the MyD88-dependent IL-6 signaling pathway. Exp Biol Med (Maywood) 2015;240:1279-86. [PMID: 25790822 DOI: 10.1177/1535370215570189] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 3.2] [Reference Citation Analysis]
461 Fwu C, Chien Y, Kirk GD, Nelson KE, You S, Kuo H, Feinleib M, Chen C. Hepatitis B Virus Infection and Hepatocellular Carcinoma Among Parous Taiwanese Women: Nationwide Cohort Study. JNCI: Journal of the National Cancer Institute 2009;101:1019-27. [DOI: 10.1093/jnci/djp146] [Cited by in Crossref: 36] [Cited by in F6Publishing: 31] [Article Influence: 3.0] [Reference Citation Analysis]
462 Xu B, Li SH, Zheng R, Gao SB, Ding LH, Yin ZY, Lin X, Feng ZJ, Zhang S, Wang XM, Jin GH. Menin promotes hepatocellular carcinogenesis and epigenetically up-regulates Yap1 transcription. Proc Natl Acad Sci U S A 2013;110:17480-5. [PMID: 24101467 DOI: 10.1073/pnas.1312022110] [Cited by in Crossref: 41] [Cited by in F6Publishing: 36] [Article Influence: 5.1] [Reference Citation Analysis]
463 Banerjee A, Thamphiwatana S, Carmona EM, Rickman B, Doran KS, Obonyo M. Deficiency of the myeloid differentiation primary response molecule MyD88 leads to an early and rapid development of Helicobacter-induced gastric malignancy. Infect Immun 2014;82:356-63. [PMID: 24166959 DOI: 10.1128/IAI.01344-13] [Cited by in Crossref: 24] [Cited by in F6Publishing: 16] [Article Influence: 3.0] [Reference Citation Analysis]
464 Fujimoto M, Naka T. SOCS1, a Negative Regulator of Cytokine Signals and TLR Responses, in Human Liver Diseases. Gastroenterol Res Pract 2010;2010:470468. [PMID: 20862390 DOI: 10.1155/2010/470468] [Cited by in Crossref: 61] [Cited by in F6Publishing: 62] [Article Influence: 5.5] [Reference Citation Analysis]
465 Chang Q, Chen J, Beezhold KJ, Castranova V, Shi X, Chen F. JNK1 activation predicts the prognostic outcome of the human hepatocellular carcinoma. Mol Cancer 2009;8:64. [PMID: 19686584 DOI: 10.1186/1476-4598-8-64] [Cited by in Crossref: 47] [Cited by in F6Publishing: 51] [Article Influence: 3.9] [Reference Citation Analysis]
466 Behrens C, Feng L, Kadara H, Kim HJ, Lee JJ, Mehran R, Hong WK, Lotan R, Wistuba II. Expression of interleukin-1 receptor-associated kinase-1 in non-small cell lung carcinoma and preneoplastic lesions. Clin Cancer Res 2010;16:34-44. [PMID: 20028769 DOI: 10.1158/1078-0432.CCR-09-0650] [Cited by in Crossref: 22] [Cited by in F6Publishing: 15] [Article Influence: 1.8] [Reference Citation Analysis]
467 Kanaan N, Raggi C, Goffin E, De Meyer M, Mourad M, Jadoul M, Beguin C, Kabamba B, Borbath I, Pirson Y. Outcome of hepatitis B and C virus-associated hepatocellular carcinoma occurring after renal transplantation. J Viral Hepat. 2017;24:430-435. [PMID: 27917563 DOI: 10.1111/jvh.12655] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
468 Dey P, Kim JB, Chitchumroonchokchai C, Li J, Sasaki GY, Olmstead BD, Stock KL, Thomas-Ahner JM, Clinton SK, Bruno RS. Green tea extract inhibits early oncogenic responses in mice with nonalcoholic steatohepatitis. Food Funct 2019;10:6351-61. [PMID: 31503268 DOI: 10.1039/c9fo01199d] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 9.0] [Reference Citation Analysis]
469 Wang L, Sun R, Vasile T, Chang Y, Li L. High-Throughput Optical Sensing Immunoassays on Smartphone. Anal Chem 2016;88:8302-8. [DOI: 10.1021/acs.analchem.6b02211] [Cited by in Crossref: 37] [Cited by in F6Publishing: 28] [Article Influence: 7.4] [Reference Citation Analysis]
470 Candido J, Hagemann T. Cancer-related inflammation. J Clin Immunol. 2013;33 Suppl 1:S79-S84. [PMID: 23225204 DOI: 10.1212/01.wnl.0000436611.28210.ec] [Cited by in Crossref: 28] [Cited by in F6Publishing: 24] [Article Influence: 3.1] [Reference Citation Analysis]
471 Mansell A, Jenkins BJ. Dangerous liaisons between interleukin-6 cytokine and toll-like receptor families: A potent combination in inflammation and cancer. Cytokine & Growth Factor Reviews 2013;24:249-56. [DOI: 10.1016/j.cytogfr.2013.03.007] [Cited by in Crossref: 25] [Cited by in F6Publishing: 18] [Article Influence: 3.1] [Reference Citation Analysis]
472 Gosain R, Anwar S, Miller A, Iyer R, Mukherjee S. Interleukin-6 as a biomarker in patients with hepatobiliary cancers. J Gastrointest Oncol 2019;10:537-45. [PMID: 31183205 DOI: 10.21037/jgo.2019.01.09] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
473 Yang P, Markowitz GJ, Wang XF. The hepatitis B virus-associated tumor microenvironment in hepatocellular carcinoma. Natl Sci Rev 2014;1:396-412. [PMID: 25741453 DOI: 10.1093/nsr/nwu038] [Cited by in Crossref: 34] [Cited by in F6Publishing: 30] [Article Influence: 4.9] [Reference Citation Analysis]
474 Qiu W, Wang X, Leibowitz B, Yang W, Zhang L, Yu J. PUMA-mediated apoptosis drives chemical hepatocarcinogenesis in mice. Hepatology. 2011;54:1249-1258. [PMID: 21725994 DOI: 10.1002/hep.24516] [Cited by in Crossref: 65] [Cited by in F6Publishing: 61] [Article Influence: 6.5] [Reference Citation Analysis]
475 You DJ, Lee HY, Taylor-Just AJ, Linder KE, Bonner JC. Sex differences in the acute and subchronic lung inflammatory responses of mice to nickel nanoparticles. Nanotoxicology 2020;14:1058-81. [PMID: 32813574 DOI: 10.1080/17435390.2020.1808105] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
476 Humphries C. Sex differences: Luck of the chromosomes. Nature 2014;516:S10-1. [DOI: 10.1038/516s10a] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
477 Ghazeeri G, Abdullah L, Abbas O. Immunological differences in women compared with men: overview and contributing factors. Am J Reprod Immunol 2011;66:163-9. [PMID: 21749547 DOI: 10.1111/j.1600-0897.2011.01052.x] [Cited by in Crossref: 40] [Cited by in F6Publishing: 33] [Article Influence: 4.0] [Reference Citation Analysis]
478 Hartman ZC, Yang XY, Glass O, Lei G, Osada T, Dave SS, Morse MA, Clay TM, Lyerly HK. HER2 overexpression elicits a proinflammatory IL-6 autocrine signaling loop that is critical for tumorigenesis. Cancer Res 2011;71:4380-91. [PMID: 21518778 DOI: 10.1158/0008-5472.CAN-11-0308] [Cited by in Crossref: 85] [Cited by in F6Publishing: 56] [Article Influence: 8.5] [Reference Citation Analysis]
479 Lokau J, Schoeder V, Haybaeck J, Garbers C. Jak-Stat Signaling Induced by Interleukin-6 Family Cytokines in Hepatocellular Carcinoma. Cancers (Basel) 2019;11:E1704. [PMID: 31683891 DOI: 10.3390/cancers11111704] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 10.5] [Reference Citation Analysis]
480 Jiang CM, Pu CW, Hou YH, Chen Z, Alanazy M, Hebbard L. Non alcoholic steatohepatitis a precursor for hepatocellular carcinoma development. World J Gastroenterol 2014;20:16464-73. [PMID: 25469014 DOI: 10.3748/wjg.v20.i44.16464] [Cited by in CrossRef: 30] [Cited by in F6Publishing: 28] [Article Influence: 5.0] [Reference Citation Analysis]
481 Li H, Weiser-Evans MC, Nemenoff R. Anti- and Protumorigenic Effects of PPARγ in Lung Cancer Progression: A Double-Edged Sword. PPAR Res 2012;2012:362085. [PMID: 22934105 DOI: 10.1155/2012/362085] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
482 Hou J, Xu J, Jiang R, Wang Y, Chen C, Deng L, Huang X, Wang X, Sun B. Estrogen-sensitive PTPRO expression represses hepatocellular carcinoma progression by control of STAT3. Hepatology. 2013;57:678-688. [PMID: 22821478 DOI: 10.1002/hep.25980] [Cited by in Crossref: 41] [Cited by in F6Publishing: 37] [Article Influence: 4.6] [Reference Citation Analysis]
483 Leenders MW, Nijkamp MW, Borel Rinkes IH. Mouse models in liver cancer research: a review of current literature. World J Gastroenterol. 2008;14:6915-6923. [PMID: 19058325 DOI: 10.3748/wjg.14.6915] [Cited by in CrossRef: 55] [Cited by in F6Publishing: 41] [Article Influence: 4.6] [Reference Citation Analysis]
484 Samraj AN, Pearce OM, Läubli H, Crittenden AN, Bergfeld AK, Banda K, Gregg CJ, Bingman AE, Secrest P, Diaz SL, Varki NM, Varki A. A red meat-derived glycan promotes inflammation and cancer progression. Proc Natl Acad Sci U S A 2015;112:542-7. [PMID: 25548184 DOI: 10.1073/pnas.1417508112] [Cited by in Crossref: 205] [Cited by in F6Publishing: 168] [Article Influence: 29.3] [Reference Citation Analysis]
485 Cha H, Lee EJ, Seong J. Multi-analyte analysis of cytokines that predict outcomes in patients with hepatocellular carcinoma treated with radiotherapy. World J Gastroenterol 2017;23:2077-85. [PMID: 28373775 DOI: 10.3748/wjg.v23.i11.2077] [Cited by in CrossRef: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
486 O'Brien MH, Pitot HC, Chung SH, Lambert PF, Drinkwater NR, Bilger A. Estrogen Receptor-α Suppresses Liver Carcinogenesis and Establishes Sex-Specific Gene Expression. Cancers (Basel) 2021;13:2355. [PMID: 34068249 DOI: 10.3390/cancers13102355] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
487 Zender L, Kubicka S. Androgen receptor and hepatocarcinogenesis: what do we learn from HCC mouse models? Gastroenterology. 2008;135:738-740. [PMID: 18692055 DOI: 10.1053/j.gastro.2008.07.034] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
488 Song CH, Kim N, Lee SM, Nam RH, Choi SI, Kang SR, Shin E, Lee DH, Lee HN, Surh YJ. Effects of 17β-estradiol on colorectal cancer development after azoxymethane/dextran sulfate sodium treatment of ovariectomized mice. Biochem Pharmacol 2019;164:139-51. [PMID: 30981879 DOI: 10.1016/j.bcp.2019.04.011] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 8.0] [Reference Citation Analysis]
489 Hsu SH, Wang B, Kota J, Yu J, Costinean S, Kutay H, Yu L, Bai S, La Perle K, Chivukula RR, Mao H, Wei M, Clark KR, Mendell JR, Caligiuri MA, Jacob ST, Mendell JT, Ghoshal K. Essential metabolic, anti-inflammatory, and anti-tumorigenic functions of miR-122 in liver. J Clin Invest. 2012;122:2871-2883. [PMID: 22820288 DOI: 10.1172/jci63539] [Cited by in Crossref: 532] [Cited by in F6Publishing: 313] [Article Influence: 59.1] [Reference Citation Analysis]
490 Yu GY, He G, Li CY, Tang M, Grivennikov S, Tsai WT, Wu MS, Hsu CW, Tsai Y, Wang LH, Karin M. Hepatic expression of HCV RNA-dependent RNA polymerase triggers innate immune signaling and cytokine production. Mol Cell. 2012;48:313-321. [PMID: 22959272 DOI: 10.1016/j.molcel.2012.07.032] [Cited by in Crossref: 43] [Cited by in F6Publishing: 39] [Article Influence: 4.8] [Reference Citation Analysis]
491 Chung W, Kim M, de la Monte S, Longato L, Carlson R, Slagle BL, Dong X, Wands JR. Activation of signal transduction pathways during hepatic oncogenesis. Cancer Lett. 2016;370:1-9. [PMID: 26433160 DOI: 10.1016/j.canlet.2015.09.016] [Cited by in Crossref: 23] [Cited by in F6Publishing: 26] [Article Influence: 3.8] [Reference Citation Analysis]
492 Wang L, Chang Y, Sun R, Li L. A multichannel smartphone optical biosensor for high-throughput point-of-care diagnostics. Biosensors and Bioelectronics 2017;87:686-92. [DOI: 10.1016/j.bios.2016.09.021] [Cited by in Crossref: 101] [Cited by in F6Publishing: 74] [Article Influence: 25.3] [Reference Citation Analysis]
493 Yang YM, Kim SY, Seki E. Inflammation and Liver Cancer: Molecular Mechanisms and Therapeutic Targets. Semin Liver Dis. 2019;39:26-42. [PMID: 30809789 DOI: 10.1055/s-0038-1676806] [Cited by in Crossref: 56] [Cited by in F6Publishing: 49] [Article Influence: 28.0] [Reference Citation Analysis]
494 Rappa F, Greco A, Podrini C, Cappello F, Foti M, Bourgoin L, Peyrou M, Marino A, Scibetta N, Williams R, Mazzoccoli G, Federici M, Pazienza V, Vinciguerra M. Immunopositivity for histone macroH2A1 isoforms marks steatosis-associated hepatocellular carcinoma. PLoS One 2013;8:e54458. [PMID: 23372727 DOI: 10.1371/journal.pone.0054458] [Cited by in Crossref: 37] [Cited by in F6Publishing: 43] [Article Influence: 4.6] [Reference Citation Analysis]
495 Zhou X, Niu X, Li J, Zhang S, Yang W, Yang Y, Mao Q, Liu Y. Risk Factors for Early Mortality in Patients with Primary Central Nervous System Lymphoma: A Large-Cohort Retrospective Study. World Neurosurg 2020;138:e905-12. [PMID: 32251807 DOI: 10.1016/j.wneu.2020.03.150] [Reference Citation Analysis]
496 Tellechea M, Buxadé M, Tejedor S, Aramburu J, López-Rodríguez C. NFAT5-Regulated Macrophage Polarization Supports the Proinflammatory Function of Macrophages and T Lymphocytes. J Immunol 2018;200:305-15. [PMID: 29150563 DOI: 10.4049/jimmunol.1601942] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 6.0] [Reference Citation Analysis]
497 M'Koma AE, Moses HL, Adunyah SE. Inflammatory bowel disease-associated colorectal cancer: proctocolectomy and mucosectomy do not necessarily eliminate pouch-related cancer incidences. Int J Colorectal Dis 2011;26:533-52. [PMID: 21311893 DOI: 10.1007/s00384-011-1137-4] [Cited by in Crossref: 25] [Cited by in F6Publishing: 20] [Article Influence: 2.5] [Reference Citation Analysis]
498 Sun T, Warrington NM, Rubin JB. Why does Jack, and not Jill, break his crown? Sex disparity in brain tumors. Biol Sex Differ 2012;3:3. [PMID: 22277186 DOI: 10.1186/2042-6410-3-3] [Cited by in Crossref: 39] [Cited by in F6Publishing: 30] [Article Influence: 4.3] [Reference Citation Analysis]
499 Koch M, Reinartz S, Saggau J, Knittel G, Rosen N, Fedorchenko O, Thelen L, Barthel R, Reinart N, Seeger-Nukpezah T, Reinhardt HC, Hallek M, Nguyen PH. Meta-Analysis Reveals Significant Sex Differences in Chronic Lymphocytic Leukemia Progression in the Eµ-TCL1 Transgenic Mouse Model. Cancers (Basel) 2020;12:E1980. [PMID: 32698538 DOI: 10.3390/cancers12071980] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
500 Ding N, Nie H, Sun X, Sun W, Qu Y, Liu X, Yao Y, Liang X, Chen CC, Li Y. Human serum N-glycan profiles are age and sex dependent. Age Ageing 2011;40:568-75. [PMID: 21807702 DOI: 10.1093/ageing/afr084] [Cited by in Crossref: 50] [Cited by in F6Publishing: 47] [Article Influence: 5.0] [Reference Citation Analysis]
501 Carter AB, Misyak SA, Hontecillas R, Bassaganya-Riera J. Dietary modulation of inflammation-induced colorectal cancer through PPARγ. PPAR Res 2009;2009:498352. [PMID: 19390648 DOI: 10.1155/2009/498352] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 1.3] [Reference Citation Analysis]
502 Lee CH, Wu CL, Shiau AL. Toll-like receptor 4 signaling promotes tumor growth. J Immunother. 2010;33:73-82. [PMID: 19952954 DOI: 10.1097/CJI.0b013e3181b7a0a4] [Cited by in Crossref: 37] [Cited by in F6Publishing: 23] [Article Influence: 3.4] [Reference Citation Analysis]
503 Tacke F. Targeting hepatic macrophages to treat liver diseases. J Hepatol. 2017;66:1300-1312. [PMID: 28267621 DOI: 10.1016/j.jhep.2017.02.026] [Cited by in Crossref: 334] [Cited by in F6Publishing: 300] [Article Influence: 83.5] [Reference Citation Analysis]
504 Chen N, Nishio N, Ito S, Tanaka Y, Sun Y, Isobe K. Growth arrest and DNA damage-inducible protein (GADD34) enhanced liver inflammation and tumorigenesis in a diethylnitrosamine (DEN)-treated murine model. Cancer Immunol Immunother 2015;64:777-89. [PMID: 25832002 DOI: 10.1007/s00262-015-1690-8] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
505 Eddie SL, Kim JJ, Woodruff TK, Burdette JE. Microphysiological modeling of the reproductive tract: a fertile endeavor. Exp Biol Med (Maywood) 2014;239:1192-202. [PMID: 24737736 DOI: 10.1177/1535370214529387] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 2.7] [Reference Citation Analysis]
506 Muto Y, Moroishi T, Ichihara K, Nishiyama M, Shimizu H, Eguchi H, Moriya K, Koike K, Mimori K, Mori M, Katayama Y, Nakayama KI. Disruption of FBXL5-mediated cellular iron homeostasis promotes liver carcinogenesis. J Exp Med 2019;216:950-65. [PMID: 30877170 DOI: 10.1084/jem.20180900] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 6.0] [Reference Citation Analysis]
507 Naugler WE, Karin M. NF-kappaB and cancer-identifying targets and mechanisms. Curr Opin Genet Dev. 2008;18:19-26. [PMID: 18440219 DOI: 10.1016/j.gde.2008.01.020] [Cited by in Crossref: 416] [Cited by in F6Publishing: 396] [Article Influence: 32.0] [Reference Citation Analysis]
508 Dash S, Aydin Y, Widmer KE, Nayak L. Hepatocellular Carcinoma Mechanisms Associated with Chronic HCV Infection and the Impact of Direct-Acting Antiviral Treatment. J Hepatocell Carcinoma 2020;7:45-76. [PMID: 32346535 DOI: 10.2147/JHC.S221187] [Cited by in Crossref: 15] [Cited by in F6Publishing: 9] [Article Influence: 15.0] [Reference Citation Analysis]
509 Zhang W, Tsuda M, Yang GX, Tsuneyama K, Rong G, Ridgway WM, Ansari AA, Flavell RA, Coppel RL, Lian ZX. Deletion of interleukin-6 in mice with the dominant negative form of transforming growth factor beta receptor II improves colitis but exacerbates autoimmune cholangitis. Hepatology. 2010;52:215-222. [PMID: 20578264 DOI: 10.1002/hep.23664] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 2.2] [Reference Citation Analysis]
510 Rosa-Caldwell ME, Greene NP. Muscle metabolism and atrophy: let's talk about sex. Biol Sex Differ 2019;10:43. [PMID: 31462271 DOI: 10.1186/s13293-019-0257-3] [Cited by in Crossref: 35] [Cited by in F6Publishing: 32] [Article Influence: 17.5] [Reference Citation Analysis]
511 Lu C, Rong D, Zhang B, Zheng W, Wang X, Chen Z, Tang W. Current perspectives on the immunosuppressive tumor microenvironment in hepatocellular carcinoma: challenges and opportunities. Mol Cancer. 2019;18:130. [PMID: 31464625 DOI: 10.1186/s12943-019-1047-6] [Cited by in Crossref: 60] [Cited by in F6Publishing: 61] [Article Influence: 30.0] [Reference Citation Analysis]
512 Kadekar S, Peddada S, Silins I, French JE, Högberg J, Stenius U. Gender differences in chemical carcinogenesis in National Toxicology Program 2-year bioassays. Toxicol Pathol 2012;40:1160-8. [PMID: 22585941 DOI: 10.1177/0192623312446527] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]
513 Multhoff G, Radons J. Radiation, inflammation, and immune responses in cancer. Front Oncol. 2012;2:58. [PMID: 22675673 DOI: 10.3389/fonc.2012.00058] [Cited by in Crossref: 86] [Cited by in F6Publishing: 95] [Article Influence: 9.6] [Reference Citation Analysis]
514 Hallam S, Escorcio-Correia M, Soper R, Schultheiss A, Hagemann T. Activated macrophages in the tumour microenvironment-dancing to the tune of TLR and NF-kappaB. J Pathol 2009;219:143-52. [PMID: 19662665 DOI: 10.1002/path.2602] [Cited by in Crossref: 46] [Cited by in F6Publishing: 39] [Article Influence: 3.8] [Reference Citation Analysis]
515 Pham T, Claudepierre P, Constantin A, de Bandt M, Fautrel B, Gossec L, Gottenberg JE, Goupille P, Guillaume S, Hachulla E, Masson C, Morel J, Puéchal X, Saraux A, Schaeverbeke T, Wendling D, Bruckert E, Pol S, Mariette X, Sibilia J; Club Rhumatismes et Inflammation (CRI). Tocilizumab: therapy and safety management. Joint Bone Spine 2010;77 Suppl 1:S3-100. [PMID: 20610315 DOI: 10.1016/S1297-319X(10)70001-4] [Cited by in Crossref: 42] [Cited by in F6Publishing: 7] [Article Influence: 3.8] [Reference Citation Analysis]
516 Zhu Y, Li F, Guo GL. Tissue-specific function of farnesoid X receptor in liver and intestine. Pharmacol Res. 2011;63:259-265. [PMID: 21211565 DOI: 10.1016/j.phrs.2010.12.018] [Cited by in Crossref: 58] [Cited by in F6Publishing: 54] [Article Influence: 5.8] [Reference Citation Analysis]
517 Mancino A, Lawrence T. Nuclear factor-kappaB and tumor-associated macrophages. Clin Cancer Res. 2010;16:784-789. [PMID: 20103670 DOI: 10.1158/1078-0432.ccr-09-1015] [Cited by in Crossref: 92] [Cited by in F6Publishing: 60] [Article Influence: 8.4] [Reference Citation Analysis]
518 Aghemo A, Colombo M. Hepatocellular carcinoma in chronic hepatitis C: from bench to bedside. Semin Immunopathol 2013;35:111-20. [DOI: 10.1007/s00281-012-0330-z] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 2.2] [Reference Citation Analysis]
519 Pedram A, Razandi M, Evinger AJ, Lee E, Levin ER. Estrogen inhibits ATR signaling to cell cycle checkpoints and DNA repair. Mol Biol Cell 2009;20:3374-89. [PMID: 19477925 DOI: 10.1091/mbc.e09-01-0085] [Cited by in Crossref: 59] [Cited by in F6Publishing: 46] [Article Influence: 4.9] [Reference Citation Analysis]
520 Eder K, Baffy N, Falus A, Fulop AK. The major inflammatory mediator interleukin-6 and obesity. Inflamm Res. 2009;58:727-736. [PMID: 19543691 DOI: 10.1007/s00011-009-0060-4] [Cited by in Crossref: 233] [Cited by in F6Publishing: 208] [Article Influence: 19.4] [Reference Citation Analysis]
521 Hong GQ, Cai D, Gong JP, Lai X. Innate immune cells and their interaction with T cells in hepatocellular carcinoma. Oncol Lett 2021;21:57. [PMID: 33281968 DOI: 10.3892/ol.2020.12319] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
522 Greten TF. Gender disparity in HCC: Is it the fat and not the sex? J Exp Med 2019;216:1014-5. [PMID: 31000682 DOI: 10.1084/jem.20190441] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
523 Kang SY, Kim YJ, Park HS. Trends in the Prevalence of Non-Alcoholic Fatty Liver Disease and Its Future Predictions in Korean Men, 1998-2035. J Clin Med 2020;9:E2626. [PMID: 32823604 DOI: 10.3390/jcm9082626] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
524 Weiss DS. The great escape: microbiotal LPS takes a toll on the liver. Cancer Prev Res (Phila) 2012;5:1078-80. [PMID: 22952210 DOI: 10.1158/1940-6207.CAPR-12-0248] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
525 Johansson M, Denardo DG, Coussens LM. Polarized immune responses differentially regulate cancer development. Immunol Rev. 2008;222:145-154. [PMID: 18363999 DOI: 10.1111/j.1600-065x.2008.00600.x] [Cited by in Crossref: 137] [Cited by in F6Publishing: 74] [Article Influence: 11.4] [Reference Citation Analysis]
526 Chew V, Tow C, Teo M, Wong HL, Chan J, Gehring A, Loh M, Bolze A, Quek R, Lee VK, Lee KH, Abastado JP, Toh HC, Nardin A. Inflammatory tumour microenvironment is associated with superior survival in hepatocellular carcinoma patients. J Hepatol. 2010;52:370-379. [PMID: 19720422 DOI: 10.1016/j.jhep.2009.07.013] [Cited by in Crossref: 144] [Cited by in F6Publishing: 149] [Article Influence: 12.0] [Reference Citation Analysis]
527 Subramaniam A, Shanmugam MK, Perumal E, Li F, Nachiyappan A, Dai X, Swamy SN, Ahn KS, Kumar AP, Tan BK, Hui KM, Sethi G. Potential role of signal transducer and activator of transcription (STAT)3 signaling pathway in inflammation, survival, proliferation and invasion of hepatocellular carcinoma. Biochim Biophys Acta 2013;1835:46-60. [PMID: 23103770 DOI: 10.1016/j.bbcan.2012.10.002] [Cited by in Crossref: 57] [Cited by in F6Publishing: 120] [Article Influence: 6.3] [Reference Citation Analysis]
528 Kenny EF, O'Neill LA. Signalling adaptors used by Toll-like receptors: an update. Cytokine 2008;43:342-9. [PMID: 18706831 DOI: 10.1016/j.cyto.2008.07.010] [Cited by in Crossref: 248] [Cited by in F6Publishing: 230] [Article Influence: 19.1] [Reference Citation Analysis]
529 Trindade-da-Silva CA, Reis CF, Vecchi L, Napimoga MH, Sperandio M, Matias Colombo BF, Alves PT, Ward LS, Ueira-Vieira C, Goulart LR. 15-Deoxy-Δ(12,14)-prostaglandin J2 Induces Apoptosis and Upregulates SOCS3 in Human Thyroid Cancer Cells. PPAR Res 2016;2016:4106297. [PMID: 27190500 DOI: 10.1155/2016/4106297] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
530 Pearce OM, Läubli H, Verhagen A, Secrest P, Zhang J, Varki NM, Crocker PR, Bui JD, Varki A. Inverse hormesis of cancer growth mediated by narrow ranges of tumor-directed antibodies. Proc Natl Acad Sci U S A 2014;111:5998-6003. [PMID: 24711415 DOI: 10.1073/pnas.1209067111] [Cited by in Crossref: 47] [Cited by in F6Publishing: 42] [Article Influence: 6.7] [Reference Citation Analysis]
531 Berasain C, Perugorria MJ, Latasa MU, Castillo J, Goñi S, Santamaría M, Prieto J, Avila MA. The epidermal growth factor receptor: a link between inflammation and liver cancer. Exp Biol Med (Maywood) 2009;234:713-25. [PMID: 19429859 DOI: 10.3181/0901-MR-12] [Cited by in Crossref: 88] [Cited by in F6Publishing: 44] [Article Influence: 7.3] [Reference Citation Analysis]
532 Wu EM, Wong LL, Hernandez BY, Ji JF, Jia W, Kwee SA, Kalathil S. Gender differences in hepatocellular cancer: disparities in nonalcoholic fatty liver disease/steatohepatitis and liver transplantation. Hepatoma Res 2018;4:66. [PMID: 30687780 DOI: 10.20517/2394-5079.2018.87] [Cited by in Crossref: 33] [Cited by in F6Publishing: 23] [Article Influence: 11.0] [Reference Citation Analysis]
533 Cartlidge CR, U MRA, Alkhatib AMA, Taylor-Robinson SD. The utility of biomarkers in hepatocellular carcinoma: review of urine-based 1H-NMR studies - what the clinician needs to know. Int J Gen Med 2017;10:431-42. [PMID: 29225478 DOI: 10.2147/IJGM.S150312] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
534 Ashraf NU, Altaf M. Epigenetics: An emerging field in the pathogenesis of nonalcoholic fatty liver disease. Mutat Res Rev Mutat Res 2018;778:1-12. [PMID: 30454678 DOI: 10.1016/j.mrrev.2018.07.002] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
535 Ali Kamkar MM, Ahmad R, Alsmadi O, Behbehani K. Insight into the impact of diabetes mellitus on the increased risk of hepatocellular carcinoma: mini-review. J Diabetes Metab Disord. 2014;13:57. [PMID: 24918094 DOI: 10.1186/2251-6581-13-57] [Cited by in Crossref: 9] [Cited by in F6Publishing: 12] [Article Influence: 1.3] [Reference Citation Analysis]
536 García ER, Gutierrez EA, de Melo FCSA, Novaes RD, Gonçalves RV. Flavonoids Effects on Hepatocellular Carcinoma in Murine Models: A Systematic Review. Evid Based Complement Alternat Med 2018;2018:6328970. [PMID: 29681978 DOI: 10.1155/2018/6328970] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
537 Yamada K, Mito F, Matsuoka Y, Ide S, Shikimachi K, Fujiki A, Kusakabe D, Ishida Y, Enoki M, Tada A, Ariyoshi M, Yamasaki T, Yamato M. Fluorescence probes to detect lipid-derived radicals. Nat Chem Biol 2016;12:608-13. [DOI: 10.1038/nchembio.2105] [Cited by in Crossref: 25] [Cited by in F6Publishing: 17] [Article Influence: 5.0] [Reference Citation Analysis]
538 Chawanthayatham S, Valentine CC 3rd, Fedeles BI, Fox EJ, Loeb LA, Levine SS, Slocum SL, Wogan GN, Croy RG, Essigmann JM. Mutational spectra of aflatoxin B1 in vivo establish biomarkers of exposure for human hepatocellular carcinoma. Proc Natl Acad Sci U S A 2017;114:E3101-9. [PMID: 28351974 DOI: 10.1073/pnas.1700759114] [Cited by in Crossref: 67] [Cited by in F6Publishing: 44] [Article Influence: 16.8] [Reference Citation Analysis]
539 Xu D, Wang X, Yan S, Yin Y, Hou J, Wang X, Sun B. Interaction of PTPRO and TLR4 signaling in hepatocellular carcinoma. Tumour Biol. 2014;35:10267-10273. [PMID: 25034527 DOI: 10.1007/s13277-014-2302-5] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
540 Tye H, Jenkins BJ. Tying the knot between cytokine and toll-like receptor signaling in gastrointestinal tract cancers. Cancer Sci. 2013;104:1139-1145. [PMID: 23710764 DOI: 10.1111/cas.12205] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 2.4] [Reference Citation Analysis]
541 Wang SH, Yeh SH, Lin WH, Wang HY, Chen DS, Chen PJ. Identification of androgen response elements in the enhancer I of hepatitis B virus: a mechanism for sex disparity in chronic hepatitis B. Hepatology. 2009;50:1392-1402. [PMID: 19670412 DOI: 10.1002/hep.23163] [Cited by in Crossref: 103] [Cited by in F6Publishing: 103] [Article Influence: 8.6] [Reference Citation Analysis]
542 Sheppard S, Guedes J, Mroz A, Zavitsanou AM, Kudo H, Rothery SM, Angelopoulos P, Goldin R, Guerra N. The immunoreceptor NKG2D promotes tumour growth in a model of hepatocellular carcinoma. Nat Commun 2017;8:13930. [PMID: 28128200 DOI: 10.1038/ncomms13930] [Cited by in Crossref: 31] [Cited by in F6Publishing: 29] [Article Influence: 7.8] [Reference Citation Analysis]
543 Lu Y, Li S, Ma L, Li Y, Zhang X, Peng Q, Mo C, Huang L, Qin X, Liu Y. Type conversion of secretomes in a 3D TAM2 and HCC cell co-culture system and functional importance of CXCL2 in HCC. Sci Rep 2016;6:24558. [PMID: 27117207 DOI: 10.1038/srep24558] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 2.6] [Reference Citation Analysis]
544 Chen F. JNK-induced apoptosis, compensatory growth, and cancer stem cells. Cancer Res. 2012;72:379-386. [PMID: 22253282 DOI: 10.1158/0008-5472.CAN-11-1982] [Cited by in Crossref: 139] [Cited by in F6Publishing: 75] [Article Influence: 15.4] [Reference Citation Analysis]
545 Huang X, Tian Y, Shi W, Chen J, Yan L, Ren L, Zhang X, Zhu J. Role of inflammation in the malignant transformation of pleural mesothelial cells induced by multi-walled carbon nanotubes. Nanotoxicology 2020;14:947-67. [PMID: 32574520 DOI: 10.1080/17435390.2020.1777477] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
546 Roh YS, Seki E. Toll-like receptors in alcoholic liver disease, non-alcoholic steatohepatitis and carcinogenesis. J Gastroenterol Hepatol. 2013;28 Suppl 1:38-42. [PMID: 23855294 DOI: 10.1111/jgh.12019] [Cited by in Crossref: 147] [Cited by in F6Publishing: 139] [Article Influence: 21.0] [Reference Citation Analysis]
547 Seki E, Brenner DA. Toll-like receptors and adaptor molecules in liver disease: update. Hepatology. 2008;48:322-335. [PMID: 18506843 DOI: 10.1002/hep.22306] [Cited by in Crossref: 467] [Cited by in F6Publishing: 433] [Article Influence: 35.9] [Reference Citation Analysis]
548 Rutkowski MR, Svoronos N, Perales-Puchalt A, Conejo-Garcia JR. The Tumor Macroenvironment: Cancer-Promoting Networks Beyond Tumor Beds. Adv Cancer Res 2015;128:235-62. [PMID: 26216635 DOI: 10.1016/bs.acr.2015.04.011] [Cited by in Crossref: 34] [Cited by in F6Publishing: 27] [Article Influence: 5.7] [Reference Citation Analysis]
549 Wang N, Zheng Y, Jiang Q, Yu X, Chen Y. Tea and reduced liver cancer mortality. Epidemiology 2008;19:761. [PMID: 18941364 DOI: 10.1097/EDE.0b013e3181811603] [Cited by in Crossref: 1] [Cited by in F6Publishing: 5] [Article Influence: 0.1] [Reference Citation Analysis]
550 Xiang WQ, Feng WF, Ke W, Sun Z, Chen Z, Liu W. Hepatitis B virus X protein stimulates IL-6 expression in hepatocytes via a MyD88-dependent pathway. J Hepatol. 2011;54:26-33. [PMID: 20937539 DOI: 10.1016/j.jhep.2010.08.006] [Cited by in Crossref: 48] [Cited by in F6Publishing: 48] [Article Influence: 4.4] [Reference Citation Analysis]
551 Li Q, Yu CH, Yu JH, Liu L, Xie SS, Li WW, Yang X, Fan WB, Gai ZT, Chen SJ. ABO blood group and the risk of hepatocellular carcinoma: a case-control study in patients with chronic hepatitis B. PLoS One. 2012;7:e29928. [PMID: 22235351 DOI: 10.1371/journal.pone.0029928] [Cited by in Crossref: 19] [Cited by in F6Publishing: 22] [Article Influence: 2.1] [Reference Citation Analysis]
552 Romanov N, Kuhn M, Aebersold R, Ori A, Beck M, Bork P. Disentangling Genetic and Environmental Effects on the Proteotypes of Individuals. Cell 2019;177:1308-1318.e10. [PMID: 31031010 DOI: 10.1016/j.cell.2019.03.015] [Cited by in Crossref: 26] [Cited by in F6Publishing: 14] [Article Influence: 13.0] [Reference Citation Analysis]
553 Li CL, Yeh KH, Liu WH, Chen CL, Chen DS, Chen PJ, Yeh SH. Elevated p53 promotes the processing of miR-18a to decrease estrogen receptor-α in female hepatocellular carcinoma. Int J Cancer. 2015;136:761-770. [PMID: 24975878 DOI: 10.1002/ijc.29052] [Cited by in Crossref: 27] [Cited by in F6Publishing: 28] [Article Influence: 3.9] [Reference Citation Analysis]
554 Gu Q, Kong Y, Yu ZB, Bai L, Xiao YB. Hypoxia-induced SOCS3 is limiting STAT3 phosphorylation and NF-κB activation in congenital heart disease. Biochimie 2011;93:909-20. [PMID: 21354254 DOI: 10.1016/j.biochi.2011.02.009] [Cited by in Crossref: 23] [Cited by in F6Publishing: 18] [Article Influence: 2.3] [Reference Citation Analysis]
555 Badellino KO, Wolfe ML, Reilly MP, Rader DJ. Endothelial Lipase Is Increased In Vivo by Inflammation in Humans. Circulation 2008;117:678-85. [DOI: 10.1161/circulationaha.107.707349] [Cited by in Crossref: 78] [Cited by in F6Publishing: 44] [Article Influence: 6.0] [Reference Citation Analysis]
556 Johnson BA 3rd, Baban B, Mellor AL. Targeting the immunoregulatory indoleamine 2,3 dioxygenase pathway in immunotherapy. Immunotherapy 2009;1:645-61. [PMID: 20161103 DOI: 10.2217/IMT.09.21] [Cited by in F6Publishing: 37] [Reference Citation Analysis]
557 Klein SL. Sex differences in prophylaxis and therapeutic treatments for viral diseases. Handb Exp Pharmacol 2012;:499-522. [PMID: 23027464 DOI: 10.1007/978-3-642-30726-3_22] [Cited by in Crossref: 9] [Cited by in F6Publishing: 12] [Article Influence: 1.1] [Reference Citation Analysis]
558 Davis GL, Dempster J, Meler JD, Orr DW, Walberg MW, Brown B, Berger BD, O'Connor JK, Goldstein RM. Hepatocellular carcinoma: management of an increasingly common problem. Proc (Bayl Univ Med Cent). 2008;21:266-280. [PMID: 18628926 DOI: 10.1080/08998280.2008.11928410] [Cited by in Crossref: 105] [Cited by in F6Publishing: 97] [Article Influence: 10.5] [Reference Citation Analysis]
559 Zou H, Wang W, Liu Y, Braddock M, Zheng M, Huang D. Toll-like receptors in hepatocellular carcinoma: potential novel targets for pharmacological intervention. Expert Opinion on Therapeutic Targets 2016;20:1127-35. [DOI: 10.1517/14728222.2016.1168809] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.4] [Reference Citation Analysis]
560 Souza CLSE, Oliveira HBM, Santos Júnior MN, Silva MDO, Coqueiro IL, Silva ÍBSD, Campos GB, Silva RAAD, Soares TDJ, Oliveira MVD, Timenetsky J, Marques LM. Ovarian hormones influence immune response to Staphylococcus aureus infection. The Brazilian Journal of Infectious Diseases 2020;24:534-44. [DOI: 10.1016/j.bjid.2020.10.004] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
561 Servais FA, Kirchmeyer M, Hamdorf M, Minoungou NWE, Rose-John S, Kreis S, Haan C, Behrmann I. Modulation of the IL-6-Signaling Pathway in Liver Cells by miRNAs Targeting gp130, JAK1, and/or STAT3. Mol Ther Nucleic Acids 2019;16:419-33. [PMID: 31026677 DOI: 10.1016/j.omtn.2019.03.007] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 5.5] [Reference Citation Analysis]
562 Maruyama K, Selmani Z, Ishii H, Yamaguchi K. Innate immunity and cancer therapy. Int Immunopharmacol 2011;11:350-7. [PMID: 20955832 DOI: 10.1016/j.intimp.2010.09.012] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 1.5] [Reference Citation Analysis]
563 Kukurba KR, Parsana P, Balliu B, Smith KS, Zappala Z, Knowles DA, Favé MJ, Davis JR, Li X, Zhu X, Potash JB, Weissman MM, Shi J, Kundaje A, Levinson DF, Awadalla P, Mostafavi S, Battle A, Montgomery SB. Impact of the X Chromosome and sex on regulatory variation. Genome Res 2016;26:768-77. [PMID: 27197214 DOI: 10.1101/gr.197897.115] [Cited by in Crossref: 57] [Cited by in F6Publishing: 44] [Article Influence: 11.4] [Reference Citation Analysis]
564 Cahill CM, Rogers JT. Interleukin (IL) 1beta induction of IL-6 is mediated by a novel phosphatidylinositol 3-kinase-dependent AKT/IkappaB kinase alpha pathway targeting activator protein-1. J Biol Chem 2008;283:25900-12. [PMID: 18515365 DOI: 10.1074/jbc.M707692200] [Cited by in Crossref: 124] [Cited by in F6Publishing: 81] [Article Influence: 9.5] [Reference Citation Analysis]
565 Hashimoto M, Tashiro H, Kobayashi T, Kuroda S, Hamaoka M, Ohdan H. Clinical characteristics and prognosis of non-B, non-C hepatocellular carcinoma: The impact of patient sex on disease-free survival - A retrospective cohort study. Int J Surg 2017;39:206-13. [PMID: 28159713 DOI: 10.1016/j.ijsu.2017.01.110] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
566 Salcedo R, Cataisson C, Hasan U, Yuspa SH, Trinchieri G. MyD88 and its divergent toll in carcinogenesis. Trends Immunol 2013;34:379-89. [PMID: 23660392 DOI: 10.1016/j.it.2013.03.008] [Cited by in Crossref: 59] [Cited by in F6Publishing: 52] [Article Influence: 7.4] [Reference Citation Analysis]
567 Spannbauer MM, Trautwein C, Kowdley K, Mccaughan G, Trautwein C. Frequent in-frame somatic deletions activate gp130 in inflammatory hepatocellular tumors. Hepatology 2009;49:1387-9. [DOI: 10.1002/hep.22902] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
568 Hung MH, Tai WT, Shiau CW, Chen KF. Downregulation of signal transducer and activator of transcription 3 by sorafenib: a novel mechanism for hepatocellular carcinoma therapy. World J Gastroenterol. 2014;20:15269-15274. [PMID: 25386075 DOI: 10.3748/wjg.v20.i41.15269] [Cited by in CrossRef: 22] [Cited by in F6Publishing: 20] [Article Influence: 3.7] [Reference Citation Analysis]
569 Li X, Jiang S, Tapping RI. Toll-like receptor signaling in cell proliferation and survival. Cytokine. 2010;49:1-9. [PMID: 19775907 DOI: 10.1016/j.cyto.2009.08.010] [Cited by in Crossref: 187] [Cited by in F6Publishing: 170] [Article Influence: 15.6] [Reference Citation Analysis]
570 Barikbin R, Neureiter D, Wirth J, Erhardt A, Schwinge D, Kluwe J, Schramm C, Tiegs G, Sass G. Induction of heme oxygenase 1 prevents progression of liver fibrosis in Mdr2 knockout mice. Hepatology 2012;55:553-62. [PMID: 21953613 DOI: 10.1002/hep.24711] [Cited by in Crossref: 38] [Cited by in F6Publishing: 37] [Article Influence: 4.2] [Reference Citation Analysis]
571 Sugamori KS, Brenneman D, Sanchez O, Doll MA, Hein DW, Pierce WM Jr, Grant DM. Reduced 4-aminobiphenyl-induced liver tumorigenicity but not DNA damage in arylamine N-acetyltransferase null mice. Cancer Lett 2012;318:206-13. [PMID: 22193722 DOI: 10.1016/j.canlet.2011.12.022] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 1.5] [Reference Citation Analysis]
572 Tachi K, Agyei-Nkansah A, Archampong T. Hepatocellular carcinoma in Ghana: a retrospective analysis of a tertiary hospital data. Pan Afr Med J 2020;36:43. [PMID: 32774619 DOI: 10.11604/pamj.2020.36.43.21085] [Reference Citation Analysis]
573 Nishida N, Goel A. Genetic and epigenetic signatures in human hepatocellular carcinoma: a systematic review. Curr Genomics. 2011;12:130-137. [PMID: 21966251 DOI: 10.2174/138920211795564359] [Cited by in Crossref: 120] [Cited by in F6Publishing: 121] [Article Influence: 12.0] [Reference Citation Analysis]
574 Lesnikov V, Gorden N, Fausto N, Spaulding E, Campbell J, Shulman H, Fleming RE, Deeg HJ. Transferrin fails to provide protection against Fas-induced hepatic injury in mice with deletion of functional transferrin-receptor type 2. Apoptosis 2008;13:1005-12. [PMID: 18561026 DOI: 10.1007/s10495-008-0233-6] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
575 Nault JC, Zucman-Rossi J. Building a bridge between obesity, inflammation and liver carcinogenesis. J Hepatol 2010;53:777-9. [PMID: 20633947 DOI: 10.1016/j.jhep.2010.05.011] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
576 Sakurai T, Yada N, Hagiwara S, Arizumi T, Minaga K, Kamata K, Takenaka M, Minami Y, Watanabe T, Nishida N, Kudo M. Gankyrin induces STAT3 activation in tumor microenvironment and sorafenib resistance in hepatocellular carcinoma. Cancer Sci 2017;108:1996-2003. [PMID: 28777492 DOI: 10.1111/cas.13341] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 5.0] [Reference Citation Analysis]
577 Niu KY, Ro JY. Changes in intramuscular cytokine levels during masseter inflammation in male and female rats. Neurosci Lett 2011;487:223-7. [PMID: 20969918 DOI: 10.1016/j.neulet.2010.10.027] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
578 Nakagawa H, Hayata Y, Yamada T, Kawamura S, Suzuki N, Koike K. Peribiliary Glands as the Cellular Origin of Biliary Tract Cancer. Int J Mol Sci. 2018;19. [PMID: 29895797 DOI: 10.3390/ijms19061745] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 3.3] [Reference Citation Analysis]
579 Dougan M, Dranoff G. Inciting inflammation: the RAGE about tumor promotion. J Exp Med 2008;205:267-70. [PMID: 18268042 DOI: 10.1084/jem.20080136] [Cited by in Crossref: 34] [Cited by in F6Publishing: 28] [Article Influence: 2.6] [Reference Citation Analysis]
580 Komaki Y, Komaki F, Micic D, Ido A, Sakuraba A. Risk of colorectal cancer in chronic liver diseases: a systematic review and meta-analysis. Gastrointest Endosc 2017; 86: 93-104. e5. [PMID: 28011280 DOI: 10.1016/j.gie.2016.12.009] [Cited by in Crossref: 21] [Cited by in F6Publishing: 14] [Article Influence: 4.2] [Reference Citation Analysis]
581 Patel P, Schutzer SE, Pyrsopoulos N. Immunobiology of hepatocarcinogenesis: Ways to go or almost there? World J Gastrointest Pathophysiol 2016;7:242-55. [PMID: 27574562 DOI: 10.4291/wjgp.v7.i3.242] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
582 Chen S, Zheng P, Wang W, Yi M, Chen P, Cai J, Li J, Peng Q, Ban Y, Zhou Y, Zeng Z, Li X, Xiong W, Li G, Xiang B. Abberent expression of NOR1 protein in tumor associated macrophages contributes to the development of DEN-induced hepatocellular carcinoma. J Cell Physiol 2018;233:5002-13. [PMID: 29227538 DOI: 10.1002/jcp.26349] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 4.7] [Reference Citation Analysis]
583 Hou J, Zhou Y, Zheng Y, Fan J, Zhou W, Ng IO, Sun H, Qin L, Qiu S, Lee JM, Lo CM, Man K, Yang Y, Yang Y, Yang Y, Zhang Q, Zhu X, Li N, Wang Z, Ding G, Zhuang SM, Zheng L, Luo X, Xie Y, Liang A, Wang Z, Zhang M, Xia Q, Liang T, Yu Y, Cao X. Hepatic RIG-I predicts survival and interferon-α therapeutic response in hepatocellular carcinoma. Cancer Cell 2014;25:49-63. [PMID: 24360797 DOI: 10.1016/j.ccr.2013.11.011] [Cited by in Crossref: 131] [Cited by in F6Publishing: 121] [Article Influence: 16.4] [Reference Citation Analysis]
584 Xing P, Liao Z, Ren Z, Zhao J, Song F, Wang G, Chen K, Yang J. Roles of low-density lipoprotein receptor-related protein 1 in tumors. Chin J Cancer 2016;35:6. [PMID: 26738504 DOI: 10.1186/s40880-015-0064-0] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 4.8] [Reference Citation Analysis]
585 Zhang W, Borcherding N, Kolb R. IL-1 Signaling in Tumor Microenvironment. Adv Exp Med Biol 2020;1240:1-23. [PMID: 32060884 DOI: 10.1007/978-3-030-38315-2_1] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 12.0] [Reference Citation Analysis]
586 Ma HY, Xu J, Liu X, Zhu Y, Gao B, Karin M, Tsukamoto H, Jeste DV, Grant I, Roberts AJ, Contet C, Geoffroy C, Zheng B, Brenner D, Kisseleva T. The role of IL-17 signaling in regulation of the liver-brain axis and intestinal permeability in Alcoholic Liver Disease. Curr Pathobiol Rep 2016;4:27-35. [PMID: 27239399 DOI: 10.1007/s40139-016-0097-3] [Cited by in Crossref: 19] [Cited by in F6Publishing: 12] [Article Influence: 3.8] [Reference Citation Analysis]
587 Behrens C, Rocha P, Parra ER, Feng L, Rodriguez-Canales J, Solis LM, Mino B, Zhang J, Gibbons DL, Sepesi B, Rice D, Heymach JV, Moran C, Creighton CJ, Lee JJ, Kadara H, Wistuba II. Female Gender Predicts Augmented Immune Infiltration in Lung Adenocarcinoma. Clin Lung Cancer 2021;22:e415-24. [PMID: 32763065 DOI: 10.1016/j.cllc.2020.06.003] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
588 Farsakoglu Y, Palomino-Segura M, Latino I, Zanaga S, Chatziandreou N, Pizzagalli DU, Rinaldi A, Bolis M, Sallusto F, Stein JV, Gonzalez SF. Influenza Vaccination Induces NK-Cell-Mediated Type-II IFN Response that Regulates Humoral Immunity in an IL-6-Dependent Manner. Cell Rep 2019;26:2307-2315.e5. [PMID: 30811982 DOI: 10.1016/j.celrep.2019.01.104] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 14.0] [Reference Citation Analysis]
589 Yang JD, Nakamura I, Roberts LR. The tumor microenvironment in hepatocellular carcinoma: current status and therapeutic targets. Semin Cancer Biol 2011;21:35-43. [PMID: 20946957 DOI: 10.1016/j.semcancer.2010.10.007] [Cited by in Crossref: 216] [Cited by in F6Publishing: 195] [Article Influence: 19.6] [Reference Citation Analysis]
590 Aliyu G, El-Kamary SS, Abimiku A, Blattner W, Charurat M. Demography and the dual epidemics of tuberculosis and HIV: Analysis of cross-sectional data from Sub-Saharan Africa. PLoS One 2018;13:e0191387. [PMID: 30192746 DOI: 10.1371/journal.pone.0191387] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 3.3] [Reference Citation Analysis]
591 Brady CW. Liver disease in menopause. World J Gastroenterol. 2015;21:7613-7620. [PMID: 26167064 DOI: 10.3748/wjg.v21.i25.7613] [Cited by in CrossRef: 53] [Cited by in F6Publishing: 37] [Article Influence: 10.6] [Reference Citation Analysis]
592 Ruud J, Bäckhed F, Engblom D, Blomqvist A. Deletion of the gene encoding MyD88 protects from anorexia in a mouse tumor model. Brain Behav Immun 2010;24:554-7. [PMID: 20093176 DOI: 10.1016/j.bbi.2010.01.006] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
593 Fekry B, Ribas-Latre A, Baumgartner C, Deans JR, Kwok C, Patel P, Fu L, Berdeaux R, Sun K, Kolonin MG, Wang SH, Yoo SH, Sladek FM, Eckel-Mahan K. Incompatibility of the circadian protein BMAL1 and HNF4α in hepatocellular carcinoma. Nat Commun 2018;9:4349. [PMID: 30341289 DOI: 10.1038/s41467-018-06648-6] [Cited by in Crossref: 31] [Cited by in F6Publishing: 26] [Article Influence: 10.3] [Reference Citation Analysis]
594 Walzer N, Kulik LM. Hepatocellular carcinoma: latest developments. Curr Opin Gastroenterol 2008;24:312-9. [PMID: 18408459 DOI: 10.1097/MOG.0b013e3282fafef3] [Cited by in Crossref: 12] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
595 Yu L, Liu X, Wang X, Dang Z, Jiang Y, Wang X, Yang Z. Impact of gender as a prognostic factor in HBV-related Hepatocellular Carcinoma: the survival strength of female patients in BCLC stage 0-B. J Cancer 2019;10:4237-44. [PMID: 31413742 DOI: 10.7150/jca.33430] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
596 Kao JT, Lai HC, Tsai SM, Lin PC, Chuang PH, Yu CJ, Cheng KS, Su WP, Hsu PN, Peng CY, Wu YY. Rather than interleukin-27, interleukin-6 expresses positive correlation with liver severity in naïve hepatitis B infection patients. Liver Int 2012;32:928-36. [PMID: 22230324 DOI: 10.1111/j.1478-3231.2011.02742.x] [Cited by in Crossref: 31] [Cited by in F6Publishing: 32] [Article Influence: 3.4] [Reference Citation Analysis]
597 Liang H, Block TM, Wang M, Nefsky B, Long R, Hafner J, Mehta AS, Marrero J, Gish R, Norton PA. Interleukin-6 and oncostatin M are elevated in liver disease in conjunction with candidate hepatocellular carcinoma biomarker GP73. Cancer Biomark 2012;11:161-71. [PMID: 23144154 DOI: 10.3233/CBM-2012-00276] [Cited by in Crossref: 29] [Cited by in F6Publishing: 18] [Article Influence: 3.6] [Reference Citation Analysis]
598 Shwartz A, Goessling W, Yin C. Macrophages in Zebrafish Models of Liver Diseases. Front Immunol 2019;10:2840. [PMID: 31867007 DOI: 10.3389/fimmu.2019.02840] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
599 Xie Y, Jiang L, Qiu J, Wang Y. A comparative evaluation of the immunotoxicity and immunomodulatory effects on macrophages exposed to aromatic trihalogenated DBPs. Immunopharmacol Immunotoxicol 2019;41:319-26. [PMID: 31046488 DOI: 10.1080/08923973.2019.1608444] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
600 Schulien I, Hasselblatt P. Diethylnitrosamine-induced liver tumorigenesis in mice. Methods Cell Biol 2021;163:137-52. [PMID: 33785162 DOI: 10.1016/bs.mcb.2020.08.006] [Reference Citation Analysis]
601 Leuenberger N, Pradervand S, Wahli W. Sumoylated PPARalpha mediates sex-specific gene repression and protects the liver from estrogen-induced toxicity in mice. J Clin Invest 2009;119:3138-48. [PMID: 19729835 DOI: 10.1172/JCI39019] [Cited by in Crossref: 84] [Cited by in F6Publishing: 41] [Article Influence: 7.6] [Reference Citation Analysis]
602 Chen K, Ma J, Jia X, Ai W, Ma Z, Pan Q. Advancing the understanding of NAFLD to hepatocellular carcinoma development: From experimental models to humans. Biochim Biophys Acta Rev Cancer. 2019;1871:117-125. [PMID: 30528647 DOI: 10.1016/j.bbcan.2018.11.005] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 6.7] [Reference Citation Analysis]
603 Takahashi A, Tokita H, Takahashi K, Takeoka T, Murayama K, Tomotsune D, Ohira M, Iwamatsu A, Ohara K, Yazaki K, Koda T, Nakagawara A, Tani K. A novel potent tumour promoter aberrantly overexpressed in most human cancers. Sci Rep 2011;1:15. [PMID: 22355534 DOI: 10.1038/srep00015] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.1] [Reference Citation Analysis]
604 Jones SA, Scheller J, Rose-John S. Therapeutic strategies for the clinical blockade of IL-6/gp130 signaling. J Clin Invest 2011;121:3375-83. [PMID: 21881215 DOI: 10.1172/JCI57158] [Cited by in Crossref: 441] [Cited by in F6Publishing: 224] [Article Influence: 44.1] [Reference Citation Analysis]
605 Tsuda N, Mine T, Ioannides CG, Chang DZ. Synthetic microRNA targeting glioma-associated antigen-1 protein. Methods Mol Biol. 2009;487:435-449. [PMID: 19301660 DOI: 10.1007/978-1-60327-547-7_21] [Cited by in Crossref: 1] [Cited by in F6Publishing: 9] [Article Influence: 0.1] [Reference Citation Analysis]
606 Chow MT, Möller A, Smyth MJ. Inflammation and immune surveillance in cancer. Semin Cancer Biol 2012;22:23-32. [PMID: 22210181 DOI: 10.1016/j.semcancer.2011.12.004] [Cited by in Crossref: 115] [Cited by in F6Publishing: 96] [Article Influence: 11.5] [Reference Citation Analysis]
607 Olney KC, Brotman SM, Andrews JP, Valverde-Vesling VA, Wilson MA. Reference genome and transcriptome informed by the sex chromosome complement of the sample increase ability to detect sex differences in gene expression from RNA-Seq data. Biol Sex Differ 2020;11:42. [PMID: 32693839 DOI: 10.1186/s13293-020-00312-9] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 8.0] [Reference Citation Analysis]
608 Zhu B, Chen S, Hu X, Jin X, Le Y, Cao L, Yuan Z, Lin Z, Jiang S, Sun L, Yu L. Knockout of the Nogo-B Gene Attenuates Tumor Growth and Metastasis in Hepatocellular Carcinoma. Neoplasia 2017;19:583-93. [PMID: 28628795 DOI: 10.1016/j.neo.2017.02.007] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 3.8] [Reference Citation Analysis]
609 Nakagawa H, Maeda S, Yoshida H, Tateishi R, Masuzaki R, Ohki T, Hayakawa Y, Kinoshita H, Yamakado M, Kato N. Serum IL-6 levels and the risk for hepatocarcinogenesis in chronic hepatitis C patients: an analysis based on gender differences. Int J Cancer. 2009;125:2264-2269. [PMID: 19585572 DOI: 10.1002/ijc.24720] [Cited by in Crossref: 114] [Cited by in F6Publishing: 110] [Article Influence: 9.5] [Reference Citation Analysis]
610 Zhao B, Wang Y, Tan X, Ke K, Zheng X, Wang F, Lan S, Liao N, Cai Z, Shi Y, Zheng Y, Lai Y, Wang L, Li Q, Liu J, Huang A, Liu X. Inflammatory Micro-environment Contributes to Stemness Properties and Metastatic Potential of HCC via the NF-κB/miR-497/SALL4 Axis. Mol Ther Oncolytics 2019;15:79-90. [PMID: 31650028 DOI: 10.1016/j.omto.2019.08.009] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 5.5] [Reference Citation Analysis]
611 Glauert HP, Tharappel JC, Banerjee S, Chan NL, Kania-Korwel I, Lehmler HJ, Lee EY, Robertson LW, Spear BT. Inhibition of the promotion of hepatocarcinogenesis by 2,2',4,4',5,5'-hexachlorobiphenyl (PCB-153) by the deletion of the p50 subunit of NF-kappa B in mice. Toxicol Appl Pharmacol 2008;232:302-8. [PMID: 18644402 DOI: 10.1016/j.taap.2008.06.013] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 1.4] [Reference Citation Analysis]
612 Yu LX, Ling Y, Wang HY. Role of nonresolving inflammation in hepatocellular carcinoma development and progression. NPJ Precis Oncol 2018;2:6. [PMID: 29872724 DOI: 10.1038/s41698-018-0048-z] [Cited by in Crossref: 75] [Cited by in F6Publishing: 69] [Article Influence: 25.0] [Reference Citation Analysis]
613 Kessler SM, Simon Y, Gemperlein K, Gianmoena K, Cadenas C, Zimmer V, Pokorny J, Barghash A, Helms V, van Rooijen N. Fatty acid elongation in non-alcoholic steatohepatitis and hepatocellular carcinoma. Int J Mol Sci. 2014;15:5762-5773. [PMID: 24714086 DOI: 10.3390/ijms15045762] [Cited by in Crossref: 29] [Cited by in F6Publishing: 27] [Article Influence: 4.1] [Reference Citation Analysis]
614 Braicu C, Burz C, Berindan-Neagoe I, Balacescu O, Graur F, Cristea V, Irimie A. Hepatocellular Carcinoma: Tumorigenesis and Prediction Markers. Gastroenterology Res 2009;2:191-9. [PMID: 27942274 DOI: 10.4021/gr2009.07.1304] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 0.3] [Reference Citation Analysis]
615 Ganz M, Csak T, Szabo G. High fat diet feeding results in gender specific steatohepatitis and inflammasome activation. World J Gastroenterol 2014;20:8525-34. [PMID: 25024607 DOI: 10.3748/wjg.v20.i26.8525] [Cited by in CrossRef: 66] [Cited by in F6Publishing: 62] [Article Influence: 11.0] [Reference Citation Analysis]
616 Wattanawaraporn R, Woo LL, Belanger C, Chang SC, Adams JE, Trudel LJ, Bouhenguel JT, Egner PA, Groopman JD, Croy RG, Essigmann JM, Wogan GN. A single neonatal exposure to aflatoxin b1 induces prolonged genetic damage in two loci of mouse liver. Toxicol Sci 2012;128:326-33. [PMID: 22539618 DOI: 10.1093/toxsci/kfs151] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
617 Koptan DMT, Rasheed Bahgat DM, Abdelrasool AA, Allam RSHM, Elgengehy FT, Abdel Baki NM, Medhat BM. Analysis of Nuclear Receptor Coactivator 5 (NCOA5) Messenger RNA Expression and rs2903908 Single Nucleotide Polymorphism of NCOA5 in an Egyptian Cohort with Behçet's Disease: A Single-Center Case-control Study. Ocul Immunol Inflamm 2021;:1-11. [PMID: 34255592 DOI: 10.1080/09273948.2021.1889610] [Reference Citation Analysis]
618 Ghiringhelli F, Apetoh L, Tesniere A, Aymeric L, Ma Y, Ortiz C, Vermaelen K, Panaretakis T, Mignot G, Ullrich E, Perfettini JL, Schlemmer F, Tasdemir E, Uhl M, Génin P, Civas A, Ryffel B, Kanellopoulos J, Tschopp J, André F, Lidereau R, McLaughlin NM, Haynes NM, Smyth MJ, Kroemer G, Zitvogel L. Activation of the NLRP3 inflammasome in dendritic cells induces IL-1beta-dependent adaptive immunity against tumors. Nat Med 2009;15:1170-8. [PMID: 19767732 DOI: 10.1038/nm.2028] [Cited by in Crossref: 1096] [Cited by in F6Publishing: 1028] [Article Influence: 91.3] [Reference Citation Analysis]
619 Kay JE, Corrigan JJ, Armijo AL, Nazari IS, Kohale IN, Torous DK, Avlasevich SL, Croy RG, Wadduwage DN, Carrasco SE, Dertinger SD, White FM, Essigmann JM, Samson LD, Engelward BP. Excision of mutagenic replication-blocking lesions suppresses cancer but promotes cytotoxicity and lethality in nitrosamine-exposed mice. Cell Rep 2021;34:108864. [PMID: 33730582 DOI: 10.1016/j.celrep.2021.108864] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
620 Kanda K, Komekado H, Sawabu T, Ishizu S, Nakanishi Y, Nakatsuji M, Akitake-Kawano R, Ohno M, Hiraoka Y, Kawada M, Kawada K, Sakai Y, Matsumoto K, Kunichika M, Kimura T, Seno H, Nishi E, Chiba T. Nardilysin and ADAM proteases promote gastric cancer cell growth by activating intrinsic cytokine signalling via enhanced ectodomain shedding of TNF-α. EMBO Mol Med 2012;4:396-411. [PMID: 22351606 DOI: 10.1002/emmm.201200216] [Cited by in Crossref: 30] [Cited by in F6Publishing: 24] [Article Influence: 3.3] [Reference Citation Analysis]
621 Zhou Z, Zhang L, Ding M, Luo Z, Yuan S, Bansal MB, Gilkeson G, Lang R, Jiang W. Estrogen decreases tight junction protein ZO-1 expression in human primary gut tissues. Clin Immunol 2017;183:174-80. [PMID: 28867253 DOI: 10.1016/j.clim.2017.08.019] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 5.0] [Reference Citation Analysis]
622 Arano T, Nakagawa H, Tateishi R, Ikeda H, Uchino K, Enooku K, Goto E, Masuzaki R, Asaoka Y, Kondo Y. Serum level of adiponectin and the risk of liver cancer development in chronic hepatitis C patients. Int J Cancer. 2011;129:2226-2235. [PMID: 21170963 DOI: 10.1002/ijc.25861] [Cited by in Crossref: 46] [Cited by in F6Publishing: 48] [Article Influence: 4.6] [Reference Citation Analysis]
623 Robertson CL, Srivastava J, Siddiq A, Gredler R, Emdad L, Rajasekaran D, Akiel M, Shen XN, Guo C, Giashuddin S. Genetic deletion of AEG-1 prevents hepatocarcinogenesis. Cancer Res. 2014;74:6184-6193. [PMID: 25193383 DOI: 10.1158/0008-5472.CAN-14-1357] [Cited by in Crossref: 34] [Cited by in F6Publishing: 24] [Article Influence: 4.9] [Reference Citation Analysis]
624 Karin M. NF-kappaB as a critical link between inflammation and cancer. Cold Spring Harb Perspect Biol 2009;1:a000141. [PMID: 20066113 DOI: 10.1101/cshperspect.a000141] [Cited by in Crossref: 495] [Cited by in F6Publishing: 461] [Article Influence: 45.0] [Reference Citation Analysis]
625 Giraldez MD, Carneros D, Garbers C, Rose-John S, Bustos M. New insights into IL-6 family cytokines in metabolism, hepatology and gastroenterology. Nat Rev Gastroenterol Hepatol 2021. [PMID: 34211157 DOI: 10.1038/s41575-021-00473-x] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
626 Kudo Y, Sugimoto M, Arias E, Kasashima H, Cordes T, Linares JF, Duran A, Nakanishi Y, Nakanishi N, L'Hermitte A, Campos A, Senni N, Rooslid T, Roberts LR, Cuervo AM, Metallo CM, Karin M, Diaz-Meco MT, Moscat J. PKCλ/ι Loss Induces Autophagy, Oxidative Phosphorylation, and NRF2 to Promote Liver Cancer Progression. Cancer Cell 2020;38:247-262.e11. [PMID: 32589943 DOI: 10.1016/j.ccell.2020.05.018] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 16.0] [Reference Citation Analysis]
627 Molgora M, Bonavita E, Ponzetta A, Riva F, Barbagallo M, Jaillon S, Popović B, Bernardini G, Magrini E, Gianni F, Zelenay S, Jonjić S, Santoni A, Garlanda C, Mantovani A. IL-1R8 is a checkpoint in NK cells regulating anti-tumour and anti-viral activity. Nature 2017;551:110-4. [PMID: 29072292 DOI: 10.1038/nature24293] [Cited by in Crossref: 111] [Cited by in F6Publishing: 101] [Article Influence: 27.8] [Reference Citation Analysis]
628 Debes JD, Romagnoli PA, Prieto J, Arrese M, Mattos AZ, Boonstra A, On Behalf Of The Escalon Consortium. Serum Biomarkers for the Prediction of Hepatocellular Carcinoma. Cancers (Basel) 2021;13:1681. [PMID: 33918270 DOI: 10.3390/cancers13071681] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
629 Kaneko S, Li X. X chromosome protects against bladder cancer in females via a KDM6A-dependent epigenetic mechanism. Sci Adv 2018;4:eaar5598. [PMID: 29928692 DOI: 10.1126/sciadv.aar5598] [Cited by in Crossref: 35] [Cited by in F6Publishing: 27] [Article Influence: 11.7] [Reference Citation Analysis]
630 Song IJ, Yang YM, Inokuchi-Shimizu S, Roh YS, Yang L, Seki E. The contribution of toll-like receptor signaling to the development of liver fibrosis and cancer in hepatocyte-specific TAK1-deleted mice. Int J Cancer. 2018;142:81-91. [PMID: 28875549 DOI: 10.1002/ijc.31029] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 5.5] [Reference Citation Analysis]
631 Thuy le TT, Matsumoto Y, Thuy TT, Hai H, Suoh M, Urahara Y, Motoyama H, Fujii H, Tamori A, Kubo S, Takemura S, Morita T, Yoshizato K, Kawada N. Cytoglobin deficiency promotes liver cancer development from hepatosteatosis through activation of the oxidative stress pathway. Am J Pathol 2015;185:1045-60. [PMID: 25665792 DOI: 10.1016/j.ajpath.2014.12.017] [Cited by in Crossref: 37] [Cited by in F6Publishing: 34] [Article Influence: 6.2] [Reference Citation Analysis]
632 Bishayee A. The role of inflammation and liver cancer. Adv Exp Med Biol. 2014;816:401-435. [PMID: 24818732 DOI: 10.1007/978-3-0348-0837-8_16] [Cited by in Crossref: 130] [Cited by in F6Publishing: 113] [Article Influence: 18.6] [Reference Citation Analysis]
633 Lee SH, Yim SY, Shim J, Lee J. Molecular Subtypes and Genomic Signatures of Hepatocellular Carcinoma for Prognostication and Therapeutic Decision-Making. In: Hoshida Y, editor. Hepatocellular Carcinoma. Cham: Springer International Publishing; 2019. pp. 109-23. [DOI: 10.1007/978-3-030-21540-8_6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
634 Mei Y, Zhou C, Liang CY, Lu GM, Zeng MS, Wang JJ, Feng GK. A method to establish a c-Myc transgenic mouse model of hepatocellular carcinoma. MethodsX 2020;7:100921. [PMID: 32489910 DOI: 10.1016/j.mex.2020.100921] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
635 Hsu I, Yeh CR, Slavin S, Miyamoto H, Netto GJ, Tsai YC, Muyan M, Wu XR, Messing EM, Guancial EA, Yeh S. Estrogen receptor alpha prevents bladder cancer via INPP4B inhibited akt pathway in vitro and in vivo. Oncotarget 2014;5:7917-35. [PMID: 25277204 DOI: 10.18632/oncotarget.1421] [Cited by in Crossref: 42] [Cited by in F6Publishing: 41] [Article Influence: 7.0] [Reference Citation Analysis]
636 Abdel-Hamid NM, Wahid A, Mohamed EM, Abdel-Aziz MA, Mohafez OM, Bakar S. New pathways driving the experimental hepatoprotective action of tempol (4-hydroxy-2,2,6,6-tetramethylpiperidine-1-oxyl) against acute hepatotoxicity. Biomed Pharmacother 2016;79:215-21. [PMID: 27044831 DOI: 10.1016/j.biopha.2016.02.016] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
637 Danese S, Gao B. Interleukin-6: a therapeutic Jekyll and Hyde in gastrointestinal and hepatic diseases. Gut 2010;59:149-51. [PMID: 20176636 DOI: 10.1136/gut.2008.173534] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
638 Chang D, Gao F, Slavney A, Ma L, Waldman YY, Sams AJ, Billing-Ross P, Madar A, Spritz R, Keinan A. Accounting for eXentricities: analysis of the X chromosome in GWAS reveals X-linked genes implicated in autoimmune diseases. PLoS One 2014;9:e113684. [PMID: 25479423 DOI: 10.1371/journal.pone.0113684] [Cited by in Crossref: 71] [Cited by in F6Publishing: 58] [Article Influence: 10.1] [Reference Citation Analysis]
639 Sriwattanapong K, Slocum SL, Chawanthayatham S, Fedeles BI, Egner PA, Groopman JD, Satayavivad J, Croy RG, Essigmann JM. Editor's Highlight: Pregnancy Alters Aflatoxin B1 Metabolism and Increases DNA Damage in Mouse Liver. Toxicol Sci 2017;160:173-9. [PMID: 28973694 DOI: 10.1093/toxsci/kfx171] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
640 Dougan M, Dranoff G. The Immune Response to Tumors. Current Protocols in Immunology 2009;85. [DOI: 10.1002/0471142735.im2011s85] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.3] [Reference Citation Analysis]
641 Miyakoshi M, Yamamoto M, Tanaka H, Ogawa K. Serine 727 phosphorylation of STAT3: an early change in mouse hepatocarcinogenesis induced by neonatal treatment with diethylnitrosamine. Mol Carcinog 2014;53:67-76. [PMID: 22911886 DOI: 10.1002/mc.21949] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 2.0] [Reference Citation Analysis]
642 Nawaz R, Zahid S, Idrees M, Rafique S, Shahid M, Ahad A, Amin I, Almas I, Afzal S. HCV-induced regulatory alterations of IL-1β, IL-6, TNF-α, and IFN-ϒ operative, leading liver en-route to non-alcoholic steatohepatitis. Inflamm Res 2017;66:477-86. [PMID: 28285394 DOI: 10.1007/s00011-017-1029-3] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
643 Galvez AS, Duran A, Linares JF, Pathrose P, Castilla EA, Abu-Baker S, Leitges M, Diaz-Meco MT, Moscat J. Protein kinase Czeta represses the interleukin-6 promoter and impairs tumorigenesis in vivo. Mol Cell Biol 2009;29:104-15. [PMID: 18955501 DOI: 10.1128/MCB.01294-08] [Cited by in Crossref: 64] [Cited by in F6Publishing: 43] [Article Influence: 4.9] [Reference Citation Analysis]
644 Dapito DH, Mencin A, Gwak GY, Pradere JP, Jang MK, Mederacke I, Caviglia JM, Khiabanian H, Adeyemi A, Bataller R, Lefkowitch JH, Bower M, Friedman R, Sartor RB, Rabadan R, Schwabe RF. Promotion of hepatocellular carcinoma by the intestinal microbiota and TLR4. Cancer Cell 2012;21:504-16. [PMID: 22516259 DOI: 10.1016/j.ccr.2012.02.007] [Cited by in Crossref: 637] [Cited by in F6Publishing: 583] [Article Influence: 70.8] [Reference Citation Analysis]
645 Lee CH, Chang CJ, Lin YJ, Yeh CN, Chen MF, Hsieh SY. Viral hepatitis-associated intrahepatic cholangiocarcinoma shares common disease processes with hepatocellular carcinoma. Br J Cancer. 2009;100:1765-1770. [PMID: 19436294 DOI: 10.1038/sj.bjc.6605063] [Cited by in Crossref: 93] [Cited by in F6Publishing: 90] [Article Influence: 7.8] [Reference Citation Analysis]
646 Sin SH, Kang SA, Kim Y, Eason A, Tan K, An H, Dittmer DP. Kaposi's Sarcoma-Associated Herpesvirus Latency Locus Compensates for Interleukin-6 in Initial B Cell Activation. J Virol 2016;90:2150-4. [PMID: 26656696 DOI: 10.1128/JVI.02456-15] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
647 Isse K, Specht SM, Lunz JG, Kang LI, Mizuguchi Y, Demetris AJ. Estrogen stimulates female biliary epithelial cell interleukin-6 expression in mice and humans. Hepatology. 2010;51:869-880. [PMID: 20043322 DOI: 10.1002/hep.23386] [Cited by in Crossref: 31] [Cited by in F6Publishing: 30] [Article Influence: 2.8] [Reference Citation Analysis]
648 Gao B, Xie W, Wu X, Wang L, Guo J. Functionally analyzing the important roles of hepatocyte nuclear factor 3 (FoxA) in tumorigenesis. Biochim Biophys Acta Rev Cancer 2020;1873:188365. [PMID: 32325165 DOI: 10.1016/j.bbcan.2020.188365] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
649 Ohishi W, Cologne JB, Fujiwara S, Suzuki G, Hayashi T, Niwa Y, Akahoshi M, Ueda K, Tsuge M, Chayama K. Serum interleukin-6 associated with hepatocellular carcinoma risk: a nested case-control study. Int J Cancer. 2014;134:154-163. [PMID: 23784949 DOI: 10.1002/ijc.28337] [Cited by in Crossref: 51] [Cited by in F6Publishing: 50] [Article Influence: 6.4] [Reference Citation Analysis]
650 Yang F, Yin Y, Wang F, Zhang L, Wang Y, Sun S. An altered pattern of liver apolipoprotein A-I isoforms is implicated in male chronic hepatitis B progression. J Proteome Res. 2010;9:134-143. [PMID: 19788185 DOI: 10.1021/pr900593r] [Cited by in Crossref: 20] [Cited by in F6Publishing: 23] [Article Influence: 1.8] [Reference Citation Analysis]
651 Akahoshi K, Tanaka S, Mogushi K, Shimada S, Matsumura S, Akiyama Y, Aihara A, Mitsunori Y, Ban D, Ochiai T, Kudo A, Arii S, Tanabe M. Expression of connective tissue growth factor in the livers of non-viral hepatocellular carcinoma patients with metabolic risk factors. J Gastroenterol 2016;51:910-22. [PMID: 26739296 DOI: 10.1007/s00535-015-1159-8] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
652 Carlessi R, Köhn-gaone J, Olynyk JK, Tirnitz-parker JEE; School of Pharmacy and Biomedical Sciences, Curtin Health Innovation Research Institute, Bentley, WA, Australia, School of Pharmacy and Biomedical Sciences, Curtin Health Innovation Research Institute, Bentley, WA, Australia, Fiona Stanley and Fremantle Hospitals, Fremantle and Murdoch, WA, Australia, School of Health and Medical Sciences, Edith Cowan University, Joondalup, WA, Australia, School of Pharmacy and Biomedical Sciences, Curtin Health Innovation Research Institute, Bentley, WA, Australia, Centre for Cell Therapy and Regenerative Medicine, School of Biomedical Sciences, The University of Western Australia, Crawley WA, Australia. Mouse Models of Hepatocellular Carcinoma. In: Tirnitz-parker JE, editor. Hepatocellular Carcinoma. Codon Publications; 2019. pp. 69-94. [DOI: 10.15586/hepatocellularcarcinoma.2019.ch4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
653 Pimentel-Coelho PM, Michaud JP, Rivest S. Evidence for a gender-specific protective role of innate immune receptors in a model of perinatal brain injury. J Neurosci 2013;33:11556-72. [PMID: 23843525 DOI: 10.1523/JNEUROSCI.0535-13.2013] [Cited by in Crossref: 38] [Cited by in F6Publishing: 15] [Article Influence: 4.8] [Reference Citation Analysis]
654 Wang YC, Xu GL, Jia WD, Han SJ, Ren WH, Wang W, Liu WB, Zhang CH, Chen H. Estrogen suppresses metastasis in rat hepatocellular carcinoma through decreasing interleukin-6 and hepatocyte growth factor expression. Inflammation. 2012;35:143-149. [PMID: 21302136 DOI: 10.1007/s10753-011-9299-3] [Cited by in Crossref: 28] [Cited by in F6Publishing: 27] [Article Influence: 3.1] [Reference Citation Analysis]
655 Wong ET, Tergaonkar V. Roles of NF-kappaB in health and disease: mechanisms and therapeutic potential. Clin Sci (Lond) 2009;116:451-65. [PMID: 19200055 DOI: 10.1042/CS20080502] [Cited by in Crossref: 126] [Cited by in F6Publishing: 57] [Article Influence: 10.5] [Reference Citation Analysis]
656 Creasy KT, Jiang J, Ren H, Peterson ML, Spear BT. Zinc Fingers and Homeoboxes 2 (Zhx2) Regulates Sexually Dimorphic Cyp Gene Expression in the Adult Mouse Liver. Gene Expr 2016;17:7-17. [PMID: 27197076 DOI: 10.3727/105221616X691712] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.6] [Reference Citation Analysis]
657 Hassanipour S, Mohammadzadeh M, Mansour-Ghanaei F, Fathalipour M, Joukar F, Salehiniya H, Abdzadeh E, Samadani AA, Nikbakht HA, Arab-Zozani M. The Incidence of Hepatocellular Carcinoma in Iran from 1996 to 2016: a Systematic Review and Meta-analysis. J Gastrointest Cancer 2019;50:193-200. [PMID: 30725358 DOI: 10.1007/s12029-019-00207-y] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
658 Lee SR, Lee JG, Heo JH, Jo SL, Ryu J, Kim G, Yon JM, Lee MS, Lee GS, An BS, Shin HJ, Woo DC, Baek IJ, Hong EJ. Loss of PGRMC1 Delays the Progression of Hepatocellular Carcinoma via Suppression of Pro-Inflammatory Immune Responses. Cancers (Basel) 2021;13:2438. [PMID: 34069911 DOI: 10.3390/cancers13102438] [Reference Citation Analysis]
659 Zou Y, Qin F, Chen J, Meng J, Wei L, Wu C, Zhang Q, Wei D, Chen X, Wu H, Chen X, Dai S. sTLR4/MD-2 complex inhibits colorectal cancer in vitro and in vivo by targeting LPS. Oncotarget 2016;7:52032-44. [PMID: 27409669 DOI: 10.18632/oncotarget.10496] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
660 Wei Q, Guo P, Mu K, Zhang Y, Zhao W, Huai W, Qiu Y, Li T, Ma X, Liu Y, Chen X, Han L. Estrogen suppresses hepatocellular carcinoma cells through ERβ-mediated upregulation of the NLRP3 inflammasome. Lab Invest 2015;95:804-16. [DOI: 10.1038/labinvest.2015.63] [Cited by in Crossref: 56] [Cited by in F6Publishing: 50] [Article Influence: 9.3] [Reference Citation Analysis]
661 Supek F, Lehner B. Clustered Mutation Signatures Reveal that Error-Prone DNA Repair Targets Mutations to Active Genes. Cell 2017;170:534-547.e23. [PMID: 28753428 DOI: 10.1016/j.cell.2017.07.003] [Cited by in Crossref: 101] [Cited by in F6Publishing: 73] [Article Influence: 25.3] [Reference Citation Analysis]
662 Xue TC, Zhang L, Ren ZG, Chen RX, Cui JF, Ge NL, Ye SL. Sex-determination gene SRY potentially associates with poor prognosis but not sex bias in hepatocellular carcinoma. Dig Dis Sci 2015;60:427-35. [PMID: 25274159 DOI: 10.1007/s10620-014-3377-y] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
663 Kato T, Yamada T, Nakamura H, Igarashi A, Anders RA, Sesaki H, Iijima M. The Loss of Nuclear PTEN Increases Tumorigenesis in a Preclinical Mouse Model for Hepatocellular Carcinoma. iScience 2020;23:101548. [PMID: 33083717 DOI: 10.1016/j.isci.2020.101548] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
664 Mauvais-Jarvis F, Klein SL, Levin ER. Estradiol, Progesterone, Immunomodulation, and COVID-19 Outcomes. Endocrinology 2020;161:bqaa127. [PMID: 32730568 DOI: 10.1210/endocr/bqaa127] [Cited by in Crossref: 49] [Cited by in F6Publishing: 38] [Article Influence: 49.0] [Reference Citation Analysis]
665 Kim EJ, Oh HY, Heo H, Hong JE, Jung S, Lee KW, Park JH, Hur C, Park JHY. Biological features of core networks that result from a high-fat diet in hepatic and pulmonary tissues in mammary tumour-bearing, obesity-resistant mice. Br J Nutr 2013;110:241-55. [DOI: 10.1017/s0007114512004965] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
666 Schumacher N, Yan K, Gandraß M, Müller M, Krisp C, Häsler R, Carambia A, Nofer JR, Bernardes JP, Khouja M, Thomsen I, Chalupsky K, Bolik J, Hölscher C, Wunderlich T, Herkel J, Rosenstiel P, Schramm C, Schlüter H, Renné T, Mittrücker HW, Rose-John S, Schmidt-Arras D. Cell-autonomous hepatocyte-specific GP130 signaling is sufficient to trigger a robust innate immune response in mice. J Hepatol 2021;74:407-18. [PMID: 32987028 DOI: 10.1016/j.jhep.2020.09.021] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [